The application of artificial intelligent techniques in oral cancer prognosis based on clinicopathologic and genomic markers / Chang Siow Wee by Chang, Siow Wee
  
THE APPLICATION OF ARTIFICIAL INTELLIGENT 
TECHNIQUES IN ORAL CANCER PROGNOSIS BASED ON 
CLINICOPATHOLOGIC AND GENOMIC MARKERS  
 
 
 
 
 
 
 
 
CHANG SIOW WEE 
 
 
 
 
 
 
 
 
 
 
FACULTY OF COMPUTER SCIENCE &  
INFORMATION TECHNOLOGY 
UNIVERSITY OF MALAYA 
KUALA LUMPUR 
2013 
 
 
  
THE APPLICATION OF ARTIFICIAL INTELLIGENT 
TECHNIQUES IN ORAL CANCER PROGNOSIS BASED ON 
CLINICOPATHOLOGIC AND GENOMIC MARKERS  
 
 
 
 
 
CHANG SIOW WEE 
 
 
 
 
 
 
THESIS SUBMITTED IN FULFILMENT  
OF THE REQUIREMENTS  
FOR THE DEGREE OF DOCTOR OF PHILOSOPHY 
 
 
 
 
FACULTY OF COMPUTER SCIENCE &  
INFORMATION TECHNOLOGY 
UNIVERSITY OF MALAYA 
KUALA LUMPUR 
2013 
 
III 
 
UNIVERSITI MALAYA 
ORIGINAL LITERARY WORK DECLARATION 
 
Name of Candidate: CHANG SIOW WEE                 (I.C/Passport No: 770320-01-6038) 
Registration/Matric No: WHA070024 
Name of Degree: Doctor of Philosophy (PhD) 
Title of Project Paper/Research Report/Dissertation/Thesis (“this Work”): 
THE APPLICATION OF ARTIFICIAL INTELLIGENT TECHNIQUES IN ORAL CANCER 
PROGNOSIS BASED ON CLINICOPATHOLOGIC AND GENOMIC MARKERS 
 
Field of Study: ARTIFICIAL INTELLIGENCE 
 
I do solemnly and sincerely declare that: 
 
(1) I am the sole author/writer of this Work; 
(2) This Work is original; 
(3) Any use of any work in which copyright exists was done by way of fair dealing and for 
permitted purposes and any excerpt or extract from, or reference to or reproduction of any 
copyright work has been disclosed expressly and sufficiently and the title of the Work and its 
authorship have been acknowledged in this Work; 
(4) I do not have any actual knowledge nor do I ought reasonably to know that the making of this 
work constitutes an infringement of any copyright work; 
(5) I hereby assign all and every rights in the copyright to this Work to the University of Malaya 
(“UM”), who henceforth shall be owner of the copyright in this Work and that any 
reproduction or use in any form or by any means whatsoever is prohibited without the written 
consent of UM having been first had and obtained; 
(6) I am fully aware that if in the course of making this Work I have infringed any copyright 
whether intentionally or otherwise, I may be subject to legal action or any other action as 
may be determined by UM. 
 
 
 
 Candidate’s Signature  Date 
 
 
Subscribed and solemnly declared before, 
 
 
 
Witness’s Signature  Date 
 
Name:  
Designation:  
iii 
 
 
ABSTRACT 
Artificial intelligent (AI) techniques are becoming useful as an alternative approach to 
conventional medical diagnosis or prognosis. AI techniques are good for handling noisy 
and incomplete data, and significant results can be attained despite small sample size.  
Various AI techniques have been applied in medical research such as artificial neural 
networks, fuzzy logic, genetic algorithm and other hybrid methods. AI techniques have 
been proved to generate more accurate predictions than statistical methods and the 
predictions are based on the individual patient’s conditions as opposed to the statistical 
methods which made predictions based on a cohort of patients. 
 
Traditionally, clinicians make prognostic decisions based on clinicopathologic markers. 
However, it is not easy for the most skilful clinician to come out with an accurate 
prognosis by using these markers alone. In order to make a more accurate prognosis, 
one needs to include both clinicopathologic markers and genomic markers. Currently, 
there are very few published articles on researches that combine both clinicopathologic 
and genomic data. Thus, there is a need to use both of the clinicopathologic and 
genomic markers to improve the accuracy of cancer prognosis.  
 
In addition, the mortality rate for oral cancer is high (at approximately 50%) and almost 
two-thirds of oral cancer occurs in developing countries such as Asian countries, yet 
there are very few studies using AI techniques in the prognosis of oral cancer. 
Furthermore, there is no Malaysian study yet on the application of AI techniques in the 
prognosis of oral cancer. Therefore, there is a need to investigate how AI techniques can 
be used in the prognosis of oral cancer.  
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The main aim of this research is to apply AI techniques in the prognosis of oral cancer 
based on the parameters of correlation of clinicopathologic and genomic markers. To 
this end, a hybrid AI model, namely ReliefF-GA-ANFIS was proposed. The proposed 
model consists of two stages, where in the first stage, ReliefF-GA is used as feature 
selection method and in the second stage ANFIS with k-fold cross-validation is used as 
classifier. The proposed prognostic model was experimented on the oral cancer dataset 
with optimum feature subsets and validated against three other models which are 
artificial neural networks, support vector machine and logistic regression. The results 
for the proposed model of ReliefF-GA-ANFIS outperformed the other three models and 
the results revealed that the prognosis is superior with the presence of genomic markers.  
  
This research provides an insight to apply AI techniques in oral cancer prognosis based 
on both clinicopathologic and genomic markers. It is hoped that this research is capable 
of setting a basis for embarking more Malaysians in medical informatics research, 
particularly in the field of genomic markers.  
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ABSTRAK 
Teknik pembuatan pintar (AI) semakin berguna sebagai pendekatan alternatif untuk 
diagnosis atau prognosis perubatan konvensional. Teknik AI berguna dalam 
mengendalikan data yang bising dan tidak lengkap, dan keputusan yang signifikan 
boleh dicapai dengan saiz sampel yang kecil. Pelbagai teknik AI yang telah digunakan 
dalam penyelidikan perubatan adalah seperti artificial neural network, fuzzy logic, 
genetic algorithm dan kaedah hibrid yang lain. AI teknik telah terbukti dapat membuat 
ramalan yang lebih tepat daripada kaedah statistik dan ramalan AI adalah berdasarkan 
kepada keadaan-keadaan dalam pesakit individu manakala kaedah statistik pula 
membuat ramalan berdasarkan kepada kohort pesakit. 
 
Secara tradisinya, pakar perubatan membuat keputusan prognosis berdasarkan kepada 
penanda klinikopathologik. Walau bagaimanapun, ia tidak mudah untuk pakar 
perubatan untuk mengeluarkan keputusan prognosis yang tepat dengan menggunakan 
penanda ini sahaja. Oleh yang demikian, terdapat keperluan untuk menggunakan 
penanda genomik untuk meningkatkan ketepatan prognosis. Dalam usaha untuk 
membuat ramalan yang lebih tepat, kedua-dua penanda klinikopathologik dan penanda 
genomik diperlukan. Kini, tidak banyak artikel yang memaparkan penyelidikan yang 
menggabungkan kedua-dua data klinikopathologik dan genomik. Oleh itu, terdapat 
keperluan untuk menggunakan kedua-dua penanda clinicopathologic dan genomik 
untuk meningkatkan ketepatan prognosis kanser. 
 
Tambahan pula, kadar kematian bagi kanser mulut adalah tinggi (pada kira-kira 50%) 
dan hampir dua pertiga daripada kanser mulut berlaku di negara-negara membangun 
seperti negara-negara di Asia. Akan tetapi, hanya terdapat sedikit kajian yang 
menggunakan teknik AI dalam prognosis kanser mulut. Di samping itu, tidak ada kajian 
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di Malaysia yang mengaplikasikan teknik AI dalam prognosis kanser mulut. Oleh itu, 
terdapat keperluan untuk menyiasat bagaimana teknik AI boleh digunakan dalam 
prognosis kanser mulut. 
 
Tujuan utama kajian ini adalah untuk menggunakan teknik-teknik AI dalam prognosis 
kanser mulut berdasarkan kepada parameter korelasi penanda klinikopathologik dan 
genomik. Untuk mencapai matlamat ini, model hibrid AI, iaitu ReliefF-GA-ANFIS 
telah dicadangkan. Model yang dicadangkan ini terdiri daripada dua peringkat, di mana 
peringkat pertama terdiri daripada ReliefF-GA yang digunakan sebagai kaedah 
pemilihan penanda-penanda utama (feature selection) dan peringkat kedua ANFIS 
dengan k-fold cross-validation digunakan sebagai pengelas (classifier). Model yang 
dicadangkan telah diaplikasikan ke atas dataset kanser mulut dengan subset ciri 
optimum dan dibandingkan dengan tiga model yang lain iaitu artificial neural network, 
support vector machine dan logistic regression. Keputusan yang didapati telah 
menunjukkan bahawa model yang dicadangkan iaitu ReliefF-GA-ANFIS adalah lebih 
baik berbanding dengan ketiga-tiga model yang lain dan keputusan juga menunjukkan 
bahawa prognosis yang lebih jitu boleh diperolehi dengan kehadiran penanda genomik.  
 
Penyelidikan ini telah membuktikan potensi yang baik untuk menaplikasikan teknik AI 
dalam prognosis kanser mulut berdasarkan kepada penanda-penanda klinikopathologik 
dan genomik. Maka dengan ini, diharapkan bahawa kajian ini mampu menetapkan asas 
untuk menggalakan lebih ramai rakyat Malaysia terlibat dalam penyelidikan informatik 
perubatan, terutamanya dalam bidang petanda genomik. 
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CHAPTER 1 
 
INTRODUCTION 
 
1.1 Background 
Various artificial intelligent (AI) methods have been applied in the diagnosis or 
prognosis of cancer research such as, artificial neural networks, fuzzy logic, genetic 
algorithm, support vector machine and other hybrid techniques (Baker and Abdul-
Kareem, 2007; Abdul-Kareem et al., 2002; Dom et al., 2007; Futschik et al., 2003; 
Gevaert et al., 2006; Hassan et al., 2010; Kawazu et al., 2003; Li et al., 2007a; Passaro 
et al., 2005; Rao et al. 2011; Saritas et al. 2010; Seker et al., 2003; Thongkam et al., 
2008; Xu et al., 2005; Zhong et al., 2011). From the medical perspective, diagnosis is to 
identify a disease by its signs and symptoms while prognosis is to predict the outcome 
of the disease and the status of the patient, whether the patient can survive or recover 
from the disease or vice versa. Researchers have proved that AI methods could generate 
more accurate diagnosis or prognosis results as compared to traditional statistical 
methods (Dom et al., 2007; Kawazu et al., 2003; Li et al., 2007a; Passaro et al., 2005; 
Rao, et al., 2011; Seker et al., 2003; Thongkam et al., 2008).  
 
Normally, clinical data, pathological data or genomic data/microarray data together with 
socio-demographic data are used in researches either involving diagnosis or that with 
respect to prognosis. Clinical data refers to the signs and symptoms directly observable 
by the physicians, examples are the size of primary lesion, clinical neck node, clinical 
staging, metastasis, and so on. While, pathological data relates to the results obtained 
from the laboratory examination and the parameters are pathological staging, number of 
neck nodes, tumour size and thickness and other post surgical pathologic parameters. In 
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some researches, both clinical and pathological data are used, and are referred as the 
term clinicopathologic data. 
 
On the other hand, genomic marker is the alterations in the DNA that may indicate an 
increased risk of developing a specific disease or disorder (Institute, 2010). A genomic 
marker may be used to see how well the body responds to a treatment for a disease or 
condition (Institute, 2010). Different types of cancers might have different genomic 
markers, the most common genomic marker that is currently being investigated by the 
researchers is p53. 
 
Currently, there are very few published articles on researches that combine both 
clinicopathologic and genomic data. Research has shown that prognosis results are more 
accurate when using both clinicopathologic and genomic data, the examples are 
Futschik et al., (2003) in diffuse large B-cell lymphoma (DLBCL) cancer, Gevaert et al., 
(2006) and Sun et al., (2007) in breast cancer, Exarchos et al. (2011), Oliveira et al., 
(2008), and Passaro et al., (2005) in oral cancer, and Catto et al., (2006) in bladder 
cancer.  
 
Oral cancer starts in the mouth, also called the oral cavity. The oral cavity includes the 
lips, the inside lining of the lips and cheeks (buccal mucosa), the teeth, the gums, the 
front two-thirds of the tongue, the floor of the mouth below the tongue, the bony roof of 
the mouth (hard palate), and the area behind the wisdom teeth (retromolar trigone) 
(Society, 2010).  
 
The mortality rate for oral cancer is high (at approximately 50%) because the cancer is 
usually discovered late in its development. Well known risks associated with this cancer 
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include smoking, alcohol consumption, tobacco use, and betel quid chewing. The World 
Health Organization (WHO) expects a worldwide rise in oral cancer incidence in the 
next few decades due to high smoking prevalence and increasing cases of unhealthy diet. 
Almost two-thirds of oral cancer occurs in developing countries such as African and 
Asian countries, and this geographic variation probably reflects the prevalence of 
specific environmental influences (Oliveira et al., 2008). Besides socio-demographic 
and habits factors, there are still other factors associated with oral cancer such as viral 
infection, genetic factors, diet, and poor oral hygiene (Jefferies and Foulkes, 2001; 
Mehrotra and Yadav, 2006; Oliveira et al., 2008; Reichart, 2001; Sunitha and Gabriel, 
2004).  
 
According to the Malaysian Cancer Statistics, Peninsular Malaysia 2006, oral cancer 
can be divided into five main categories based on the cancer sites, namely, tongue, 
mouth, salivary glands, lip and other sites. In Malaysia, Indians are more susceptible to 
oral cancer and Indian women face the greatest risk, this might be related to their habits 
of betel quid chewing (Omar et al., 2006). Tongue cancer is listed as the sixth top most 
frequent cancer (4.6%) in Indian male (after colorectal cancer, prostate gland cancer, 
lung cancer, stomach cancer and bladder cancer), and mouth cancer is listed as the 
fourth top most frequent cancer (7.3%) in Indian female (after breast cancer, cervix uteri 
cancer and colorectal cancer).  
 
A common problem associated with medical dataset is small sample size. It is time 
consuming and costly to obtain large amount of samples in medical research and the 
samples are usually inconsistent, incomplete or noisy in nature. Moreover, high 
accuracy and reliable estimation is needed in medical diagnosis and prognosis where the 
subsequent decisions have serious consequences on patients. Thus, identifying the high 
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risk diagnostic/prognostic markers will aid the clinicians in improving the accuracy of 
prediction of an individual patient's diagnosis/prognosis. The small sample size problem 
is more visible in the oral cancer research since oral cancer is not one of the top ten 
most common cancers in Malaysia, hence there are not many cases. For example, in 
Peninsular Malaysia, there are only 1,921 new oral cancer cases from 2003 to 2005 
(Gerard et al., 2005) and 592 new oral cancer cases in the year 2006 (Omar et al., 2006) 
as compared to breast cancer, where the incidence between 2003 and 2005 is 12,209 and 
the incidence for 2006 is 3,591. Out of these oral cancer cases, some patients are lost to 
follow-up, some patients seek treatments in other private hospitals and thus, their data 
are not available for this research. Another reason for small sample size is caused by the 
medical confidentiality problems. This can be viewed from two aspects, namely, 
patients and clinicians. Some patients do not wish to reveal any information about their 
diseases to others, and are not willing to donate their tissues for research/educational 
purposes. As for clinicians, some may not want to share patients’ data with others 
especially those from the non-medical fields, while some do not keep their medical 
records in the correct medical form. From those available cases, some patients’ 
clinicopathologic data are incomplete, some tissues are missing due to improper 
management and some are duplicated cases. Due to that, the number of cases that can 
actually be used for this research is very limited.  
 
In this research, an oral cancer prognostic model is developed. This research used real-
world oral cancer dataset which has been collected locally in the Oral Cancer Research 
and Coordinating Centre (OCRCC), Faculty of Dentistry, University of Malaya, 
Malaysia. Clinicopathologic data is available from the OCRCC while the genomic data 
is obtained through the process of immunohistochemistry (IHC) staining on selected 
oral cancer tissues. IHC is a method of localizing the antigens or proteins in cells or 
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tissues by the use of primary antibody as specific reagents through antigen-antibody 
interactions that are visualized by a marker such as fluorescent dye or enzyme. The 
prediction model is designed for small datasets where high accuracy can be achieved 
using only a small sample size. The model takes both clinicopathologic and genomic 
data that have been determined in order to investigate the relationship of each marker or 
combination of markers to the accuracy of the prognosis of oral cancer. 
 
1.2 Problem Statement 
The mortality rate of oral cancer is high yet there are very few studies using AI 
techniques in the prognosis of oral cancer. The application of AI techniques in oral 
cancer susceptibility prediction was done by Arulchinnappan et al. (2011); Dom et al. 
(2007, 2008 & 2010); Passaro et al. (2005) and Baronti & Starita (2007). Screening 
prediction was done by Speight & Hammond (2001). The prediction of lymph nodes 
metastasis in oral cancer was done by Kawazu et al. (2003) and oral cancer diagnosis 
prediction was done by Kent (1996). The prediction of oral cancer reoccurrence was 
done by Exarchos et al. (2011). Furthermore, there is no Malaysian study yet on the 
application of AI techniques in the prognosis of oral cancer. A previous study that 
utilized AI techniques in oral cancer was done by Dom et al. (2007, 2008 & 2010) and it 
was on the susceptibility prediction. Therefore, there is a need to investigate how AI 
techniques can be used in the prognosis of oral cancer. We believe the research will 
result in the development of a tool that is adaptable to the multi-ethnic society in 
Malaysia, and hence, benefit the Malaysian people. 
 
Second, in order to make an accurate prognosis/survival prediction, one needs to 
include both clinicopathologic markers and genomic markers. Currently, many studies 
use only clinicopathologic factors without taking into consideration the tumor biology 
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and molecular information, while some studies use genomic markers or microarray 
information only without the clinicopathologic parameters. Thus, these studies may not 
be able to predict the diagnosis/prognosis of a patient effectively. It has been proven by 
Catto et al., (2006) in bladder cancer, Futschik et al., (2003) in DBLCL cancer, Gevaert 
et al., (2006) and Sun et al., (2007) in breast cancer, Exarchos et al. (2011), Oliveira et 
al., (2008) and Passaro et al., (2005) in oral cancer, Seker et al., (2003) in breast and 
prostate cancer, that prognosis results are more accurate when using both 
clinicopathologic and genomic data. 
 
Third, traditional statistical methods such as Kaplan-Meier method, logistic regression, 
Cox regression and decision trees are usually used in the prediction of cancer survival. 
However, in Dom et al., (2007 & 2008), Jerez et al, (2010), Hayward et al. (2010), 
Kawazu et al., (2003), Li et al., (2007), Lin & Chuang, (2010), Passaro et al., (2005), 
Rao, et al., (2011), Regnier-Coudert et al. (2011), Seker et al., (2000 & 2003), and 
Thongkam et al., (2008) had proved that AI techniques can generate more accurate 
predictions than statistical methods. AI techniques are good for handling noisy and 
incomplete data, and significant results can be attained with small sample size. Thus, 
there is a need to develop an AI model which is able to improve prognosis based on the 
individual patient’s conditions.  
 
1.3  Research Aim 
The main aim for this research is to apply AI techniques in the prognosis of oral cancer 
based on the parameters of the correlation of clinicopathologic and genomic factors. 
This research is highly influenced by the works of Catto et al., (2006) in bladder cancer, 
Futschik et al., (2003) in DBLCL cancer, Gevaert et al., (2006) and Sun et al., (2007) in 
breast cancer, Exarchos et al. (2011), Oliveira et al., (2008) and Passaro et al., (2005) in 
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oral cancer, Seker et al., (2003) in breast and prostate cancer, who have used both 
factors in the prognosis of cancer studies. 
 
Passaro et al., (2005) used AI techniques in the oral cancer susceptibility studies. They 
proposed a hybrid adaptive system inspired from learning classifier system, decision 
trees and statistical hypothesis testing. The algorithm can work with different data types 
and is robust to missing data. The dataset includes both demographic data and 11 types 
of genes. Their results showed that the proposed algorithm outperformed the other 
algorithms of Naive Bayes, C4.5, neural network and XCS (Evolution of Holland’s 
Learning Classifier). However, they validated the algorithm on the Winconsin Breast 
Cancer dataset (WBC), it will be more appropriate if the benchmark dataset is chosen 
from the same type of cancer.  
 
Oliveira et al. (2008) focused on the 5-year overall survival in a group of oral squamous 
cell carcinoma (OSCC) patients and investigated the effects of demographic data, 
clinical data and genomic data, and human papillomavirus on the prognostic outcome. 
They used the statistical method for the prediction and their results showed that the 5-
year overall survival was 28.6% and highlighted the influence of p53 
immunoexpression, age and anatomic localization on OSCC prognosis. In this research, 
no AI methods were used and compared. 
 
Another oral cancer research that was done by Exarchos et al. (2011) was in the oral 
cancer reoccurrence. Bayesian network was used and compared with ANN, SVM, 
decision tree, and random forests. They used multitude of heterogeneous data which 
included clinical, imaging and genomic data. They build a separate classifier for 
different types of data and combined the best performing classification schemes. They 
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claimed that they had achieved an accuracy of 100% with the combinations of all types 
of data and proved that the prediction accuracy is the best when using all types of data. 
However, more than 70 markers are required for their final classifier. 
 
This work differs from that of the researchers named above is that we are working in the 
domain of oral cancer prognosis using AI techniques, which based on our literature 
review, is the first study in Malaysia. Furthermore we tested the system by using data 
collected locally, here in the OCRCC, Faculty of Dentistry, University of Malaya, 
Malaysia. We used the same classifier for both clinicopahologic and genomic data and 
we compared the results generated with and without the inclusion of genomic data. In 
addition, we also compared our results with the results generated by other AI methods 
and statistical method. Lastly, we validated our results with the human experts' (oral 
cancer clinicians) prediction.  
 
Since the mortality rate of oral cancer is high, there is a need to develop a computerized 
tool that can aid clinicians in the decision support stage and to identify the high risk 
markers in order to better predict the survival rate for each oral cancer patient and to 
extend the tool to other cancer/disease prognosis prediction. 
 
1.4 Research Questions 
In this research, we hypothesize that by using feature selection method, neuro-fuzzy and 
cross-validation techniques, we can predict the prognosis/survival of oral cancer more 
accurately with a few promising markers and coupled with the problem of small sample 
size. With this hypothesis, some questions are formulated: 
1. What are the clinicopathologic and genomic markers that are most commonly 
used in the prognosis of oral cancer? 
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2. How to ensure the accuracy of the immunohistochemistry (IHC) staining for 
locating the genomic markers?  
3. Which feature selection method is most suitable for the oral cancer prognosis 
dataset? 
4. What is the optimum number of markers to use in oral cancer prognosis using 
the proposed model? 
5. Is the proposed model more accurate than the traditional statistical methods, and 
other AI methods? 
6. How to evaluate the performance of the proposed model? 
 
1.5 Research Objectives 
The objectives of this study are: 
1. To identify the most common clinicopathologic markers associated with oral 
cancer prognosis. 
2. To analyse the genomic markers from the results of immunohistochemistry (IHC) 
staining.  
3. To determine the optimum subset of markers for oral cancer prognosis using 
feature selection methods. 
4. To develop a prognostic model for oral cancer prognosis using ANFIS 
techniques and to prove that the proposed model is the optimum tool for oral 
cancer prognosis.  
5. To prove that the prognosis of oral cancer is more accurate when both the 
clinicopathologic and genomic markers are considered. 
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1.6 Significance of Study  
Based on our literature review, we found out that this is the first study in Malaysia 
which applies AI techniques in oral cancer prognosis prediction using both 
clinicopathologic and genomic markers. The study is based on real world data, namely, 
the Malaysian oral cancer dataset provided by the OCRCC, Faculty of Dentistry, 
University of Malaya.  
 
As for genomic data, immunohistochemistry staining will be performed on the selected 
oral cancer tissues and the results will be analysed. We believe this is a novel study for 
oral cancer prognosis involving clinicopathologic and genomic data as we indicated in 
our early literature review. 
 
An optimum subset of markers for oral cancer prognosis will be obtained using the 
combination of feature selection method and the classification method. We believe that 
the model with fewer markers will help to predict oral cancer survival with higher 
accuracy and thus to avoid the over-fitting problems. Over-fitting occurs when there are 
too many parameters relative to the number of samples. 
 
1.7 Scope and Limitation 
This research focuses on the identification of optimum markers for oral cancer 
prognosis by using feature selection and AI methods for comparative analysis. There is 
no clinical testing/evaluation involve in this study as the developed model is not ready 
for the use of clinician yet. More tests and experiments are needed to further verify the 
results obtained in this research.  
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This research considers 17 variables which include 15 clinicopathologic variables and 2 
genomic variables. There are a number of genes that can be considered as genomic 
markers in the prognosis of oral cancer as discussed in Chapter 2. Due to time and cost 
limitations, only two genes are chosen based on the recommendations of oral 
pathologists and clinicians as well as the literature. Testing for one particular gene 
involves the cost of the testing materials (i.e. reagent, antibody, etc.), time taken for the 
tests, the efforts and time of the laboratory technician and oral pathologists as discussed 
in Chapter 5. Therefore, other genes will be included in future works and will not be 
considered in this study.  
 
1.8 Thesis Overview 
This thesis is organized as follows:  
• Chapter 1 provides the introduction of the proposed study including the problem 
statement, research aim, research questions, research objectives, significance of 
the study and the scope and limitation of the research. 
• Chapter 2 discusses various AI techniques in medical research, introduction to 
artificial neural network, fuzzy logic, neuro-fuzzy, support vector machine, and 
logistic regression techniques, re-sampling techniques, feature selection 
techniques, and the model mesurements. 
• Chapter 3 discusses the oral cancer, overview of oral cancer in Malaysia, risk 
factors of oral cancer, and clinicopathologic and genomic markers of oral cancer, 
cancer management, and survival analysis.   
• Chapter 4 discusses the general methodology used in this research.  
• Chapter 5 presents a more detailed discussion of methodology concerning on the 
preparations and procedures for acquiring oral cancer prognosis data involving 
both clinicopathologic and genomic data. 
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• Chapter 6 discusses the feature selection methods used in this research in order 
to reduce the number of inputs and to obtain an optimum subset of the markers 
and also discusses the classifier used in this research.  
• Chapter 7 discusses the results, discussions, comparisons and validation of the 
developed model with other AI and statistical models. 
• Chapter 8 concludes the presented works and proposes some future works. 
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CHAPTER 2 
ARTIFICIAL INTELLIGENCE IN CANCER RESEARCH 
 
2.1  Introduction 
There are three important areas in the application of artificial intelligent (AI) techniques 
in cancer prediction which are: the prediction of cancer susceptibility, the prediction of 
cancer recurrence and the prediction of cancer survival. In the cancer susceptibility 
prediction, one is trying to predict the likelihood of developing a type of cancer prior to 
the occurrence of the disease based on the selected risk factors. While in the cancer 
recurrence prediction, one is trying to predict the likelihood of redeveloping cancer after 
treatment and after a period of time in which no cancer could be detected. In the 
prediction of cancer survival, one is trying to predict an outcome after the diagnosis of 
the disease, that is, the chance that a patient will survive or die (Cruz et al., 2006). 
 
Typically, cancer prognosis involve multiple physicians from different specialties using 
different subsets of genomic markers and multiple clinicopathologic factors, including 
the socio-demographic data (age, gender, ethnic) of the patient, risks factors (smoking, 
alcohol drinking, betel quid chewing), the location and type of cancer, size of the 
tumour, metastasis of lymph nodes, staging classification (stage 1 to 4) and types of 
treatment (surgery, radiotherapy, chemotherapy or a combinations of these methods). It 
is not easy for even the most skilful physicians to come up with an accurate and 
reasonable prognosis, and it is not 100% accurate (Fielding et al., 1992; Catto et al., 
2006; Reichart, 2001).  
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Unfortunately these conventional clinicopathologic parameters generally do not provide 
enough information to make robust prognoses. Ideally what is needed is some very 
specific molecular details about either the tumour or the patient’s own genetic make-up 
which are the genomic markers (Colozza et al., 2005). 
 
With the rapid development of genomic (DNA sequencing, microarrays), proteomic 
(protein chips, microarrays, immunohistology) and imaging (CT scan, PET scan, MRI) 
technologies, this kind of molecular-scale information about patients or tumours can 
now be readily acquired. If these molecular patterns are combined with 
clinicopathologic data, the robustness and accuracy of cancer prognoses can be 
improved (Cruz et al., 2006).  
 
The prognostic models are complex tools in the decision making that combine two or 
more items of patient data to predict the clinical outcomes. These models are intended 
to help the clinicians in making difficult clinical decisions such as ordering invasive test 
or choose patients for certain clinical trials. However, most of the published prognostic 
models are rejected by the clinicians due to lack of clinical credibility (no clinical 
testing and evaluation, data reliability and model simplicity) and lack of clinical 
accuracy, evidence and effectiveness (Wyatt & Altman, 1995). A way to improve the 
clinical acceptability of the prognostic models is combining the prognosis generated by 
the model with the doctor's own estimate of prognosis and clinical validation (Goddard 
et al., 2011; Liu et al., 2006; Wyatt & Altman, 1995). 
 
The diagnosis/prognosis models are developed based on the clinical prediction rules. 
The purpose of clinical prediction rules is to reduce the uncertainty inherent in medical 
practice by defining how to use clinical findings to make predictions. The clinical 
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prediction rules derived from the clinical observations done by the clinicians. These 
models can help clinicians identify patients who require diagnostic tests, treatment or to 
predict the survival rate of patients (Wasson et al., 1985). The scientific methods and 
testing procedures of the prediction models were discussed in the state of the art papers 
such as Wasson et al. (1985), Spiegelhalter et al. (1983), and Wyatt & Altman (1995). 
These papers discussed the evaluation and validation of the clinical predictive models 
by using mathematical/statistical techniques. The evaluation of clinical prediction 
models has long been recognized as an important part of the overall field of medical 
computing. However, in this research, we focused on the identification of optimum 
prognosis markers for oral cancer by using feature selection and AI techniques. As this 
is a preliminary study of the research, there is no evaluation/testing/implementation of 
the developed model into clinical use. The purpose of this research is to prove that the 
prognosis is better with both clinicopathologic and genomic data if compared to only 
clinicopathologic data. 
 
There is a growing interest in the application of AI techniques in medical research. This 
is due to the nature of AI approaches that perform well in domains where the sample 
size is small, as opposed to the statistical methods which require a “big enough” sample 
size in order to achieve statistically significant results (Mitchell, 1997). It is hard to get 
a large amount of samples in medical research as it takes a long time and is very costly, 
and the samples are usually either incomplete or noisy. This is where AI techniques are 
needed in making the diagnosis or prognosis more accurate. 
 
Since the introduction of AI to this field, numerous algorithms have been designed and 
applied to medical datasets. Various methods have been applied in either the diagnosis 
or prognosis of cancer such as artificial neural network, Bayesian network, fuzzy logic, 
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support vector machine, genetic algorithm and other hybrid methods. Most of these 
researches compare a new method with the traditional ones, affirming the effectiveness 
and efficiencies of their methods in particular datasets which will be further discussed in 
section 2.2.  
 
2.2  Artificial Intelligent Techniques In Cancer Research  
This section reviews some major artificial intelligent (AI) techniques which have been 
applied in cancer research. Artificial neural network, fuzzy logic, genetic algorithm, and 
Bayesian methods are amongst the most common AI techniques used in cancer research. 
In addition, hybrid methods will be discussed too as these methods are getting more 
attention recently. Most researches focus on breast cancer study (Akay, 2008; 
Bellaachia & Guven, 2006; Delen et al., 2005; Gevaert et al., 2006; Jerez et al. 2011; 
Hassan et al., 2010; Sivaraksa et al., 2008; Seker et al., 2003; Song et al., 2005; Sun et 
al., 2007; Thongkam et al., 2008; Xu et al., 2005), diffuse large B-cell lymphoma 
(DLBCL) (Futschik et al., 2003; Xu et al., 2005), nasopharyngeal carcinoma (Abdul-
Kareem et al., 2002; Baker & Abdul-Kareem, 2007; Wang et al., 2009), bladder cancer 
(Li et al., 2007; Almal et al., 2006; Catto et al., 2006), laryngeal cancer (Jones, 2006), 
prostate cancer (Regnier-Coudert et al., 201;, Seker et al., 2003; Castanho et al., 2008) 
and pancreatic cancer (Hayward et al., 2010). Whereas, the application of AI techniques 
in oral cancer susceptibility and diagnosis was done by Arulchinnappan et al. (2011), 
Dom et al. (2007, 2008 & 2010), Passaro et al. (2005) and Baronti & Starita (2007). 
Oral cancer screening prediction was done by Speight & Hammond (2001). The 
prediction of lymph nodes metastasis in oral cancer was done by Kawazu et al. (2003), 
oral cancer diagnosis prediction by Kent (1996) and the prediction of oral cancer 
reoccurrence was done by Exarchos et al. (2011). 
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Table 2.1: Summary of cancer research using AI techniques 
Type of 
cancer 
Type of 
prediction 
AI 
technique 
Benchmark Improve-
ment (%) 
Training 
data 
Reference 
Breast Diagnosis SVM with 
feature 
selection 
N/A N/A clinical Akay F.M., 
2009 
Breast Prognostic Naïve Bayes, 
ANN, 
Decision tree 
N/A N/A Clinical Bellaachia, 
2006 
Breast Prognostic ANN, 
decision 
trees 
LR 4 Clinical Delen et 
al., 2005 
Breast Prognostic Bayesian 
network 
70 genes No 
significant 
difference 
Clinical 
& 
genomic 
Gevaert et 
al., 2006 
Breast Diagnosis Hybrid 
hidden 
Markov 
model 
(HMM)-
fuzzy 
Denfis, 
SVM, 
NEFCLASS 
Yes Clinical Hassan et 
al., 2010 
Breast  Prognostic MLP, KNN, 
SOM 
Statistical 
methods 
Yes Clinical Jerez et al., 
2011 
Breast  Prognostic ANN N/A N/A Genomic Sivaraksa 
et al., 2008 
Breast Diagnosis ANFIS Different 
feature 
selection 
algorithm 
Yes Clinical Song et al., 
2005 
Breast Prognostic I-RELIEF 70-gene  
Clinical 
20 Clinical 
& 
genomic 
Sun et al., 
2007 
Breast Prognostic AdaBoost Bagging, 
C4.5, C-
SVC, 
Random 
forest 
1 - 4 Clinical Thongkam 
et al., 2008 
Breast Prognostic SVM (GA-
CG-SVM) 
C5.6 
decision 
tree, KNN 
12.5 Genomic Zhong et 
al., (2011) 
Breast & 
Prostate 
Prognostic Fuzzy k-
nearest 
neighbour 
Logistic 
regression, 
ANN 
2 - 16 Clinical Seker et 
al., 2003 
Bladder Prognostic Genetic 
programming 
N/A N/A Genomic Almal et 
al., 2006 
Bladder Prognostic Neuro-fuzzy ANN, LR Yes Clinical 
& 
genomic 
Cotto et al., 
2006 
Bladder Diagnosis ANN (Mega- 
trend-
diffusion) 
ANN, DT 12 - 40 Genomic Li et al., 
2007 
DLBCL Prognostic ANN & 
Bayesian 
network 
Compare 
with single 
predictor 
module 
9-14 Clinical 
& 
genomic 
Futschik et 
al., 2003 
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Type of 
cancer 
Type of 
prediction 
AI 
technique 
Benchmark Improve-
ment (%) 
Training 
data 
Reference 
DLBCL Prognostic Particle 
swarm 
optimization 
(PSO) 
N/A N/A Genomic Xu et al., 
2005 
Laryngeal  Prognostic ANN Cox 
regression 
No, but 
ANN is 
more 
sensitive  
Clinical Jones et al., 
2006 
NPC Prognostic ANN (MLP, 
recurrence) 
Statistical 
methods 
ANN 
performed 
better 
Clinical Abdul-
Kareem et 
al., 2002 
NPC Prognostic Genetic 
algorithm 
N/A N/A Clinical Baker & 
Abdul-
Kareem, 
2007 
NPC, 
Leukaemia, 
colon, 
breast  
Cancer 
classificati
on 
ANN FDA, kNN, 
Bayesian 
network, 
SVM 
Yes Genomic Wang et 
al., 2009 
Oral Susceptibil
ity 
Fuzzy 
correlation 
N/A N/A Clinical Arulchinna
ppan et al., 
2011 
Oral Susceptibil
ity 
Learning 
Classifier, 
decision tree, 
statistical 
methods 
Naïve 
Bayes, 
C4.5, ANN 
6 - 20 Smoking 
& 
genomic 
Baronti & 
Starita, 
2007 
Oral  Susceptibil
ity 
Fuzzy 
regression 
Statistical, 
Logistic 
regression 
No 
significant 
difference 
Clinical 
& 
genomic 
Dom et al., 
2007, 2008 
& 2010 
Oral  Reoccuren
ce 
Bayesian 
network 
ANN, 
SVM, DT, 
random 
forests 
Bayesian 
network 
outperform
ed the 
others 
Clinical, 
genomic 
& 
imaging 
Exarchos et 
al., 2011 
Oral Lymph 
node 
metastasis 
ANN Radiologists 
prediction 
No 
significant 
difference 
Clinical Kawazu et 
al., 2003 
Oral Diagnosis Genetic 
programming 
N/A N/A Clinical Kent, 1996 
Oral Prognostic ANFIS Statistical 
methods 
ANFIS is 
more 
effective 
tool.   
Genomic Muzio et 
al., 2005 
Oral Susceptibil
ity 
XCS 
(evolution of 
Holland’s 
Learning 
Classifier) 
DT 4 - 20 Clinical 
& 
genomic 
Passaro et 
al., 2005 
Oral Screening ANN C4.5 No 
significant 
difference 
Clinical Speight & 
Hammond, 
2001 
Pancreatic Prognostic Bayesian 
network 
DT, LR, 
ANN 
AI 
techniques 
performed 
better than 
statistical 
methods 
Clinical Hayward et 
al., 2010 
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Type of 
cancer 
Type of 
prediction 
AI 
technique 
Benchmark Improve-
ment (%) 
Training 
data 
Reference 
Prostate Diagnosis Fuzzy rule-
based 
N/A N/A Clinical Castanho et 
al., 2008 
Prostate Prognostic Bayesian 
network, 
ANN 
LR Bayesian 
network 
outperform
ed the 
others 
Clinical Regnier-
Coudert et 
al., 2011 
*ANN-Artificial neural network, ANFIS-Adaptive Network Based Fuzzy Inference System, DT-Decision 
Trees, FDA-Fisher Discriminant Analysis, kNN-k-Nearest Neighbour, LR-Logistic Regression, MLP-
Multilayer perceptrons, SVM-Support Vector Machine 
 
2.2.1 Artificial Neural Network  
The use of artificial neural networks (ANNs) in cancer research has vastly proliferated 
during the last few decades. Neural network analysis has been shown to be particularly 
useful in those cases where the problem to be solved is ill defined, and development of 
an algorithmic solution is difficult. This is exactly the situation with cancer data where a 
highly nonlinear, almost brain-like, approach is required.  
 
An ANN is a computational model based on biological neural networks. It consists of 
an interconnected group of artificial neurons and processes information using a 
connectionist approach to computation. An artificial neuron is a computational model 
inspired by biological neurons. Biological neurons receive signals through synapses 
located on the dendrites or membrane of the neuron (Figure 2.1). When the signals 
received are strong enough (surpass a certain threshold), the neuron is activated and 
emits a signal though the axon. This signal might be sent to another synapse, and might 
activate other neurons. In ANN, these basically consist of inputs (like synapses), which 
are multiplied by weights, and then computed by an activation function which 
determines the output of the neuron, as shown in Figure 2.2 (Gerhenson, 2003). 
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Figure 2.1: The biological neuron 
 
 
Figure 2.2: An ANN Model 
 
The architecture of an ANN is concerned with the way the neurons are divided into 
layers in a network. The ANN has at least 2 layers, which are the input layer and the 
output layer. Most neural networks have one or more middle layers known as the hidden 
layer (Abdul-Kareem, 2001).  
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ANN can be divided into two main groups based on the pattern of connections, which 
are feed forward neural networks and recurrent neural networks. In the feed forward 
neural networks, the signal flows from input neuron to output neuron in a forward 
direction. The data processing can extend over multiple layers but there is no feedback 
connection (Abdul-Kareem, 2001). The examples of feed forward neural network are 
single-layer perceptron and multi-layer perceptron (MLP).  An example of an MLP is 
shown as in Figure 2.3.  
 
 
Figure 2.3: An example of MLP 
 
The recurrent neural networks provide feedback connections, so that the networks can 
incorporate context or temporal information. The examples of recurrent neural networks 
are Hopfield network and Elman network. Figure 2.4 shows an example of recurrent 
neural network. Most ANNs are structures using multi-layered feed-forward 
architecture, meaning they have no feedback, or no connections that loop (Cruz and 
Wishart, 2006). The design and structure of an ANN must be customized or optimized 
for each application.  
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Figure 2.4: An example of recurrent neural network 
 
An ANN needs to be trained in order to learn the patterns and change the weights 
according to the rules. The training methods can be categorised into supervised learning 
and unsupervised learning.  In supervised learning, the network is trained by providing 
it with input and output patterns. In unsupervised learning, an output is trained to 
respond to the pattern of inputs. The network discovers the similarity between the inputs, 
and the similar inputs are clustered to the same output (Rios, 2010).  
 
Kawazu et al. (2003) proposed a three-layer feed-forward network with a back-
propagation algorithm in the prediction of lymph node metastasis of patients with oral 
cancer. They constructed numerous different architectures with different number of 
hidden layers and units. The diagnosis was most accurate (= 93.6%) when the network 
consisted of two hidden layers, namely with 6 and 4 units for each layer. Their results 
showed that the network performance was equivalent to the analysis made by 
radiologists and was better than statistical analysis (Quantification theory type II).  
 
Input 
layer 
Hidden 
layer 
Output 
layer 
Context 
layer 
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Another example that utilised ANNs in the prognosis of cancer was done by Abdul-
Kareem et al. (2002) to predict the prognosis of nasopharyngeal carcinoma (NPC). Two 
neural network models were designed i.e. multi-layered feed-forward network and the 
Elman recurrent network. Both networks consisted of 22 hidden nodes in the middle 
layer. Their results showed that the predictive performance of the multi-layered feed-
forward network was better than the recurrent network and statistical method.  
 
2.2.2 Genetic Algorithm 
Genetic algorithms (GA) were formally introduced in the United States in the 1970s by 
John Holland at the University of Michigan. Genetic algorithms are categorized as 
global search heuristics. Genetic algorithms are a particular class of evolutionary 
algorithms (also known as evolutionary computation) that use techniques inspired by 
evolutionary biology such as inheritance, mutation, selection, and crossover.  
 
The algorithm starts with a set of solutions (represented by chromosomes) called the 
population. Solutions from one population are taken and used to form a new population. 
This is motivated by a hope, that the new population will be better than the old one. 
Solutions that form new offsprings are selected according to their fitness - the more 
suitable they are the more chances they have to reproduce. This is repeated until some 
condition (for example the number of populations or improvement of the best solution) 
is satisfied (Obitko, 1998). 
 
Pappalardo et al. (2006) proposed the use of genetic algorithm to find out effective 
therapies for protecting virtual mice from mammary carcinoma. An accurate model of 
the immune system responses to vaccination was developed and in silico experiments 
consisting of a large population of individual mice were performed. The genetic 
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algorithm model was used as a fitness evaluator to find a schedule which controlled the 
growth of cancer cells by a minimal number of vaccine injections. Their results showed 
that the genetic algorithm model found complete immunoprevention with a much lighter 
vaccination schedule, and the number of injections was roughly one third of those used 
in conventional schedules (Chronic).  
 
Baker et al. (2007) used genetic algorithm (GA) in the prognosis of nasopharygeal 
carcinoma (NPC). Two models were developed i.e. GA with algebraic rule-based 
classifier and GA with a hybrid function. The survival time was provided to the nearest 
one year, up to ten years. A series of sub-classifiers were generated to predict a specific 
time range for one-year interval-based classifier, and then chained together to operate in 
unison and resolved efficiently the prognosis outcome for a given patient.  
 
2.2.3 Fuzzy Logic 
The concept of Fuzzy Logic (FL) was conceived by Lotfi Zadeh, a professor at the 
University of California at Berkley. Fuzzy logic is a form of multi-valued logic derived 
from the fuzzy set theory to deal with reasoning that is approximate rather than precise. 
Fuzzy logic is used in system control and analysis design, because it shortens the time 
for engineering development and sometimes, in the case of highly complex systems, is 
the only way to solve the problem (Jang, 1993).  
 
Fuzzy logic starts with the concept of a fuzzy set. A fuzzy set is a set without a crisp, 
clearly defined boundary. It can contain elements with only a partial degree of 
membership. A membership function is a curve that defines how each point in the input 
space is mapped to a membership value (or degree of membership) between 0 and 1. 
Fuzzy logic models, called fuzzy inference systems (FIS), consist of a number of 
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conditional "if-then" rules, membership functions and logical operations. There are two 
types of fuzzy models namely the Mamdani model and the Takagi-Sugeno model. 
Mamdani's fuzzy inference method is the most commonly seen fuzzy methodology. The 
output membership functions of Mamdani’s model are fuzzy sets. The main difference 
between Mamdani and Takagi-Sugeno is that the output membersip functions of 
Takagi-Sugeno's model are either linear or constant (Kaehler, 1993).  
 
Fuentes-Uriarte et al. (2008) presented two fuzzy logic methods for breast cancer 
diagnosis namely, fuzzy clustering with the Fuzzy C-Means (FCM) algorithm and fuzzy 
inference system (FIS). They applied their algorithms to the Winsconsin Breast Cancer 
Diagnosis (WBCD) database. The FCM was used to find the similarities between 
different variables while the FIS was implemented with a genetic algorithm for creating 
and activating the optimal rules. Their simulated results showed that the FCM 
performed better by classifying 99.3% of the data in WBCD correctly as compared to 
80.136% in FIS.   
 
Dom et al. (2008) proposed a fuzzy regression model for the prediction of oral cancer 
susceptibility. The prediction of oral cancer susceptibility as a function of demographic 
profiles (age, gender, ethnicity), risk habits (smoking, alcohol drinking, tobacco 
chewing) and genetic markers (GSTM, GSTT1) were done using statistical logistic 
regression and fuzzy regression models. The models were tested on a sample of 84 oral 
cancer patients and 87 controls data. The results show that there was no significant 
difference in the prediction performance of fuzzy regression model (AUC = 0.888) and 
the logistic regression model (AUC = 0.851). Thus, it is feasible to use fuzzy regression 
model for oral cancer susceptibility studies.   
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Another example that utilised fuzzy logic in cancer research was done by Seker et al. 
(2000). They developed a model for breast cancer prognosis by using fuzzy k-nearest 
neighbour algorithm (FK-NN). The dataset consisting of 100 cases with seven inputs 
and two outputs were predicted, namely, nodal involvement assessment and 5-year 
survival analysis. Their highest accuracy for nodal involvement assessment was 78% for 
the three-marker subset and survival analysis was 88% for the five-marker subset. They 
claimed that fewer inputs were sufficient to yield more accurate results if compared to 
all inputs. 
 
2.2.4 Bayesian Network 
A Bayesian network is a probabilistic graphical model that represents a set of variables 
and their probabilistic independencies. For example, a Bayesian network could 
represent the probabilistic relationships between diseases and symptoms. Given 
symptoms, the network can be used to compute the probabilities of the presence of 
various diseases. 
 
Bayesian networks are directed acyclic graphs, where the nodes represent the variables 
and the edges represent the conditional independencies between the variables. Bayesian 
networks that model sequences of variables are called dynamic Bayesian networks 
(Sebastiani et al., 2003).  
 
An example of a research that utilized Bayesian networks in cancer research was done 
by Gevaert et al. (2006). They predicted the prognosis of breast cancer by integrating 
clinicopathologic and microarray data with Bayesian networks. The main advantage of 
this model was that the model was able to integrate these data sources in several ways 
and aided in the investigation and understanding of the structure and parameters of the 
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model. Their results showed that the partial integration method was the most promising 
method and the integrated use of clinicopathologic and microarray data outperformed 
the indices based on clinicopathologic data and has comparable performance with the 70 
genes prognosis profile.  
 
2.2.5 Support Vector Machine (SVM) 
Support vector machine (SVM) is a supervised learning algorithm that can be used for 
classification or regression problems. The SVM was developed by Corinna Cortes and 
Professor Vladimir Vapnik in 1995 (Cortes & Vapnik 1995). SVM performs the 
classification by constructing an N-dimensional hyperplane that optimally separates the 
data into two categories.  An example of a 2-dimensional hyperplane is shown in Figure 
2.5. 
 
 
 
 
 
 
Figure 2.5: An example of a 2-dimensional hyperplane 
 
When given a training set of (xi , yi), i = 1, ......., l  where xi ∈ Rn, the optimization 
solution for the support vector machine is as below: 
   min,,   
   +  ∑ 
     (2.1) 
   subject to  yi (w
T ∅(xi) + b) ≥ 1 -  ,   ≥ 0  
    w - Orthogonal vector 
    b - Bias ,  - slack variables 
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The training vector xi are mapped into a higher dimensional space by the function ∅. 
SVM finds a linear separating hyperplane with the maximal margin in this higher 
dimensional space. C > 0 is the penalty parameter of the error term (Chih-Wei, H. et al., 
2010).  
 
The K(xi , xj) ≡ ∅(xi)T ∅(xj) is the kernel function, there are four basic kernel functions 
used in the SVM, which are (Chih-Wei, H. et al., 2010):  
i. linear: K(xi , xj) =    
ii. polynomial: K(xi , xj) = ( + r)d ,  > 0 
iii. radial basis function (RBF): K(xi , xj) = exp(−|| xi − xj ||2),  > 0 
iv. sigmoid: K(xi , xj) = tanh( + r) 
 
2.2.5.1 LIBSVM 
LIBSVM is a SVM tool for classification, regression and distribution estimation. It was 
first released in the year 2000, the current version is version 3.11. Currently, LIBSVM 
is one of the most widely used SVM software, and it has been used in many areas such 
as computer vision, bioinformatics and natural language processings. LIBSVM supports 
the following learning tasks (Chih-Chung, C. & Chih-Jen, L., 2011): 
1) Support vector classification (SVC) for two-class and multi-class 
2) Support vector regression (SVR) 
3) One-class SVM 
 
There are 2 steps involve in the LIBSVM, which are, (1) the dataset is trained to obtain 
a model and (2) the model is used to predict the information for the testing dataset. For 
the SVC and SVR, can also output probability estimates (Chih-Chung, C. & Chih-Jen, 
L., 2011). 
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 2.2.6 Hybrid Artificial Intelligent Methods 
Currently, there are an increasing number of researchers (Cotto, 2006; Dom, 2007; 
Futshik, 2003; Hassan, 2010; Muzio, 2005; Zhong, 2011) that use hybrid artificial 
intelligent methods. A hybrid method involves the use of a combination of two or more 
artificial intelligent techniques for example fuzzy neural networks, genetic fuzzy system, 
fuzzy Bayesian system, evolutional neural networks and etc.  
 
Futshik et al. (2003) proposed a hybrid prognostic model for outcome prediction of 
diffuse large B-cell lymphoma (DLBCL) using the integration of microarray data and 
clinical parameters. They constructed separate modules for microarray and clinical data. 
The Bayesian classifier was used for clinical data and the fuzzy neural network 
classifier was used for genomic data. A prediction accuracy of 87.5% was achieved. 
Their study demonstrated that the integration of microarray data with clinical data 
improves disease outcome prediction.  
 
Muzio et al. (2005) evaluated the relationship between the expression of three cell cycle 
markers (surviving, MIB-1 and PCNA) and human papillomavirus (HPV) infection in 
oral cancer by using fuzzy neural networks (FNN) namely, ANFIS and traditional 
statistics. Their findings showed that the FNN is able to differentiate cell cycle pattern 
for HPV-positive vs. HPV-negative in oral cancer and HPV may have a protective role 
in the expression level of survival; especially in tobacco smokers. 
 
2.3 Neuro-Fuzzy Systems 
Neuro-fuzzy refers to the combination of artificial neural networks (ANN) and fuzzy 
logic. Fuzzy systems lack in their learning ability; they are not robust to the topological 
changes of the system, and require a priori rules and the disadvantages of ANN are, 
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high computational cost is required to minimize the over-fitting problems, difficulty in 
justifying the relations between the input and output variables which are the black box 
problem, and large sample size. The neuro-fuzzy systems solve the black box problem 
in neural network and the prior knowledge essential problem in fuzzy logic, and it 
provides the learning ability to the systems.  
 
Fuzzy systems can be categorized into two families. The first includes linguistic models 
based on collections of IF-THEN rules, whose antecedents and consequents utilize 
fuzzy values. It uses fuzzy reasoning and the system behaviour can be described in 
natural terms. The Mamdani model is one example of this group. The knowledge is 
represented as: 
 : If 
 is 
  and  is   ··· and  is  ,  
then      is         (2.2) 
where, 
                            (i=1,2, ···, l) – ith fuzzy rule 
                            (j=1,2 ···,n) - input 
                            - output of the fuzzy rule  
                           
 ,  , ···,  ,  (i=1,2, ···,l) - fuzzy membership functions  
 
The second category, based on the Takagi-Sugeno type systems, uses a rule structure 
that has fuzzy antecedent and functional consequent parts, 
 : If 
 is 
  and  is   ··· and  is   
then    = !"  + !
 
 + ··· + !       (2.3) 
 
Chapter 2- AI In Cancer Research 
 
 
31 
If one needs a more precise solution, then the Takagi-Sugeno-type is the choice, 
otherwise, the Mamdani-type maybe more suitable (Mitra & Hayashi, 2000). In medical 
research, accuracy is an important criterion when making a diagnosis or a prognosis, 
thus the Takagi-Sugeno type is more suitable. 
 
There are two ways in which neuro-fuzzy hybridization could be done. First, a neural 
network is equipped with the capability of fuzzy information i.e. fuzzy neural network 
and second, a fuzzy system augmented by neural networks to enhance some of its 
characteristics like flexibility, speed, and adaptability i.e. neuro-fuzzy system (Mitra & 
Hayashi, 2000).   
 
There are different types of neuro-fuzzy systems presented in the literature, for example, 
NEFCON (Nauck & Kruse, 1993), NEFCLASS (Nauck & Kruse, 1995), ANFIS (Jang, 
1993 & 1996), GARIC (Berenji, 1992), and FALCON (Lin & Lee, 1991). NEFCLASS 
and NEFCON (Nauck & Kruse, 1993 & 1995) use a generic fuzzy perceptron to model 
Mamdani-type neuro-fuzzy systems, thus they are not concentrating on generating the 
exact solution. Both methods use reinforcement learning rather than the supervised 
learning. GARIC (Berenji, 1992) uses a differentiable soft minimum function to 
implement a fuzzy controller. It has a self-tuning ability in the fuzzy logic controller and 
it utilises the reinforcement learning as well. FALCON’s (Lin & Lee, 1991) learning 
ability is based on the use of the Kohonen learning rule and supervised learning 
algorithm. There is no refinement of rules after the Kohenen learning using back-
propagation method.  
 
In this research, we focused on ANFIS (Jang, 1993 & 1996) as ANFIS implements a 
Sugeno-type fuzzy system and uses the back-propagation method to learn the 
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antecedent membership functions. The details about ANFIS are further discussed in the 
section 2.3.1. 
 
2.3.1 ANFIS 
ANFIS stands for Adaptive Neuro-Fuzzy Inference System. ANFIS was first proposed 
by Jyh-Shing Roger Jang from the Department of Computer Science, National Tsing 
Hua University, Hsinchu, Taiwan. ANFIS implements the Takagi-Sugeno fuzzy 
inference system. Consider a first order Sugeno fuzzy inference system which contains 
two rules (Jang, 1993 & 1996): 
 
  Rule 1: If X is A1 and Y is B1, then f1 = p1x + q1y + r1 
  Rule 2: If X is A2 and Y is B2, then f2 = p2x + q2y + r2 
 
The corresponding fuzzy reasoning mechanism is shown in Figure 2.6, where the firing 
strength w is the rule weight of all membership functions and output f is the weighted 
average of each rule’s output.  Figure 2.7 shows the architecture for ANFIS. All the 
nodes in the same layer will perform the same type of functions.  
 
Figure 2.6: First order Takagi-Sugeno fuzzy model 
 
 
W1 
W2 
f1 = p1x + q1y + r1 
f2 = p2x + q2y + r2 
# =  %&'&(%)')%&(%)   
=   *1f1 + *2f2 
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Figure 2.7: An example of ANFIS architecture 
 
ANFIS architecture has five layers, and the functions for each layer are described as 
below:  
Layer 1: Each node in this layer generates a membership function for each input 
variables. 
    +  
 = ,Ai (x) = 

 ( -./0121 -  )31
   ,  +  
 = ,Bi ( y) = 

 ( -4/0121 -  )31
  (2.4) 
   x, y - Inputs to node i;  
 Ai, Bi - Linguistic labels to this node;  
{ai, bi, ci} - Premise parameters that will change the shapes of membership 
functions.  
 
Layer 2: Each node in this layer calculates the firing strength, w, for a rule: 
    +   = wi = ,Ai (x) ,Bi (y), i = 1, 2.       (2.5) 
 
Layer 3: Normalises the rule strength:  
                 +  5 = * =  1&() , i =1, 2.       (2.6) 
 
Layer 1 Layer 2 Layer 3 Layer 4 Layer 5 
X 
A1 w1 
A2 
*1f1 
F ∑ 
B1 
B2 
w2 *2 *2f2 Y 
*1 
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Layer 4: Computes the consequents of the rules toward the overall output: 
                 +  6 =  *fi = *( pix + qi+y + ri),       (2.7) 
{pi, qi, ri} - Consequent parameters. 
 
Layer 5: Computes the overall output as the summation of contribution from each rule: 
    +  8  = overall output = ∑ *9 fi =  ∑ 11 '1 ∑ 11      (2.8) 
 
ANFIS uses backpropagation gradient learning to calculate the error signals (squared 
error) from the output layer backward to the input nodes, and uses the least mean square 
method to determine the consequents parameters.  
 
2.3.2 Advantages and Limitations of ANFIS 
The advantages of ANFIS are, fast convergence due to hybrid learning, it can construct 
good input membership functions and is suitable for small sample size. Whereas, the 
limitations of ANFIS are, it has only a single output, no rule-sharing is allowed, each 
rule has a unity weight and only is allowed for feed forward type networks. Another 
limitation of ANFIS is that it cannot cater for systems with too many inputs, as 
overfitting will occur due to too many rules are being generated. 
 
2.4 Statistical Methods 
Traditionally, statistical methods are usually used to estimate diagnosis and prognosis. 
Some of the most common statistical methods are logistic regression, t-test, Chi-Square 
test, ANOVA, linear regression, and correlation.  
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2.4.1 Logistic Regression 
Logistic regression (LR) is the most commonly used statistical method for the 
prediction of diagnosis and prognosis in medical research. LR is the prediction of a 
relationship between the response variable y and the input variables xi. Basically, there 
are two types of logistic regression, namely, simple logistic regression and multiple 
logistic regression. 
 
2.4.1.1 Simple Logistic Regression 
In the simple logistic regression, there is only 1 response variable y and 1 input variable 
x.  It is a straight-line relationship between the response variable y and the input variable 
x. The expression of simple logistic regression is given by: 
  y = α + βx        (2.9) 
The parameters of α and β are unknown and have to estimate from the data (Ross, 2010).  
 
2.4.1.2 Multiple Logistic Regression 
The multiple logistic regression is used when there is more than 1 input variables. The 
multiple logistic regression model supposes that the response y is related to the input 
values xi, i = 1, 2, ...., k, through the relationship: 
 y = βo + β1x1 + β2x2 +......+ βkxk  +  e             (2.10) 
 
In which, βo, β1, .... βk  are regression parameters which are unknown and must be 
estimated from the dataset and e is an error random variable that has mean 0 (Ross, 
2010).  
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2.5 Re-sampling Techniques 
Re-sampling methods are becoming increasingly popular as they are very robust, simple, 
and the computing intensive is no longer an issue with high computational power 
nowadays. Re-sampling is the method used to draw repeated samples from the original 
data sample. The section below describes four major types of re-sampling techniques, 
namely, permutation test, cross-validation, Jackknife, and bootstrapping.  
 
2.5.1 Permutation Test 
A permutation test is a test procedure in which data are randomly re-assigned so that an 
exact p-value is calculated based on the permutated data. A typical problem involves 
testing the hypothesis that two or more samples might belong to the same population. 
The permutation test proceeds as follows (Good, 2004): 
(i) Combine the observations from all the samples  
(ii) Shuffle them and redistribute them as re-samples of the same sizes as the 
original samples. 
(iii)Record the statistic of interest (the outcome of a statistic test that you are looking 
for, for example mean, variance, standard deviation, mean square error, p-value 
and so on). 
(iv) Repeat (ii) and (iii) for many times  
(v) Determine how often the re-sampled statistic of interest is as extreme as the 
observed value of the same statistic.  
 
2.5.2 Cross-validation 
In cross-validation, a sample is randomly divided into two or more subsets and test 
results are validated by comparing across sub-samples. Cross-validation technique is the 
world-wide acceptance technique to overcome the problem of small sample size (Braga-
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Neto & Dougherty, 2004; Fu et al., 2005; Molinaro et al., 2005). The most common 
types of cross-validation are k-fold cross-validation and leave-one-out cross-validation. 
In k-fold cross-validation, the data is divided into k subsets of equal size, train the data 
for k times (the folds), each time leaving out a single subset for validation data. 10-fold 
cross-validation is the commonly used methods. If k equals to the sample size, this is 
called leave-one-out cross-validation (Sarle, 2010).  
 
Cross-validation suffers from the same weakness as spilt-half reliability when the 
sample size is small. By dividing the sample into two halves, each analysis is limited by 
a smaller number of observations (Yu, 2003).  
 
2.5.3 Jackknife 
In Jackknife, the same test is repeated by leaving one subject out each time. It is used in 
statistical inferencing to estimate the bias and standard error in a statistic, when a 
random sample of observations is used to calculate it, but this process is more 
complicated than leave-one-out cross-validation (Sarle, 2010). 
 
2.5.4  Bootstrapping 
The re-sampling strategy of Bootstrap is more thorough in terms of the magnitude of 
replication if compared with Jackknife. In Jackknife, the number of re-samples is 
confined by the number of observations (n-1). However, in bootstrap, the original 
sample could be duplicated as many times as the computing resources allow, and then 
this expanded sample is treated as a virtual population. Then samples are drawn from 
this population to verify the estimators. Obviously the "source" for re-sampling in 
bootstrap could be much larger than that in the other two (Siow-Wee et al., 2010; Yu, 
2003).  
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In addition, unlike cross-validation and Jackknife, the bootstrap employs sampling with 
replacement. Indeed, sampling with replacement in a bootstrap is more accurate than 
sampling without replacement in terms of simulating chance. Further, in cross-
validation and Jackknife, the n in the subsample is smaller than that in the original 
sample, but in bootstrap every resample has the same number of observations as the 
original sample. Thus, the bootstrap method has the advantage of modelling the impacts 
of the actual sample size (Yu, 2003). For estimating generalization error in classification 
problems, the 0.632+bootstrap is one of the methods that has the advantage of 
performing well even when there is severe over-fitting (Sarle, 2010).  
 
2.6 Introduction to Feature Selection 
Feature selection is used to select the inputs which are most significant in the modelling 
process, in order to produce more accurate outputs. The purpose of feature selection is 
to reduce the number of inputs in the modelling process, but retain the accuracy of the 
outputs if compared to the full-input model. Thus, this can have a good predictive and 
less computationally intensive model. This is important especially in medical research 
where fewer inputs means lower test and diagnosis/prognosis costs.  
 
Feature selection can be classified into three main groups, which are filter, wrapper and 
embedded methods. Filter methods rank the variables by some chosen criterion, and 
select the variables with the highest criteria. This method, however, is independent of 
any algorithm. The examples of filter selection are Pearson's correlation coefficient, 
linear discriminant analysis (LDA), independent component analysis (ICA) and Relief-F 
method.  
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Wrapper methods evaluate the variables in subsets and use the heuristic search methods 
for an optimal subset. The embedded method is built into a classifier to search for a 
subset and it is specific to the learning algorithm (Saeys et al., 2007, Song et al., 2005). 
Genetic algorithm is one example of the wrapper approach.  
 
There are various feature selection techniques. For example, in Song et al. (2005)’s 
study, a couple of feature selection methods i.e. genetic algorithm, decision tree and 
correlation coefficient computation are proposed with ANFIS and Adaboost in order to 
reduce the computational overhead and enhance the system performance. Their results 
showed that ANFIS with the feature selection system performed better than the ANFIS 
full-input system with ANFIS-decision tree achieving the highest positive predicted 
value (97.95%).  
 
Zhang et al. (2007) proposed principal component analysis (PCA) as a feature selection 
tool for clinical pattern recognition analysis for thyroid cancer and cervical cancer. The 
PCA was applied on the multiple layer perceptron artificial neural networks (MLP 
ANN). They proved that the accuracy rate of the MLP ANN based on PCA input 
selector was improved if compared to the leave-one-out cross-validation method. They 
claimed that they achieved 100% classification rate with the proposed method. 
 
Sun et al. (2007) proposed a new feature selection algorithm named as I-RELIEF. I-
RELIEF combines the advantages of both filter and wrapper methods. It approximates 
the leave-one-out accuracy of a nearest-neighbour classifier, thus, it addresses the issues 
of feature correlation and the removal of redundant features. It is used to identify a 
hybrid signature through the combination of both genetic and clinical markers. The 
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results showed that the hybrid signature model outperformed other models for breast 
cancer prognosis.  
 
2.6.1 Genetic Algorithm (GA) 
The GA has been discussed in section 2.2.2.  In the feature selection problem the main 
interest is in representing the space of all possible subsets of the given feature set. Then, 
the simplest form of representation is the binary representation where, each feature in 
the candidate feature set is considered as a binary gene and each individual consists of a 
fixed-length binary string representing some subset of the given feature set. Generally, 
there are seven steps involved in the GA feature selection method, which are: 
 
(i) Solution Encoding 
In the feature subset selection problem, a solution is a specific feature subset that can be 
encoded as a string of n binary digits (bits). Each feature is represented by binary digits 
of 1 or 0. If a bit is equal to 1, the feature is selected; consequently, if a bit is equal to 0, 
the feature is not selected (Marinakis et al. 2009). 
 
(ii) Initial population 
The initial population is generated randomly to select a subset of variables (solutions). 
For the feature selection problems, the variables selected must be different. If the 
variables are all different, the subset is included in the initial population. If not, it 
generates again until an initial population with desired size has been created. 
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(iii) Fitness function 
The fitness function will determine which solutions can precede to the next generation. 
The fitness function will make the assessment and return a fitness value for a solution. 
Only the solutions with good/highest fitness value will be accepted.  
 
(iv) Selection 
Selection is a process to select the parent chromosome from the population to produce 
the next generation. There are many types of selection, some examples are listed as 
below (MathWorks, 2010; NeuroDimension, 2011): 
• Roulette wheel - A selection operator in which the probability of being selected 
for a chromosome is directly proportionate to the fitness. This is the most 
common type of selection. 
• Tournament - A selection operator which uses roulette wheel selection for N 
times in order to produce a tournament subset of chromosomes. The number of 
N is specified by the user. 
• Top Percent - A selection operator which randomly selects a chromosome from 
the top N percent of the population. The number of N is specified by the user. 
• Best - This operator selects the best chromosome as determined by the fitness. 
• Random - This operator selects the chromosome randomly. 
 
(v) Crossover 
The crossover function is used to combine two chromosomes and produce an offspring. 
The most common types of crossover are (MathWorks, 2010; NeuroDimension, 2011): 
• One-point - A crossover that randomly selects a point within a chromosome, 
followed by interchanging the two parent chromosomes to produce two new 
offsping. 
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• Two-point - A crossover that randomly selects two points within a chromosome, 
followed by interchanging the two parent chromosomes to produce two new 
offsping. 
• Scattered - A crossover that creates a random binary vector to select the 
chromosomes. When the vector is 1, it selects from the first parent, and when the 
vector is 0, it selects from the second parent, and these combine to form the 
offspring. 
• Arithmetic - A crossover that creates children that are the weighted arithmetic 
mean of two parents. 
• Heuristics - A crossover operator that uses the fitness values of the two parent 
chromosomes to determine the direction of the search.  
 
 (vi) Mutation 
Mutation functions specify how the genetic algorithm makes small random changes in 
the chromosomes to create mutated children. The types of mutation include 
(MathWorks, 2010; NeuroDimension, 2011): 
• Uniform - A mutation that replaces the value of a chosen gene with a uniform 
random value selected between the user-specified upper and lower bounds for 
that gene. 
• Non-uniform - A mutation that increases the probability so that the amount of 
the mutation will be close to 0 as the generation number increases. 
• Gaussian - A mutation that adds a random Gaussian distribution value to the 
chosen gene.  
• Flip bit - A mutation that inverts the value of the chosen gene (0 becomes 1 and 
1 becomes 0).  
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(vii) Stopping criteria 
The stopping criteria is used to determine when to stop the GA when to stop. The 
algorithm stops as soon as any of the stopping criteria is met. The examples of some 
common stopping criteria are, number of generations, time limit, and fitness limit. 
 
2.6.2 Pearson's Correlation Coefficient  
Pearson’s correlation coefficient, r, is used to see if the values of two variables are 
associated. It measures the strength and the direction of a linear relationship between 
two variables. It was developed by Karl Pearson and is sometimes referred to as 
Pearson's product moment correlation coefficient. The mathematical formula for 
computing r between two variables of x and y, with n sample size, is denoted as (Rosner, 
2006): 
 
:;< =  ∑ ;<= ∑ ; ∑ <> ∑ ;)=(∑ ;)) @ ∑ <)=(∑ <))               (2.11) 
 
The correlation coefficient is a number between -1 and 1.  The + and – signs are used 
for positive linear correlations and negative linear correlations, respectively. A positive 
correlation indicates a direct relationship, and a negative correlation indicates an inverse 
relationship between two variables. If there is no relationship between the predicted 
values and the actual values, the correlation coefficient is 0 or very low.  Thus, the 
higher the correlation coefficient, the better the input variable is. 
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2.6.3 Relief-F 
Relief-F is the extension to the original Relief algorithm, in which it is able to deal with 
noisy and incomplete datasets and deal with multi-class problems. Figure 2.8 shows the 
pseudo-code for the Relief-F algorithm. The key idea of Relief is to estimate attributes 
according to how well their values distinguish among instances that are near to each 
other. For that purpose, Relief-F will find the k nearest neighbours from the same class 
(nearest hit, Hj) and the k nearest neighbours from the different class (nearest miss, 
Mj(c)). It updates the quality estimation W[A] for all attributes A depending on their 
values for Ri, Hj, and Mj(c). If instances Ri and Hi have different values of the attribute A 
then the attribute A separates two instances with the same class in which W[A] will 
decrease. Whereas, if instances Ri and M have different values of the attribute A, then 
the attribute A separates two instances with different class values and W[A] will increase 
and the contribution of all the hits and all the misses are averaged. The contribution for 
each class of the misses is weighted with the prior probability of that class P(C) 
(estimated from the training set).  
 
To ensure the contributions of hits and misses in each step to be in [0,1] and also 
symmetric, the misses’ probability weights is sum to 1. As the class of hits is missing in 
the sum, each probability weight is divided with factor 1-P(class(Ri)) (sum of 
probabilities for the misses’ classes). The process is repeated for m times (Kononenko, 
1994).  
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Figure 2.8: Pseudo-code for the Relief-F algorithm (Kononenko, 1994) 
 
The estimated weight, W[A] for attribute A is an approximation of the following 
difference of probabilities as shown below (Kononenko, 1994): 
 Wx  = P (different value of A|different class) 
         −P (different value of A|same class)        (2.12) 
The rationale is that good attribute should differentiate between instances from different 
classes and should have the same value for instances from the same class. 
 
2.7 Model Performance Measurements  
Several performance measures have been used to evaluate and validate the performance 
of the proposed model. The measures are accuracy, sensitivity, specificity, and receiver 
operating characteristic (ROC) curve. The true classification performance of the model 
is defined as the area under the ROC curve (AUC) (Dom et al., 2008).  
 
A person with positive condition (alive) who is predicted as alive is termed a true 
positive (TP), whereas a person with positive condition (alive) who is predicted as 
Input: for each training instance a vector of attribute values and the class value 
Output: the vector W of estimations of the qualities of attributes 
 
set all weights W[A] := 0.0; 
for i := 1 to m do begin 
  randomly select an instance Ri; 
  find k nearest hits Hj; 
  for each class C ≠ class(Ri) do 
   from class C find k nearest misses Mj(C); 
  for A := 1 to a do 
 W[A] :=W[A] - ∑ BC##(, , D)/(F ∙ H)I
  
 
  ∑ [ K(L)
=K(MNOO(P1))LQMNOO(P1) ∑ BC##(,  , R())]/(F ∙ H)I
 ; 
end; 
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negative is termed a false negative (FN). On the other hand, a person with negative 
condition (dead) who is predicted as positive is termed as false positive (FP), while a 
person with negative condition (dead) who is predicted as negative is termed as true 
negative (TN). Table 2.2 shows the above confusion matrix for Oral Cancer Prognosis.  
 
Sensitivity is the true positive conditions divided by all the living patients. This is the 
probability that a patient will be classified as alive when he is alive. 
Sensitivity = 
TUTU(VW x 100%            (2.13) 
 
Table 2.2: Confusion Matrix for Oral Cancer Prognosis 
   
                       Actual conditions 
 
 
  
Alive (Positive) 
 
Dead (Negative) 
 
Predicted 
outcomes 
 
Alive (Positive) 
 
True positive (TP) 
 
False positive (FP) 
 
Dead (Negative) 
 
False negative (FN) 
 
True negative (TN) 
 
The specificity is the true negative conditions divided by all the dead patients. This is 
the probability that a patient will be classified as dead when he is dead.  
 
Specificity =  
TWTW(VU x 100%              (2.14) 
1-specificity is the probability that a patient will be classified as alive when he is dead. 
 
Accuracy is the proportion of true results in the samples, the higher the accuracy, the 
better the model is.  
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Accuracy = 
TW(TUTU(TW(VU(VW x 100%            (2.15) 
 
A theoretical, optimal prediction can achieve 100% sensitivity (i.e. predict all people 
from the surviving group as alive) and 100% specificity (i.e. not predict anyone from 
the dead group as alive). Positive predictive value is the proportion of patients with 
positive results (surviving) who are correctly classified as having survived and negative 
predictive value is the proportion of patients with negative results (dead) who are 
correctly classified as having dead.  
 
The ROC curve is a plot of sensitivity versus (1 - specificity) for different test results. 
To generate the ROC curve it is first necessary to determine the sensitivity and 
specificity for each test result. The X-axis (1-specificity) ranges from 0 to 1, or 0% to 
100% and is the false positive rate. The Y-axis (sensitivity) ranges from 0 to 1, or 0% to 
100% and is the true positive rate. The endpoints of the curve will run to these points 
and an area of the resulting trapezoids can therefore be calculated. The larger the area 
under the curve the better is the prediction (Adbul-Kareem, 2001). The area calculated 
under the ROC curve is termed as the area under curve (AUC).  
 
An ideal test will have an AUC of 1 because it achieves both 100% sensitivity and 100% 
specificity. A good prognostic test is one that has small false positive and false negative 
rates across a reasonable range of cut off values (Dom, 2008). Table 2.3 shows the 
formulae for the measures.  
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Table 2.3: Formulae for measures  
 
Accuracy (%) = 
TW(TUTU(TW(VU(VW  x 100% 
 
Sensitivity = 
TUTU(VW  x 100% 
 
Specificity = 
TWTW(VU  x 100% 
 
Positive Predictive Value (PPV) = 
TUTU(VU x 100% 
 
Negative Predictive Value (NPV) = 
TWTW(VW x 100% 
 
ROC curve: plot (1 - Specificity) vs. Sensitivity 
 
AUC: Area under ROC curve 
 
2.8 Summary 
This literature review gives an overview on the application of AI techniques in cancer 
research, a brief discussion on the artificial neural network, genetic algorithm, fuzzy 
logic, Bayesian networks, support vector machine and hybrid AI techniques, and a 
detail explanation on the neuro-fuzzy techniques, especially on the ANFIS technique. 
Statistical method of logistic regression has also been discussed. In addition, the major 
types of re-sampling techniques and feature selection methods are also discussed. Lastly, 
the performance measurements used in medical research to assess the proposed model 
are discussed. 
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CHAPTER 3 
ORAL CANCER 
 
3.1 Definition of Oral Cancer 
Oral cancer is part of a cancer group called the head and neck cancers, and is defined as 
an uncontrollable growth of cancerous cells that invades the mouth (oral cavity) and the 
part of the throat behind the mouth (oropharynx). There are two types of oral cancer, 
oral cavity cancer and oropharyngeal cancer:  
 
(i)  Oral cavity cancer 
The oral cavity includes the followings: 
− The front two thirds of the tongue. 
− The gingiva (gums). 
− The buccal mucosa (the lining of the inside of the cheeks). 
− The floor (bottom) of the mouth under the tongue. 
− The hard palate (the roof of the mouth). 
− The retromolar trigone (the small area behind the wisdom teeth).  
(Institute, 2009) 
 
(ii)  Oropharyngeal cancer   
The cancer that starts in the oropharynx, which includes the soft palates (the back of the 
mouth), the base of the tongue, uvula (The small piece of soft tissue that dangling down 
from the soft palate at the back of the tongue), and tonsils (one of two small masses of 
lymphoid tissue located on either side of the throat) (Morrow, 2007).  
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Around two-thirds of the oral cancers are found in the mouth, while one-third are found 
in the pharynx (Morrow, 2007). Our study is based on the oral cavity cancer only.   
 
There are two types of tumors: benign and malignant. Benign tumors refer to non-
cancerous mass or growth which are not life threatening, because benign tumors do not 
spread and damage adjacent tissues, structures, and organs. Generally, benign tumors 
can be removed, and they usually do not grow back. Malignant tumors refer to the 
cancerous mass or growth which can invade and destroy adjacent tissues and organs 
inside the body causing death. Malignant tumors often can be removed, but sometimes 
they metastasize (Institute, 2009).  
 
More than 90% of oral cancers are squamous cell in origin and are called squamous cell 
carcinomas (SCC). The squamous cells are the thin, flat cells that line the lips and oral 
cavity. Cancer cells may spread into deeper tissue as the cancer grows. Oral SCC may 
develop in areas of leukoplakia which are predominantly white patch that cannot be 
categorized (National Cancer Institute, 2004). A variant of SCC is the verrucous 
carcinoma. This is a low-grade cancer that rarely metastasises, and has a good prognosis. 
This type of oral cancer is common among patients that chew tobacco or use snuff. It 
represents less than 5 percent of all diagnosed oral cancers world widely (Morrow, 
2007).  
 
3.2 Oral Cancer Statistics 
According to the Malaysian Cancer Statistics, Peninsular Malaysia, 2006, tongue cancer 
is listed as the sixth top most cancer (4.6%) in Indian male, and mouth cancer is listed 
as fourth top most cancer (7.3%) in Indian female (Omar, 2006). In Malaysia, Indians 
are more susceptible to oral cancer and Indian women face the greatest risk, this might 
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be related to their oral habits of betel quid chewing. Although oral cancer is not listed as 
the top ten most occurring cancer in Malaysia, the high mortality rate related to this 
cancer has resulted in the need to improve its survival rate.  
 
There are over 400,000 new oral cancer cases reported worldwide each year. The 
incident rate of oral cancer differs from region to region. The annual age-adjusted 
incident rates per 100 000 in several European countries vary from 2.0 (UK, south 
Thames Region) to 9.4 in France. In the Americas the incident rates vary from 4.4 (Cali, 
Colombia) to 13.4 in Canada. In Asia, it ranges from 1.6 (Japan) to 13.5 (India). In 
Australia and New Zealand, it varies from 2.6 (New Zealand - Maori) to 7.5 in South 
Australia (Sunitha & Gabriel, 2004).  
 
The death rate associated with this cancer is particularly high not because it is hard to 
discover or diagnose, but because the cancer is routinely discovered late in its 
development. Oral cancer is particularly dangerous because in its early stages it may not 
be noticed by the patient, as it can frequently prosper without producing pain or 
symptoms that might readily be recognized, and because it has a high risk of producing 
second, primary tumors. This means that a patient who survives a first encounter with 
the disease, has up to 20 times the risk of developing a second cancer. This heightened 
risk factor can last for 5 to 10 years after the first occurrence. There are several types of 
oral cancers, but, around 90% are squamous cell carcinomas (Foundation, 2010).  
 
Oral cancers have an 80 to 90 % survival rate if diagnosed early (Foundation, 2010). 
Unfortunately at this time, the majority of oral cancer is found as late stage cancers, and 
this account for the very high death rate of about 50% at five years from diagnosis. 
According to the statistics from the World Health Organization (WHO), almost two-
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thirds of oral cancers occur in developing countries and it expects a worldwide rise in 
oral cancer incidence in the next few decades (Oliveira et al., 2008). Thus, it is 
important to have an accurate survival prediction tool in order to find out the best 
prognosis methods for individual oral cancer patients.  
 
3.3  Risks Factors of Oral Cancer  
Oral cancer has a relatively low incidence but is potentially very serious if not identified 
early. Thus, identifying the risk factors associated with oral cancer is very important in 
the early diagnosis of a patient. There are various factors which have been identified as 
risks to oral cancer. This include age, gender & ethnicity, smoking, tobacco & betel 
quid chewing, alcohol consumption, diet, virus infection, specific genes, and oral 
hygiene (Jefferies & Foulkes, 2001; Mehrotra & Yadav, 2006; Reichart, 2001; Sunitha 
& Gabriel, 2004).  
 
3.3.1 Age, Gender and Ethnicity  
Studies (Oliveira et al., 2008; Chen et al., 2007; Razak et al., 2010) have shown that the 
incidence of oral cancer increases with age. In Western countries, 98% of oral cancer 
cases occur in individuals over 40 years of age (Reichart, 2001). From a gender 
perspective, for decades this has been a cancer which affected 6 men for every woman. 
That ratio has now become 2 men to each woman (Foundation, 2010). In Malaysia, 
Indians are more susceptible to oral cancer and Indian women face the greatest risk, this 
might be related to their oral habits of betel quid chewing. According to Figure 3.1, 
adapted from the Malaysian Cancer Statistics, Peninsular Malaysia 2006, tongue cancer 
is listed as the sixth top most cancer (4.6%) in Indian male, and mouth cancer is listed 
as the fourth top most cancer (7.3%) in Indian female.  
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(a) Indian Male 
 
 
 
(b) Indian Female 
 
Figure 3.1: Ten Most Frequent Cancers in Indians, Peninsular Malaysia 2006 
* Modified from Malaysia Cancer Statistics, Peninsular Malaysia 2006 
 
In Malaysia, the oral cancer incident rate is the highest (71.6%) for individual above 50 
years old. Tongue cancer has the highest incidence rate when compared to cancers in 
other parts of the mouth. Table 3.1 shows the oral cancer frequency by age, gender and 
site for Peninsular Malaysia 2006. 
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Table 3.1: Oral Cancer Frequency by age, gender and site for  
Peninsular Malaysia 2006 
 
Sites 
Tongue Mouth 
Salivary 
Glands Lip Others Total 
Gender Age No. % No. % No. % No. % No. % No. % 
Male 0-14 2 0.3 0 0.0 1 0.2 0 0.0 0 0.0 3 0.5 
  15-49 27 4.6 12 2.0 31 5.2 3 0.5 3 0.5 76 12.8 
  50-69 63 10.6 28 4.7 24 4.1 2 0.3 6 1.0 123 20.8 
  >70 32 5.4 23 3.9 9 1.5 3 0.5 3 0.5 70 11.8 
Female  0-14 1 0.2 0 0.0 2 0.3 0 0.0 1 0.2 4 0.7 
  15-49 24 4.1 12 2.0 42 7.1 5 0.8 2 0.3 85 14.4 
  50-69 43 7.3 72 12.2 25 4.2 9 1.5 6 1.0 155 26.2 
  >70 18 3.0 43 7.3 8 1.4 6 1.0 1 0.2 76 12.8 
  Total 210 35.5 190 32.1 142 24.0 28 4.7 22 3.7 592 100.0 
 
Almost two-third of oral cancers occurred in developing countries, especially in South 
East Asia, India, and Taiwan. This geographical variation probably reflects the 
prevalence of specific environmental influences such as the traditional oral habits in 
these countries like betel quid chewing and tobacco smoking. Also, oral cancer occurs 
twice as often in the black population as in whites, and survival statistics for blacks over 
five years are also poorer at 33%, versus 55% for whites (Foundation, 2010). This might 
be related to the lifestyle choices among different ethnics.  
 
3.3.2  Tobacco, Smoking, Betel Quid Chewing 
Tobacco use account for most oral cancer. About 95% of cases of oral and pharyngeal 
cancer in the United States have been attributed to smoking (Reichart, 2001). Smoking 
cigarettes, cigars, or pipes; using chewing tobacco; and dipping snuff are all linked to 
oral cancer. The most common form of tobacco use is cigarette smoking which 
demonstrates a very high relative risk for oral cancer. The mortality risk for oral cancer 
in cigarette smokers is substantially greater than that observed among lifelong "never 
smokers." Although estimates vary, most studies have reported mortality ratios for 
smokers versus non-smokers of about 28:5, with several reporting ratios in excess of 
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10:1. Furthermore, the risk for death from oral cancer is consumption related; the more 
cigarettes consumed daily and the more years one has smoked, the greater the risk 
(Foundation, 2010). 
 
There are many different preparations of smokeless tobacco i.e. moist or dry snuff, 
chewing tobacco and etc. In South and South East Asia, smokeless tobacco 
encompasses betel quid, and many others like nass, naswar, khaini, mawa, mishri, and 
gudakhu. In Northern Africa chewing habits of shammah are also prevalent. In India, 
betel quid chewing and pan masala are popular habits among Indians and this had led to 
major health problems of oral cancer (Reichart, 2001). 
 
The preliminary results from the Malaysian Oral Cancer Database and Tissue Bank 
System (MCDTBS) indicated that among 156 oral cancer patients, the risk habits that 
was most commonly practiced was betel quid chewing (59.9%), followed by smoking 
(36.1%) and alcohol consumption (35.2%) (Mustafa et al., 2007).  
 
3.3.3 Alcohol Consumption 
Alcohol is the second most important risk factor of oral cancer. All three forms of 
alcohol (beer, hard liquor, and wine) have been associated with oral cancer, although 
hard liquor and beer have a higher associated risk. Studies that found alcohol use to be a 
factor for oral carcinogenesis have usually concluded that the level of consumption was 
important, the more you consume the higher the risk. The risk increased by 6 to 15 
times compared to non-smokers and non-drinkers if the person both drinks alcohol and 
uses tobacco (Reichart, 2001). 
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3.3.4 Diet 
Diet plays an important role in the prevention of oral cancer. Previous studies (Reichart, 
2001; Sunitha & Gabriel, 2004) have shown that a healthy diet may protect an 
individual from cancer. Increasing the intake of fibre-rich food, vegetables, fruits, and 
vitamin C can help to reduce the risk of cancer. Dietary deficiencies may cause 
epithelial atrophy, which renders the epithelium vulnerable to the action of carcinogens. 
 
A study done by the MCDTBS in comparing oral cancer patients against healthy, non-
cancer patients found that frequent intake of vegetables were higher among those who 
did not have cancer (83%) as opposed to those who have (70%).  The scenario was also 
the same for fruits consumption where it was found that more non-cancer patients 
frequently consumed fruits (50.9%) as compared to cancer patients (45%). It was 
thought that the high antioxidant content in these types of foods is responsible for the 
reduction in risk (Tan et al., 2005). 
 
3.3.5 Virus Infection 
The role of oncogenic viruses in certain human cancers is well known. Viruses are 
believed to induce cancers by altering the DNA and the chromosomal structures of the 
cells and by inducing proliferative changes of the cells. The Human papilloma viruses 
(HPV) types HPV16 and 18 which are well known for their oncogenic potential in 
cervix cancer, are also present in 80% of oral squamous cell carcinomas (Reichart 2001). 
In Bouda et al.’s (2000) study, HPV 16, 18 & 33 were detected in oral precancer and 
cancer, but not in normal oral mucosa. According to Saunders Comprehensive 
Veterinary Dictionary, precancer is the precancerous condition that tends to become 
malignant but does not necessarily do so (Blood & Studdert, 2007). 
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HPV E6 protein is known to bind to and inactivate the p53 tumour suppressor gene, 
possibly allowing chromosomal instability and subsequent neoplastic growth. HPV-16 
has also been shown to produce obviously dysplastic epithelial cells in differentiating 
tissue cultures, which are otherwise sterile. HPV-31, HPV-33 and HPV-35 have also 
been associated with oral precancers and cancers. HPVs are found in up to 10% of 
normal oral mucosa (mucous membrane that covers all structures inside the oral cavity 
except the teeth), 15-42% of leukoplakias (white patches in the oral cavity), and in 50% 
of erythroplakias (red patches in the oral cavity) and in 50-100% of oral squamous cell 
carcinomas. The prognostic significance of HPV presence in oral precancers is yet to be 
determined by large follow up investigations. Survival from oral carcinoma does not 
appear to be associated with the presence or lack of HPV (Sunitha & Gabriel, 2004).  
 
3.3.6 Specific Genes 
A number of oncogenes and tumor suppressor genes have been identified by previous 
studies associated with oral cancer (Anantharaman et al., 2007; Chen et al., 2007; 
Hamid et al., 2008; Jefferies & Foulkes, 2001; Mehrotra & Yadav, 2006; Oliveira et al., 
2008; Reichart, 2001). The tumor suppressor genes most frequently altered in 
carcinomas of the upper aerodigestive tract is the p53 gene, located on chromosome 17p. 
p53 mutation or over-expression has been demonstrated in 43% - 93% of cases of oral 
carcinoma cells than in any other human cancer. Its occurrence in oral dysplasia (pre-
cancerous condition) and microscopically normal mucosa adjacent to head and neck 
carcinomas suggest that its alteration is an event, which occurs early in carcinogenesis 
(Sunitha & Gabriel, 2004). Another possible tumour suppressor gene is the p63. Some 
studies have suggested a better prognosis for tumours with p63 immunoexpression 
(Oliveira et al., 2008). 
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Cheng et al.'s (1999) study demonstrated a significantly elevated risk of disease in 
patients with GSTM1 and GSTT1 null genotypes (odds ratio of 3.67%; 95% CI: 1.94-
6.84).  The study by Anantharaman et al. (2007) showed that the GSTM1 null genotype 
is a risk factor in oral cancer among Indian tobacco habits but GSTT1 null genotype 
emerged as a protective factor. A study by Marques et al. (2006) suggested that the 
NAT2 polymorphism, alone or combined with GSTM3, may modulate susceptibility to 
oral cancer in Rio de Janeiro. 
 
3.4 Clinicopathologic and Genomic Markers 
There are two types of markers that can be used for the prognosis of cancer, these are, 
namely, clinicopathologic markers and genomic markers. Traditionally, 
clinicopathologic markers are used by the clinicians to determine the best prognosis 
approach for the individual patient. It is not easy for the most skilful clinician to come 
out with an accurate prognosis by using clinicopathologic factors alone. Thus, there is a 
need to use genomic markers or biomarkers to improve the accuracy of the prognosis.  
 
Tumor markers, such as oncogene and tumour suppressor mutations, have been 
investigated to determine the relationship of such molecular alterations to 
clinicopathologic outcome. The development of such markers would allow treatment to 
be more properly tailored to the individual tumour. To date, however, there is no 
specific marker which has been identified that correlates with a specific cancer or 
response to treatment. 
 
3.4.1  Clinicopathologic Markers of Oral Cancer 
The clinical staging of oral cancer is of paramount importance as it helps the clinician to 
plan treatment, to evaluate various treatment modalities and to make international 
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comparisons on various aspects of this disease. The system of staging suggested has 
three parameters (UICC, 1974): T, the extent of the primary tumour; N, the condition of 
regional lymph nodes; and M, the absence or presence of distant metastasis. Two more 
parameters - S, site and P, pathology of tumour have been added subsequently. Site 
refers to the primary site of the cancer which includes tongue (excluding base of tongue), 
floor of mouth, upper gingiva, lower gingival, lips, and cheeks. The lesion evolution 
time, recurrences, and histological classification are also checked.  
 
Beside clinical factors, socio-demographic factors also need to be considered in the 
prognosis of oral cancer. The social demographic factors include age of the patient at 
the time of diagnosis, gender, ethnicity, risk habits (smoking, alcohol intake, tobacco 
and betel quid chewing), and family history of cancer.  
 
The pathological data relates to the results obtained from the laboratory examination 
and the parameters are pathological staging, number of neck nodes, tumour size and 
thickness and other post surgical pathologic parameters. The clinical factors, socio-
demographic factors and pathological factors are combined to become the 
clinicopathologic markers of oral cancer. 
 
3.4.2  Genomic Markers of Oral Cancer 
The main problem with the TNM system is that it does not take the tumour biology and 
molecular characteristics into consideration, thus, it may not predict patient outcomes 
accurately (Oliveira et al., 2008). Cancer occurs through multiple steps, each 
characterized by the sequential stimulation of additional genetic defects, followed by 
clonal expansion (Mehrotra & Yadav, 2006). The best way to identify genetic changes 
to oral cancer is to compare between the progressing and non-progressing oral lesions, 
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in which the progressing lesions are genetically different from those non-progressing 
lesions (Mehrotra & Yadav, 2006). 
 
The genetic alterations observed in oral cancer are mainly due to oncogene activation 
and tumour suppressor gene inactivation, leading to de-regulation of cell proliferation 
and death and polymorphisms in some carcinogen metabolizing enzyme genes. These 
genetic alterations include gene amplification and overexpression of oncogenes such as 
myc, erbB-2, Epidermal Growth Factor Receptor (EGFR), cyclin D1 and mutations, 
deletions and hypermethylation leading to p16, p53 and p63 tumour suppressor gene 
inactivation (Mehrotra & Yadav, 2006). Polymorphisms occur most in the GSTM1, 
GSTT1, GSTP1, CYP1A1, NAT1 and NAT2 genes.  
p53 is the most frequently associated marker in the head and neck cancers (Mehrota & 
Yadav, 2006; Oliveira, 2008). p53 is called the “Guardian of the genome”, having a role 
in maintaining genomic stability, cell cycle progression, cellular differentiation, DNA 
repair and apoptosis. Apoptosis is a programmed cell death process, which refers to the 
death of a cell resulting from a normal series of genetically programmed events, when a 
cell is no longer needed (Editors, 2010). Due to its high catabolic rate, it is not usually 
possible to demonstrate p53 protein in normal tissues using immunohistochemistry 
procedures, whereas mutated p53 exhibits a much lower catabolic rate and accumulates 
in the cells (Mehrota & Yadav, 2006).  
In addition, p63 gene, a homolog (homologous protein) of the p53 is located in 
chromosome 3q21-29, and its amplification has been associated with prognostic 
outcome in oral cancer (Thurfjell et al., 2005; Muzio et al., 2007). The p63 gene is 
highly expressed in the basal (deepest layer of the epidermis) or progenitor (stem cells) 
layers of many epithelial tissues (the cellular covering of internal and external body 
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surfaces). p63 shows remarkable structural similarity to p53 in the exon/intron 
organization (NCBI, 2010). 
Genetic alterations involving the tumor suppressor genes p16 and p53, are frequently 
observed in the head and neck tumours. Genetic abnormalities inactivating the p16 gene 
might confer cell growth defects, contributing to the tumorigenic process. p53 is 
important in maintaining genomic stability, cell cycle progression, cellular 
differentiation, DNA repair and apoptosis (programmed cell death). The study done by 
Oliveira et al. (2008) indicated that the p53 immunoexpression, age, and primary 
anatomic localization are important survival factors for oral squamous cell carcinoma.  
 
Over expression of the EGFR and Transforming growth Factor (TGF) has been found 
to be associated with oral squamous cell carcinomas (Mehrotra & Yadav, 2006). The 
study done by Teri et al. (2002) observed that frequent overexpression of apoptosis 
regulators p53, bcl-2 and bax, was observed in oral cancers and in a subset of oral 
lesions by immunohistochemistry. This indicated that evasion of apotosis via abnormal 
expression of bcl-2, bclxL, MCL-1 and p53 may contribute to oral cancer pathogenesis 
(Mehrotra & Yadav, 2006).   
 
3.4.3  Current Research that Used Clinicopathologic and Genomic Markers 
Most current researches (Baker and Abdul-Kareem, 2007; Abdul-Kareem et al., 2002; 
Hassan et al., 2010; Kawazu et al., 2003; Li et al., 2007a; Rao et al. 2011; Saritas et al. 
2010; Thongkam et al., 2008; Xu et al., 2005; Zhong et al., 2011) use clinicopathologic 
markers or genomic markers/microarray for the diagnosis or prognosis of oral cancer. 
There is very little published work that utilizes both clinicopathologic and genomic 
markers either for prognosis or diagnosis. However, the results from the works that 
combined both of the clinicopathologic and genomic markers (Catto et al., 2006; 
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Exarchos et al., 2011; Futschik et al., 2003; Gevaert et al., 2006; Oliveira et al., 2008; 
Passaro et al.,2005; Seker et al., 2003; Sun et al., 2007) have confirmed that the 
prognosis of cancer is more accurate when using both clinicopathologic and genomic 
markers. 
 
Oliveira et al. (2008) focused on the 5-year overall survival in a group of oral squamous 
cell carcinoma (OSCC) patients and investigated the effects of age, gender, anatomic 
localization, tumor evolution time, smoking and alcohol intake, nodal status, tumor 
recurrences, histologic classification, p53 and p63 immunoexpression, human 
papillomavirus, DNA presence, and treatment on the prognostic outcome. The survival 
curves were generated using the Kaplan-Meier method, and univariate and multivariate 
analyses were done using the log rank test and Cox regression. Their results showed that 
the 5-year overall survival was 28.6% and highlighted the influence of p53 
immunoexpression, age and anatomic localization on OCSS prognosis. Oliveira’s 
statistical method can better predict the outcome of OSCC patients with this specific 
subset of clinicopathologic variables.  
 
Another research that applied both clinical and genomic data is the application of a 
learning classifier system into the head and neck squamous cell carcinoma (HNSCC). 
The system was proposed by Passaro et al. (2005) and further enhanced by Baronti et al. 
(2007). The system named as Hypothesis testing with Classifier Systems (HCS), is a 
hybrid adaptive system inspired from learning classifier system, decision trees and 
statistical hypothesis testing. The algorithm can work with different data types and is 
robust to missing data. The HNSCC dataset that was used comprised of demographic 
data (age, gender, smoke and alcohol) and 9 genes involved with carcinogen-
metabolizing (CCND1, NQ01, EPHX1, CYP2A6, CYP2D6T, CYP2E1, NAT1, NAT2, 
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GSTP1) and 2 genes in DNA repair systems (OGG1, XPD). Passaro et al. applied the 
proposed algorithm in the HNSCC dataset and the Winconsin Breast Cancer dataset 
(WBC) and compared their results with Naive Bayes, C4.5, neural network and XCS 
(Evolution of Holland’s Learning Classifier). The results showed that the proposed 
algorithm outperformed the other algorithms in the HNSCC dataset. On the benchmark 
WBC dataset, all the tested algorithms had comparable results. Passaro et al.'s long-term 
goal is to identify the genes that are actually involved in the susceptibility to oral cancer.  
However, it will be more appropriate if the benchmark dataset is chosen from the same 
type of cancer.  
 
Dom et al. (2007) proposed a fuzzy regression model for the prediction of oral cancer 
susceptibility. The prediction tool is based on demographic data (age, gender, ethnicity), 
risk habits (smoking, alcohol drinking, tobacco chewing) and genetic markers (GSTM, 
GSTT1). The model was tested on a sample of 84 oral cancer patients and 87 control 
data. The results show that the highest prediction set consists of key markers of chewing 
habits, ethnic group, age, and alcohol drinking.  
 
Another study that utilised both clinical and genetic markers was carried out by Sun et 
al. (2006) to improve breast cancer prognosis. Sun et al. used both clinical (tumour 
grade, angio-invation) and genetic markers (AL080059, CEGP1 & PRAME). The 
dataset used was the van’t Veer breast cancer dataset. The dataset consists of 70-gene 
prognostic signature. A computational algorithm, I-RELIEF, was used to identify a 
hybrid signature through the combination of both genetic and clinical markers. I-
RELIEF is the first feature selection algorithm that utilizes the performance of a 
nonlinear classifier when searching for informative features and can be implemented 
efficiently through optimization and numerical analysis techniques, instead of 
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combinatorial searching. The results showed that the hybrid model outperformed those 
using the clinical markers or genetic markers alone. This proved that combination 
markers are more accurate in the prognosis of breast cancer.  
 
3.5 Immunohistochemistry Staining 
Immunohistochemistry (IHC) is a method for demonstrating the presence and location 
of proteins in tissue sections. This is very useful for assessing the progression and 
treatment of diseases such as cancer. In general, the information gained from IHC 
combined with microscopy literally provides a “big picture” that can help make sense of 
data obtained using other methods (Abcam, 2010).  
 
IHC staining is accomplished with antibodies that recognize the target protein. Since 
antibodies are highly specific, the antibody will bind only to the protein of interest in the 
tissue section. The antibody-antigen interaction can be visualized using two techniques, 
namely, chromogenic detection or fluorescent detection. In chromogenic detection, the 
enzyme will be conjugated to the antibody and cleaves a substrate to produce a coloured 
precipitate at the location of the protein. Meanwhile, for the fluorescent detection, a 
fluorophore is conjugated to the antibody and can be visualised using fluorescence 
microscopy (Abcam, 2010). In this research, we are using the chromogenic detection.  
 
3.6 Management of Cancer 
3.6.1 Diagnosis 
Cancer management can be classified into diagnosis, prognosis and follow-up. 
Diagnosis is the process of identifying a cancer from its signs and symptoms, which is 
done through a series of medical check-up by the physicians, which may include 
laboratory tests (urine test, blood test), imaging procedures (X-rays, CT scan, 
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ultrasound), and biopsy. In most cases, physicians need to do a biopsy to make a 
diagnosis of cancer. Normally, a sample tissue will be taken with a needle/endoscope or 
through a surgery, and it is sent to the pathologists for examination under a microscope. 
Upon confirmation of cancer, the patient will undergo the treatment prognosis 
procedures (Foundation, 2010). 
 
3.6.2 Treatment  
Cancer can be treated by using surgery, radiotherapy or chemotherapy. The choice of 
treatment depends on the type of cancer, stage of the cancer, location and grade of the 
tumour, as well as patient's age and general health.  
 
(i)  Surgery 
Surgery is the most common treatment for cancer patients. Normally, surgery is 
performed on less invasive tumours which tries to preserve the normal oral 
cavity and function. When a tumour is localized, a surgery may be able to 
remove the entire tumour, however, if the cancer has metastasized to other sites, 
complete surgical excision is quite impossible. Surgery can be used in 
conjunction with radiotherapy or chemotherapy as treatment for the cancer 
patients (Foundation, 2010).  
 
(ii)  Radiotherapy 
Radiotherapy is the treatment of cancer using ionizing radiation. Ionizing 
radiation destroys both healthy and cancer cells in the area being treated by 
damaging the DNA in those cells, making it impossible to continue growing. 
However, healthy cells are able to self-repair back to normal function. 
Radiotherapy is suitable to use for the treatment of localized tumours (oral 
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cancer) and also to treat those blood-forming and lymphatic cancers (leukimia 
and lymphoma cancer) (Foundation, 2010).  
 
(iii) Chemotherapy 
Chemotherapy is the treatment of cancer by using drugs/chemicals to destroy 
cells. The drugs/chemicals used in chemotherapy are targeted to all rapidly 
diving cells, both healthy and cancer cells, but healthy cells usually can self-
repair themselves. Chemotherapy is good in treating widespread cancer, which is 
cancer with more than one location in the body.  
 
3.6.3 Prognosis 
Prognosis is a prediction of the outcome of a disease and the survival status of the 
patient, either in the absence of presence of treatment. Most physicians predict 
prognosis based on several clinical factors, such as, type of cancer, stage of disease at 
diagnosis, age of patient at diagnosis, treatment type, general health of the patient and 
so on.  
 
Normally, a 5-year survival rate will be used to measure the survival rate of the cancer 
over a 5-year period of time. Survival rate for 5-year means a patient can survive or not 
after 5 years of diagnosis (Abdul-Kareem, 2001). In this research, the survival rate of up 
to 3-year was used; this is due to lack of survival information for the 5-year survival rate.  
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3.6.3.1 Follow Up / Survival Analysis 
Cancer survival analysis involves studying the length of time a cancer patient lives after 
a treatment or after the onset of a disease. It involves studying the time from diagnosis 
until the event occurs, usually death. The survival time can be measured in years, 
months, weeks, or days from the beginning of follow-up until an event occurs. While, 
the event can be death, disease incidence, relapse from remission, recovery or any 
designated experience of interest that may happen to an individual (Kleninbaum, 1995). 
It is important to state what the event is and when the period of observation starts and 
finishes (Clark, 2003).  
 
3.6.3.2   Censored Data 
The specific difficulty relating to survival analysis in cancer is that, is arises from the 
fact that different patients cannot be observed for the same length of time. This may be 
due to the fact that some patients are diagnosed at the beginning of the period under 
study; some near the end and others may be diagnosed at any other time of the study 
period. In survival analysis terminology, patients who are observed until they reach the 
end point (e.g. death) are called uncensored cases while those who survive beyond the 
end, but the exact survival time is unknown are called censored cases (Chap, 1997, 
Kareem, 2001). 
 
There are generally three reasons why censoring may occur: 
(1) A person does not experience the event by the time the study ends; 
(2) A person is lost to follow-up during the study period; 
(3) A person withdraws from the study because of other reasons or experiences a 
different event that makes further follow-up impossible.  
 
Chapter 3- Oral Cancer 
 
68 
When the actual survival time of a patient is beyond the end of the study time, or lost to 
follow-up or is withdrawn, the type of censoring is referred to as right-censoring.  In 
Figure 3.2, patients A, C, D and E are examples of right censoring. 
 
 
 
 
 
 
 
 
Figure 3.2: Right Censoring 
Left censoring is when an event occurs before the study ends. For example, in the study 
to investigate the time recurrence of a cancer for 3 months after surgery, a patient had a 
recurrence before 3 months.  
 
Interval censoring occurs when the event happen between two observations. Using the 
previous example, if the patients are disease free at 3 months and lost to follow-up 
between 3 to 6 months, they are consider as interval censored.  
 
Most survival data is right-censored. In this research, we used right censored data only.  
 
 
 
End of study 
A 
B 
C 
D 
E 
F 
Lost 
Death 
Withdrawn 
Death 
Study Time 
Chapter 3- Oral Cancer 
 
69 
3.7 Summary 
This chapter discusses the basic of oral cancer, oral cancer statistics worldwide and in 
the local scenario of Malaysia. In addition, the risk factors of oral cancer were also 
discussed. The clinical and genomic markers of oral cancer were identified and some 
existing researches that utilized both markers were discussed. This chapter also briefly 
discussed about the immunohistochemistry staining. Lastly, cancer management 
procedures namely, diagnosis, prognosis, survival analysis and the data censored which 
were used in survival analysis were also discussed.  
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CHAPTER 4 
 
RESEARCH METHODOLOGY 
 
4.1 Introduction 
In the previous chapter, various AI techniques, resampling techniques and feature 
selection algorithms which apply to cancer research have been reviewed, and the 
promising results from using both clinicopathologic and genomic data were presented. 
Therefore, in this research, an oral cancer prognosis model will be developed based on 
both clinicopathologic and genomic data. The methodology adopted in this research will 
be discussed in the following sections. 
 
Basically, there are four components in this research, which are explained in detail in 
this chapter. The findings from each component are discussed in the following chapters. 
The four components are: 
(i) Acquisition of oral cancer prognosis data for both clinicopathologic and 
genomic variables. 
(ii) The application of feature selection method on the oral cancer prognosis dataset. 
(iii)Development of oral cancer prognostic model using cross-validation ANFIS 
techniques. 
(iv) Model measurements, validation and comparison using other methods. 
 
4.2 Acquisition of Oral Cancer Prognosis Data 
Two types of data are needed for developing the oral cancer prognostic model; these are, 
clinicopathologic data and genomic data. Both types of data are collected from the Oral 
Cancer Research and Coordinating Centre (OCRCC), Faculty of Dentistry, University 
of Malaya and are taken from the same patients. The data consist of oral squamous cell 
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carcinoma (SCC) samples from Malaysia. 31 oral cancer cases have been selected for 
the purpose of this research based on the completeness and availability of the data 
(some data are not available due to medical confidentiality problems).  
 
4.2.1 Clinicopathologic Data  
Clinicopathologic data was obtained from the Malaysian Oral Cancer Database and 
Tissue Bank System (MOCDTB) maintained by the OCRCC. The database consists of 
oral cancer cases collected from participating hospitals from all over Malaysia. From 
this database, 31 cases were selected based on the completeness of the clinicopathologic 
data and the availability of the oral cancer tissue samples. The clinicopathologic data 
consists of information for social-demographic data, primary sites, clinical and 
pathological Tumour-Node-Metastasis (TNM) stage, nodal status, tumour size, invasion 
status, types of treatments, survival information and etc. The key clinicopathologic 
variables used for this research will be identified by the oral pathologists. The details of 
clinicopathologic data are discussed further in Section 5.2. 
 
4.2.2 Genomic Data 
Two genomic variables have been identified through the literature study and discussions 
with oral cancer experts as important to the prediction of oral cancer survival. The 
variables are p53 and p63. Immunohistochemistry (IHC) staining is performed on the 
selected formalin-fixed paraffin embedded oral cancer tissues. The oral cancer tissues 
are taken from the same 31 cases as in the clinicopathologic data. The procedures of 
IHC staining, analysis and scoring of the staining results are discussed in Section 5.3. 
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4.3 Development of Oral Cancer Prognostic Model 
Based on the literature review done, it has been identified that ANFIS is suitable for use 
on small sample dataset and this suits our case which has only 31 samples. Furthermore, 
ANFIS applies the Takagi-Sugeno model that has a more precise solution, which is very 
important in medical research. The framework for oral cancer prognostic model is 
shown in Figure 4.1. Clinicopathologic data from the OCRCC database and genomic 
data from IHC staining are fed into the model. Basically, there are three execution parts 
in this research for the oral cancer prognostic model which are wet-lab testing for 
genomic variables, feature selection methods and ANFIS classification model.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.1: Framework for oral cancer prognostic model  
Data taken from the same patients 
Clinicopathologic 
Data 
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4.3.1  Wet-lab Testing for Genomic Variables 
In the wet-lab testing part, the immunohistochemistry staining was performed on the 
oral cancer tissues, which taken from the same 31 oral cancer patients as indicated in the 
clinicopathologic data, in order to obtain the staining results for p53 and p63 genomic 
data.  The detail procedures are described in Chapter 5. 
 
4.3.2  Feature selection methods 
Due to the vast numbers of clinicopathologic variables and the small sample size, it is 
important to have a feature selection algorithm in the proposed model to avoid over-
fitting. It is beneficial to limit the number of inputs in a classifier in order to have a 
good predictive and less computationally intensive model. In medical research, a small 
input subset means lower test and diagnostic/prognostic costs.  
 
Five feature selection methods are proposed for use in this research to find out the most 
optimum feature subset for oral cancer prognosis. The aim is to minimize the number of 
input variables and thus to reduce the time and costs needed for oral cancer prognosis. 
The proposed feature selection methods are genetic algorithm (GA) as the wrapper 
approach, correlation coefficient (CC) and Relief-F as the filter approach, and CC-GA 
and ReliefF-GA as the hybrid approach (filter and wrapper). The methods, procedures 
and results for feature selection are discussed in Chapter 6 and Chapter 7 respectively. 
 
4.3.3 ANFIS Classification Model 
Lastly, the data with n selected features are fed into the ANFIS classification model, 
with n varying from three to seven. The final output is the classification accuracy for 
oral cancer prognosis, which classifies the patients as alive or dead after subsequent 
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years of diagnosis with the optimum feature of subset. The ANFIS was reviewed in 
section 2.3.1.  
 
Figure 4.2 shows an example of the ANFIS structure for the 3-input model and Figure 
4.3 shows the input membership functions for the same model. In the input layer, the 
number of input is defined by n, with n = 3, 4, 5, 6, 7. In the input membership (inputmf) 
layer, the number of membership function is defined by mi, with i = 2, 3, 4. The rules 
generated are based on the number of input and the number of input membership 
functions, and it is represented as (m2
n1 
x m3
n2 
x m4
n3
) rules, in which n1, n2, and n3 
represent the number of input with mi membership functions respectively, and 
n1+n2+n3=n. For example, in the ANFIS with 3-input, x, y, and z, in which input x has 
2 membership functions, input y has 2 membership functions, and input z has 4 
membership functions, hence the number of rules generated is (2
2
 x 3
0 
x 4
1
) = 16 rules 
(as in Figure 4.2).  
 
The rules generated are the output membership functions which will be computed as the 
summation of contribution from each rule towards the overall output. The output is the 
survival condition, either alive or dead after 1-year to 3-year of diagnosis. The output is 
set as 1 for dead and -1 for alive; the pseudo-code is as below: 
 if output ≥ 0 
           then set output = 1, classify as dead 
 else output < 0,  
          then set output = -1, classify as alive 
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Figure 4.2: ANFIS model structure for a 3-input model 
 
Figure 4.3: An example of membership functions for a 3-input model 
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Due to the small sample size, a re-sampling technique is needed to create more 
“versions” of samples in order to get statistically significant results. Bootstrapping and 
cross-validation (CV) are two methods which are commonly used for small dataset 
classification problems and the results are promising. In this research, CV is selected as 
the re-sampling technique. CV is normally used when a validation set is not available or 
when the data set is too small to split into training and validation sets (Hubert and 
Engelen, 2004). CV provides unbiased estimation, however, in some researches, CV 
presents high variance with small samples (Fu et al., 2005).  
 
In this research, k-fold cross-validation is used, in which k = 5. The 31 samples of oral 
cancer prognosis data are divided into 5 subsets of equal size and train for 5 times, each 
time leaving out a sample as validation data.  
 
4.4 Implementation and Testing of the Developed Model on Oral Cancer 
Prognosis Dataset 
The proposed model is tested using real-world oral cancer prognosis dataset from the 
OCRCC. The samples comprise of patients with oral squamous carcinoma and the 
dataset consists of clinicopathologic data. The dataset will be combined with the output 
of the genomic variables obtained from the IHC staining. Both of the clinicopathologic 
and genomic data are taken from the same set of patients, meaning clinicopathologic 
data of patient A are combined with the genomic data of patient A. These combined 
data are tested with the proposed feature selection and ANFIS classification model.  
 
The oral cancer prognosis dataset are divided into two groups, which are Group 1 with 
clinicopathologic data only and Group 2 with clinicopathologic and genomic data. The 
objective is to investigate if the classification accuracy from the combination of both 
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types of data is more accurate. In addition, the proposed model is tested with full-input 
model of oral cancer prognosis, in which the full-input model is the model with all the 
17 variables (15 clinicopathologic variables and 2 genomic variables). This is to 
investigate if the proposed model with fewer inputs (reduced model) is able to produce 
compatible results. The prediction ability of the proposed model is measured using the 
techniques as described in the next section. Besides that, the proposed model is 
compared with other AI methods such as artificial neural network (ANN) and support 
vector machine (SVM), and also statistical method of logistic regression (LR). 
 
4.5 Model Performance Measurements, Validation and Comparison 
The performance measures used to assess the oral cancer prognostic model are accuracy, 
sensitivity, specificity, ROC and AUC as discussed in section 2.7. For the purpose of 
validation and comparison, two commonly used AI methods, which are ANN and SVM 
are used as the benchmark. As the comparison between the proposed model and the 
statistical model, a LR model is used. The results and discussions are shown in Chapter 
7. 
 
4.6 Summary 
This chapter describes the methodology proposed for this research. Two types of 
variables are used as the input variables, namely, clinicopathologic variables and 
genomic variables. An oral cancer prognosis model which is based on the ANFIS 
techniques is proposed. The model is specifically designed for small dataset. The model 
consists of three parts, first the wet-lab testing for obtaining the genomic data, followed 
by the feature selection parts where five feature selection methods are proposed, namely, 
genetic algorithm, correlation coefficient, ReliefF, CC-GA, and ReliefF-GA with the 
aim to find out the optimum feature subset for oral cancer. The proposed model is tested 
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using real-world oral cancer prognosis dataset, measured for its performance using the 
formulae for measures as described in the section 2.7, validated and compared with two 
other AI methods which are ANN and SVM  and a statistical method of LR.  
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CHAPTER 5 
 
THE ORAL CANCER PROGNOSIS DATASET  
 
5.1 Introduction 
Traditionally, the diagnosis and prognosis of cancer have been based on the assessment 
of clinicopathological features from the patient. This method, however, depends 
strongly on the expertise and training of the pathologist examining the tissue samples, 
so the final diagnosis or prognosis may be subjective. Recent studies have demonstrated 
that genomic markers provide a powerful new approach for determining disease 
outcome (Muzio et al., 2005; Sun et al., 2007; Oliveira et al., 2008; Gaveart et al., 2006; 
Cotto et al., 2006; Futschik et al., 2003; Passaro et al., 2005).   
 
In this chapter, methods, preparations and procedures for acquiring oral cancer 
prognosis data are discussed. First, clinicopathologic data for oral cancer prognosis are 
discussed as in section 5.2. Next, the genomic markers for oral cancer are identified as 
in section 5.3. The selection of oral cancer cases and tissue preparations are described in 
section 5.4, followed by procedures of immunohistochemistry (IHC) staining in section 
5.5, and finally results analysis and scoring for IHC staining is discussed in section 5.6. 
 
5.2 Clinicopathologic Data 
A total of 31 oral cancer cases were selected from the Malaysian Oral Cancer Database 
and Tissue Bank System (MOCDTBS) coordinated by the Oral Cancer Research and 
Coordinating Centre (OCRCC), Faculty of Dentistry, University of Malaya. The 
selection was based on the completeness of clinicopathologic data, the availability of 
tissues and the availability of data (some data were not available for use due to medical 
confidentiality problems). Most of the cases selected for this research were obtained 
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from the Intensification for Research in Priority Areas (IRPA) project, funded by the 
Ministry of Science, Technology and the Environment, Malaysia. The MOCDTBS 
reused from the IRPA project, in which all patients’ records were well kept and 
followed up. Thus, this provides us with the completeness of the data needed for our 
research. 
 
The selected cases are based on the oral cancer cases seen in Faculty of Dentistry, 
University of Malaya and Hospital Tunku Ampuan Rahimah, Klang, a Malaysian 
government hospital, from the year 2003 to 2007. These cases were diagnosed and 
followed up and the data were recorded in the standardised forms prepared by the 
MOCDTBS. Later, MOCDTBS transcribed all the data from paper to electronic version 
and stored in the database. The role of OCRCC is to house the MOCDTBS which 
maintains and coordinates all the data collected from different hospitals for record and 
research purposes. All the cases selected are diagnosed as squamous cell carcinomas 
(SCC).  
 
Basically, three types of data are available for each oral cancer case, namely, social 
demographic data (risk factors, ethnicity, age, occupation, marital status and others), 
clinical data (type of lesion, size of lesion, primary site, clinical neck node and etc.), and 
pathological data (pathological TNM, neck node metastasis, bone invasion, tumour 
thickness and etc.). Pathological data were obtained from the biopsy reports before and 
after surgical procedures. In this research, we refer to the clinical and pathological data 
as clinicopathologic data. Based on the discussions with oral cancer experts, 15 key 
variables have been identified as important prognostic factors of oral cancer. These 
variables were commonly used in oral cancer prognosis as discussed in the literature 
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study of Chapter 2. Table 5.1 lists out the selected 15 key variables and Table 5.2 shows 
the descriptive statistics for the clinicopathologic variables. 
 
Table 5.1: The Selected 15 Clinicopathologic Variables 
  Name Description  
1 Age Age at diagnosis 
2 Eth Ethnicity 
3 Gen Gender 
4 Smoke Smoking habit 
5 Drink Alcohol drinking habit 
6 Chew Quid chewing habit 
7 Site Primary site of tumor 
8 Subtype Subtype and differentiation for SCC 
9 Inv Depth of Invasion front 
10 Node Neck nodes 
11 PT Pathological tumor staging 
12 PN Pathological lymph nodes 
13 Stage Overall stage 
14 Size Size of tumor 
15 Treat Type of treatment 
 
Based on Table 5.2, we can see that there was a much higher case of female at 77.4% 
while male was 22.6%, of which, the majority of the cases were Indian (74.2%).  All 31 
cases selected in our research were within the age of 40-80 years old. In terms of risk 
factors, the most common practice was betel quid chewing (71%), followed by drinking 
(19.4%) and smoking (16.1%). As for the clinical variables, the most common site of 
oral cancer was buccal mucosa (41.9%) and most patients had tumour with the size 
between 4-6cm (35.5%). 64.5% of the cases belonged to the moderately differentiated 
squamous cell carcinoma while 35.5% belonged to the subtype of well differentiated. 
Most of the cases had non-cohesive invasive front (83.9%) and the neck node status 
were almost equal, with 45.2% positive node status and 54.8% negative status. For the 
pathological TNM stages, 45.2% were in the final stage of T4, 61.3% had nodal status 
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of N0 (No regional lymph node metastasis). Most of the cases were diagnosed only at 
stage 4 (67.7%) and the most common treatment was surgery and radiotherapy (54.8%).  
 
Table 5.2: Descriptive statistics of clinicopathologic variables for 31 cases 
Variable Description No % Variable Description No % 
Gender Male 7 22.6 Invasion Cohesive 5 16.1 
  Female 24 77.4   Non-cohesive 26 83.9 
Ethnicity Malay 5 16.1 Nodes Positive 14 45.2 
  Chinese 3 9.7   Negative 17 54.8 
  Indian 23 74.2 Subtype Well differentiated 11 35.5 
Age 40-50 6 19.4   Moderate differentiated 20 64.5 
  >50-60 9 29.0   Poorly differentiated 0 0.0 
  >60-70 12 38.7 PT T0 0 0.0 
  >70 4 12.9   Tis 0 0.0 
Smoke Yes 5 16.1   T1 4 12.9 
  No 23 74.2   T2 7 22.6 
  No info 3 9.7   T3 6 19.4 
Drink Yes 6 19.4   T4 14 45.2 
  No 22 71.0 PN N0 19 61.3 
  No info 3 9.7   N1 3 9.7 
Chew Yes 22 71.0   N2A 1 3.2 
  No 6 19.4   N2B 8 25.8 
  No info 3 9.7   N2C 0 0.0 
Site Buccal mucosa 13 41.9   N3 0 0.0 
  Tongue 3 9.7 Stage Stage I 3 9.7 
  Floor 3 9.7   Stage II 4 12.9 
  Others 9 29.0   Stage III 3 9.7 
  No info 3 9.7   Stage IV 21 67.7 
Size 0-2cm 6 19.4 Treatment Surgery only 8 25.8 
  >2-4cm 6 19.4   Surgery + Radiotherapy 17 54.8 
  >4-6cm 11 35.5   
Surgery + 
Chemotherapy 4 12.9 
  >6cm 6 19.4   No info 2 6.5 
  No info 2 6.5 
     
For these 31 cases, based on a 1-year follow-up, 27 had survived and 4 were dead; for a 
2-year follow-up, 19 had survived, 10 were dead and 2 were lost to follow-up; while for 
a 3-year follow-up, 17 had survived, 11 were dead and 3 cases were lost to follow-up, as 
shown in Table 5.3. Figure 5.1 shows the bar charts for each of the clinicopathologic 
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variables. There are some missing data and the methods of handling these data are 
discussed in Chapter 6. 
 
Table 5.3: 1-year, 2-year and 3-year survival 
Duration of follow-up Survival No % 
1-year  Survive 27 87.1 
  Dead 4 12.9 
  Lost of follow-up 0 0.0 
2-year Survive 19 61.3 
  Dead 10 32.3 
  Lost of follow-up 2 6.5 
3-year Survive 17 54.8 
  Dead 11 38.7 
  Lost of follow-up 3 9.7 
 
 
      
(a)      (b) 
      
(c)      (d) 
Figure 5.1: Bar Charts for clinicopathologic variables 
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Figure 5.1: Bar Charts for clinicopathologic variables (continued) 
 
0
10
20
30
Yes No No info
Drink
0
10
20
30
Yes No No info
Chew
0
5
10
15
Buccal 
mucosa
Tongue Floor Others No info
Site
0
5
10
15
0-2cm >2-4cm >4-6cm >6cm No info
Size
0
10
20
30
Cohesive Non-cohesive
Invasion
0
5
10
15
20
Positive Negative
Nodes
Chapter 5- The Oral Cancer Prognosis Dataset 
 
85 
 
     
(k)      (l) 
      
(m)      (n) 
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Figure 5.1: Bar Charts for clinicopathologic variables (continued) 
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5.3 Identification of Genomic Markers for Oral Cancer 
Previous literature studies have revealed a number of genomic factors which are 
associated with oral cancer prognosis, as discussed in section 3.3.6 and 3.4.2. Genetic 
polymorphisms in GSTM1, GSTT1, GSTP1, NAT1 and NAT2, (Jefferies & Foulkes, 
2001; Anantahraman et al. 2007), tumour suppressor genes such as p53, p16 and p63 
(Mehrota & Yadav, 2006; Muzio et al. 2005, 2007), overexpression of the epidermal 
growth factor receptor (Brinkman & Wong 2006) are amongst the most popular genetic 
factors in oral cancer prognosis.  
 
In this research, due to time, cost and tissue constraints, only two genomic markers are 
selected, both are tumour suppressor genes, namely p53 and p63. The review for p53 
and p63 is in section 3.4.2. The selection is done based on the literature studies and 
discussions with two oral pathologists, Professor Rosnah Binti Zain and Dr Thomas 
George from Department of Oral Pathology and Oral Medicine and Periodontology, 
Faculty of Dentistry, University of Malaya.  
 
5.4 Selection of Oral Cancer Cases and Tissue Preparations 
31 oral cancer cases had been selected from the OCRCC database based on the 
completeness of the clinicopathological data. The cases selected were the same as in the 
clinicopathologic data. The archival formalin-fixed paraffin embedded tissues were 
obtained from the Oral Pathology Diagnostic Laboratory, Faculty of Dentistry, 
University of Malaya. Tissue containing tumour were cored and re-embedded and made 
into Tissue Macroarray blocks (TMaA). A total of 4-µm-thick sections of the resulting 
TMaA blocks were cut and placed on the poly-L-lysine-coated glass slides for 
immunohistochemistry staining. Figure 5.2 shows the macroarray (TMaA) slides 
prepared for this research.  
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Figure 5.2: Macroarray (TMaA) slides prepared for this research 
 
5.5 Immunohistochemistry Staining 
IHC staining was performed on 4-µm-thick sections cut from the TMaA blocks. The 
samples were mounted on the glass slides and ready for IHC staining.  In this research, 
Dako REAL
TM
 EnVision
TM
 Detection Kit was used. Figure 5.3 lists the procedures for 
immuno peroxidise EnVision
TM
 Technique. 
 
The IHC staining was done in the Oral Pathology Diagnostic Laboratory, Faculty of 
Dentistry, University of Malaya on 10
th
 March 2010 with the help from the laboratory 
technicians, oral pathologists, and staff from the OCRCC. In total, 15 TMaA slides with 
31 oral cancer cases were stained where some cases were repeated. Two types of 
antibodies were used namely Monoclonal Mouse Anti-Human p53 protein, clone 318-6-
11 for p53 and Monoclonal Mouse Anti-Human p63 protein, clone 4A4 for p63. Figure 
5.4 shows the slides being stained with selected antibody and incubated at room 
temperature. 
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Figure 5.3: Procedures for Immuno Peroxidase EnVision
TM
 Techniques 
 
1. Deparaffinize and bring sections to water: 
a. Xylene I  - 5 min 
b. Xylene II - 4 min 
c. Absolute alcohol - 3 min 
d. 95% alcohol - 3 min 
e. 70% alcohol - 3 min 
2. Place the slides in a microwave-resistant plastic staining jar containing Tris-EDTA 
pH9.0 antigen retrieval buffer (10mM Tris, 1mM EDTA). Make sure the slides are fully 
covered with buffer. 
a. Operate the microwave oven at 99 degrees. 
b. Let the slides cool at room temperature. 
c. Wash in running water for 5 min. 
3. Endogenous peroxidise blocking: 
a. Place the slides in a trough filled with 3% hydrogen peroxide in methanol. 
b. Ensure the slides are fully covered with solution. 
c. Incubate 10 min at room temperature 
d. Wash in 2 baths of TRIS buffer saline (TBS), pH7.6 
e. Drain off excess fluid and wipe the slide carefully 
4. Primary antibody** for 30- 40 min in room temperature: 
a. Place the slides on a flat lever surface. Do not allow slides to touch to each 
other. 
b. Add enough antibody to cover the whole section. 
c. Incubate the sections for 30 – 40 min in room temperature. 
d. Rinse in 2 baths of TBS 
e. Allow each slide to drain off excess fluid and wipe the slides. 
5. Second antibody**  for 30 min in room temperature: 
a. Place the slides on a flat lever surface. Do not allow slides to touch to each 
other. 
b. Add enough antibody to cover the whole section. 
c. Incubate the sections for 30 min in room temperature. 
d. Rinse in 2 baths of TBS. 
e. Allow each slide to drain off excess fluid and wipe the slides. 
6. Incubate in Diaminobenzidine (DAB) for 5 min: 
a. Apply enough drops of freshly prepared substrate mixture to cover the tissue 
section. 
b. Incubate for 5 min. 
c. Washing gently with running water for 5 min. 
7. Counter stain, dehydrate and coverslip with the followings: 
a. Harris haemotoxylin, 1 min, wash in running water, 3 min, 
b. Acid alcohol, 10 seconds, wash in running water, 3 min, 
c. Potassium acetate, 4 dips, wash in running water, 
d. 95% alcohol for 2 min, 
e. Absolute alcohol, 2 min for 2 times, 
f. Xylene, 2 min for 3 times, and 
g. Mount with Depex 
 
** Monoclonal Mouse Anti-Human p53 protein, clone 318-6-11 for p53 
Monoclonal Mouse Anti-Human p63 protein, clone 4A4 for p63 
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Figure 5.4: Slides stained with antibody and incubated at room temperature 
 
5.6 Results Analysis and Scoring 
The results of staining are analyzed and the images are captured by using an image 
analyzer system which consists of the Nikon Eclipse E400 Microscope with CFI plan 
Fluor 40X objective for measurements, QImaging Evolution digital colour cooled 
camera with 5.0 megapixels, a personal computer (Pentium 4, 2.5Ghz, 2GB RAM) and 
MediaCybernatics Image Pro Plus version 6.3 image analysis software. Figure 5.5 
shows the above mentioned image analyzer system.  
  
Each slide was first examined under the microscope with lower objective, that is, the 4X 
objective. Cases were considered sufficient for evaluation if there were tumour cells 
presented in the sections. Next, the slide was divided into 20 grid cells and numbered 
accordingly from left to right. A simple randomization program was used to generate 
random numbers. For each case, five tumour representative areas were selected. If the 
number falls on the non-tumour representative area, the next number (cell) was chosen 
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until all five areas were selected. Next, five selective areas were examined under the 
microscope using a higher objective, that is, the 40X objective and the images were 
captured. The percentage of positive nuclear cells for each area was counted and the 
average for five areas was calculated.  The staining result is considered positive if there 
is more than 10% positive nuclear stained, in accordance with the practice used in the 
previous studies (Oliveira et al., 2008; Ziguener et al. 2004). The procedures of the 
results analysis and scoring as illustrated in Figure 5.6. 
 
 
Figure 5.5: Image analyzer system 
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For positively stained slides, nuclear slide will have the nuclear stained in brown colour 
while negatively stained slide will have the colour of blue/purple. Figure 5.7(a) shows 
an example of positive stained slide and (b) is an example for negative stained slide. 
The staining results and descriptive statistics for the results are summarised in Table 5.4 
and Table 5.5 respectively.  
Table 5.4: Results for IHC staining 
No. Macroarray Slides p53 p63 
1 TMaA 1-1,4-3 neg neg 
2 TMaA 1-1,2-7 neg pos 
3 TMaA 1-2,2-9 pos neg 
4 TMaA 1-2,2-8 neg pos 
5 TMaA 1-3,2-9 pos pos 
6 TMaA 1-8,4-2 neg pos 
7 TMaA 1-4,4-3 pos pos 
8 TMaA 1-5,2-7,2-10,3-2 pos neg 
9 TMaA 1-6,2-7,4-3 neg pos 
10 TMaA 1-7,4-1 neg pos 
11 TMaA 1-7,3-1,4-1 pos pos 
12 TMaA 1-8,3-1,4-2 pos neg 
13 TMaA 1-8,2-8,4-4 neg pos 
14 TMaA 3-1 neg neg 
15 TMaA 3-2 neg neg 
16 TMaA 1-2,3-2,4-1 neg pos 
17 TMaA 3-2 neg pos 
18 TMaA 3-3 neg neg 
19 TMaA 3-3 neg pos 
20 TMaA 3-4 neg neg 
21 TMaA 3-4,4-1 neg pos 
22 TMaA 8-3A pos pos 
23 TMaA 8-3A pos pos 
24 TMaA 1-6,4-2,8-5A neg pos 
25 TMaA 8-5A neg pos 
26 TMaA 1-4 neg pos 
27 TMaA 1-3 neg pos 
28 TMaA 2-9 neg neg 
29 TMaA 3-1 pos pos 
30 TMaA 8-3a neg neg 
31 TMaA 8-3a pos pos 
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Table 5.5: Descriptive Statistics for IHC Staining Results 
Genomic Markers Results Total Percentage (%) 
p53 Positive 11 35.5 
  Negative 20 64.5 
p63 Positive 20 64.5 
  Negative 11 35.5 
 
 
   
        (a) Positive Stained    (b) Negative Stained 
Figure 5.7: Example of IHC staining results 
 
5.7 Summary  
In this chapter, the selection of oral cancer cases for this research is described and 15 
clinicopathologic variables which are used in this research have been identified.  
Descriptive statistics for the selected clinicopathological variables are analysed and 
explained in detail. Besides that, two genomic markers have been identified to be used 
in this research, these are, namely, p53 and p63. 31 oral cancer cases have been selected 
with the help from oral pathologists and 15 TMaA slides have been prepared. Next, 
immunohistochemistry staining was performed on the TMaA slides by using the Dako 
REAL
TM
 EnVision
TM
 Detection Kit and the selected antibodies. Steps and procedures of 
the staining are clearly defined in this chapter. The results from the staining were 
analysed and scored by using an image analyzer system and the staining result is 
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considered positive if more than 10% of the nuclear is positively stained. These two 
types of markers are combined and served as the inputs for our developed oral cancer 
prognosis model, which are further explained in the following chapters.  
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CHAPTER 6 
 
DEVELOPMENT OF ORAL CANCER  
PROGNOSTIC MODEL 
 
6.1 Introduction 
Data pre-processing is an important step in computer modelling, especially for medical 
modelling where the samples are usually noisy, incomplete and maybe small. In this 
chapter, data processing methods which are applied on the oral cancer prognosis dataset 
are discussed, which are namely, data cleansing, data discretization, data transformation 
and feature selection/input reduction.  
 
There are numerous input variables that can be used for medical modelling, for example 
demographic variables, risk factors, clinical variables, pathological variables and 
genomic variables. Each type of variables may consist from ten up to hundreds of inputs. 
Furthermore, in medical research, it takes time to collect sufficient samples and thus, the 
sample size is usually small. Hence, there is a need to implement feature selection 
methods to identify significant variables that are important to the clinical outcomes and 
to avoid the over-fitting problem. In this research, the purpose of implementing feature 
selection method is to find an optimal number of features for the small sample of oral 
cancer prognosis data. 
 
This chapter discusses the development of oral cancer prognostic model. First, the data 
pre-processing methods and feature selection methods which have been implemented in 
this research are discussed. The architecture for five feature selection methods, which 
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are genetic algorithm (GA), Correlation Coefficient (CC), Relief-F algorithm, CC-GA, 
and ReliefF-GA are discussed and compared. Next, the implementation of ANFIS 
classification model in the oral cancer prognostic dataset is discussed and the results are 
shown in Chapter 7.  
 
6.2 Data Pre-processing 
Data pre-processing describes the processing methods performed on raw data to 
transform the data into a format that will be more easily and effectively processed for 
the purpose of the modelling.  
 
There are different methods used for data pre-processing, which include (Markov, 2011; 
Pyle, 1999): 
(a) Data cleansing - filling in missing values, smoothing noisy data, identifying or 
removing outliers, and resolving inconsistencies. 
(b) Discretization & sampling - selecting a representative subset from a large 
population of data. 
(c) Transformation – normalising and aggregating 
(d) Feature selection/data reducing - extracting specified data that is significant in 
some particular context. 
 
Data pre-processing is an important process in any data modelling prediction. The 
accuracy of predictive model depends largely on the quality of the data. Usually, 
medical dataset is incomplete, noisy and contains a lot of missing data. Therefore, we 
need to pre-process the selected dataset before we implement the feature selection 
methods. As described in Section 4.6, we obtained the oral cancer prognosis data from 
the MOCDTBS database. The original dataset consists of various information for 
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patients such as personal details, risk factors, oral health related quality of life 
assessment, clinical and pathological findings, details of surgery, post surgical 
pathology, details of radiotherapy and chemotherapy and dietary pattern. With the help 
from oral cancer experts (Zain & George, 2009), we have identified and selected 15 
clinicopathological variables and 2 genomic variables, which are commonly used in oral 
cancer prognosis for the purpose of this research. Based on that, only 31 samples were 
selected based on the completeness of data and the availability of formalin fixed 
paraffin embedded tissues, the detail of the oral cancer prognosis dataset is described in 
Chapter 4.  
 
6.2.1 Data Cleansing 
The first step of data pre-processing is the data cleansing. From the selected dataset, we 
found out that there are 16 missing data and 4 incomplete data. The missing data are 
mostly on the risk habits. Incomplete data are usually survival information such as lost 
of follow-up cases in a 3-year study, in which the patient had died and the date had not 
been recorded.  
 
There are some common methods to deal with missing values, such as case deletion, 
mean imputation, median imputation and mode imputation. Case deletion which 
discards the case with missing values in any one feature is not feasible in our research 
since our sample size is very small. Mean and median imputation is suitable for numeric 
or continuous data and mode imputation is for nominal (categorical) data. In this 
research, median imputation is taken for numeric data and mode imputation is taken for 
nominal data. Median imputation is selected because it is suitable to use when the 
distribution of the values is skewed and mean imputation is affected by the values of 
outliers (Acuna, & Rodriguez, 2004). 
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In this research, we have only three cases of lost to follow-up patients. We assumed that 
the patients “survived” for 3-year, which means no event occurred within 3-year of 
follow-up. The number of patients lost to follow-up is small, thus very little bias is 
likely to have resulted (Clark, 2003).  
 
6.2.2  Data Discretization and Transformation 
Next, we categorized and coded the data according to the groups and format that are 
needed for our predictive modelling. Besides that, three new variables are coded 
inferred by existing variables, they are status for 1-year survival, 2-year survival and 3-
year survival. All the cases in this research are right censored cases; which means the 
event (death) happened after the follow-up period, and non-censored cases. A sample of 
oral cancer dataset is listed as in Table 6.1. The categorization results for the dataset are 
listed in the Appendix (b).   
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Table 6.1: A Sample of oral cancer dataset 
N
o. 
A-
ge 
Ethni
-city 
Gen-
der 
Smo
-ke 
Dri
-nk 
Ch-
ew Site Diagnosis Invasion Nodes PT PN Stage Size  
Treatme
nt p53 p63 
1-yr 
survival 
2-yr 
survival 
3-yr 
survival 
1 41 Malay M Yes No No 
Right 
cheek 
Moderate 
Differentiated 
Non 
cohesive Positive T2 N2b IV 
0 – 
2 
Surgery 
+ 
chemoth
erapy pos pos Survive Survive survive 
2 79 Indian F No Yes Yes Gingiva 
Well 
Differentiated 
Non 
cohesive Positive T4 N0 IV >6 
Surgery 
+ 
radiother
apy neg neg Survive Survive survive 
3 50 Indian F No No Yes 
Buccal 
mucosa 
Moderately 
Differentiated 
Non 
cohesive Positive T4 N1 IV >6 
Surgery 
+ 
radiother
apy neg pos Survive Survive survive 
4 48 Malay F  No No No Tongue 
Moderately 
Differentiated 
Non 
cohesive Negative T3 N0 III 
>2 – 
4 Surgery pos pos Survive Survive survive 
5 66 
Chine
se M No Yes No 
Left 
side of 
tongue 
Moderately-
differentiated 
Non 
cohesive Negative T3 N0 III 
>2 – 
4 
Surgery 
+ 
radiother
apy pos pos Survive Dead Dead 
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6.2.3 Feature selection/Data Reduction 
The number of variables in the dataset was considered too many (17 variables) if 
compared to the sample size (31 cases). Thus, feature selection method is needed to 
reduce the number of variables and to select only the variables that are significant to 
oral cancer prognosis. The details of feature selection methods implemented in this 
research are explained in Section 6.3.  
 
6.3 Feature Selection Methods 
Feature selection is used to select the inputs which are most significant in the modelling 
process, in order to produce more accurate outputs. The purpose of feature selection is 
to reduce the number of inputs in the modelling process, but retain or increase the 
accuracy of the outputs as compared to the full-input model. Thus, this can produce a 
more predictive and cost effective model. This is important especially in medical 
research where fewer inputs means lower test and diagnosis/prognosis costs.  
 
In this research, the purpose of feature selection is to find an optimal number of features 
for the small samples of oral cancer prognosis data. Five feature selection methods had 
been selected and implemented in this research, which were genetic algorithm (GA), 
Pearson's correlation coefficient, Relief-F, CC-GA, and ReliefF-GA. The above 
methods were discussed in Section 2.6.  
 
6.3.1 Genetic Algorithm (GA) 
In this research, a GA algorithm for the oral cancer prognosis dataset was proposed. The 
solutions of the GA will form the clinicopathologic or genomic variables that will 
subsequently be used in the oral cancer prognosis and the output will indicate how well 
the solutions can predict oral cancer survival.  
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Before the implementation of GA feature selection method, a simple GA was run to find 
out the optimal number of inputs (n-input model) from the 17 inputs of 
clinicopathologic and genomic data. The numbers of inputs with the lower error rate are 
chosen. The error rate for each n-input model is shown in Table 6.2 which shows that 
for Group 1, there are four models with the lowest error rate of 0.3871, which are the 3-
input, 4-input, 5-input, and 6-input model. Meanwhile, for Group 2, the model with the 
lowest error rate is the 3-input model with an error rate of 0.2581. In this case, for 
comparison purposes, the number of inputs between 3-input to 7-input are chosen. 
Hence n is set as n = 3, 4, 5, 6, 7 for the feature selection method. 
 
Table 6.2: Error rate for n-input model 
 
  Group 1 Group 2 
2-input 0.4193 0.2903 
3-input 0.3871 0.2581 
4-input 0.3871 0.2903 
5-input 0.3871 0.3226 
6-input 0.3871 0.3548 
7-input 0.4571 0.3548 
8-input 0.4839 0.4194 
9-input 0.5161 0.4516 
 
The pseudo-code of the proposed GA is listed in Figure 6.1 and is repeated for the n-
input model. The details of the GA components are discussed below, and the flowchart 
for GA is illustrated in Figure 6.2. 
 
(i) Solution Encoding 
As discussed in section 2.6.1, each feature is represented by binary digits of 0 or 1. For 
example, in the oral cancer prognosis dataset, if the solution is a 011001000010000 
string of 15 binary digits, it indicates that features 2, 3, 6, and 11 are selected as the 
feature subset. 
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Figure 6.1: Pseudo-code for the proposed GA 
(ii) Initial population 
In this proposed GA feature selection method, if the features are all different, the subset 
is included in the initial population. If not, it is regenerated until an initial population 
with the desired size is created. 
 
(iii) Fitness function 
The function is used to classify between two groups, which are alive and dead. The 
error rate of the classification is calculated using a 10-fold cross-validation. The fitness 
function is the final error rate obtained. The subset of variables with the lowest error 
rate is being selected. 
 
(iv) Selection, Crossover, Mutation and Stopping Criteria 
The selection, crossover, mutation and stopping criteria used in this method are listed in 
Table 6.3. 
 
 
 
While selecting initial population with n-input 
 Generate initial population randomly without repetition variables 
End while 
Evaluate the fitness function of each individual using classification error 
rate estimated using 10-fold cross-validation 
While stopping criteria not exceeded 
Select parents from the population 
Perform crossover operation 
Perform mutation operation 
Evaluate the fitness function using classification error rate 
estimated using 10-fold cross-validation 
Replace the fittest individual 
End while 
Return the best solution for n-input model 
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Figure 6.2: Genetic algorithm feature selection flowchart 
 
 
Table 6.3: Selection, crossover, mutation and stopping criteria for the 
GA feature selection method 
Selection Roulette wheel 
Crossover Scattered. Crossover fraction = 0.5 
Mutation Uniform. Mutation rate = 0.30 
Stopping Criteria Number of generation = 100 or 
Time limit = 600s whichever occur first 
 
Oral Cancer Prognosis Data 
Fitness function for each individual 
(Error rate using 10-fold cross-validation) 
Initial  
population with n-input 
Crossover operation 
Selection operation 
No 
Stopping criteria 
with different 
variables 
Yes 
No 
Mutation operation 
Fitness function for each solution 
(Error rate using 10-fold cross-validation) 
Best solution for n-input model 
start 
End 
Yes 
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6.3.2  Pearson's Correlation Coefficient (CC) 
In this research, the correlation coefficient, r, is calculated and ranked for each of the 
feature input and the one with the highest r is selected. For example, for the 3-input 
model, the top three inputs with the highest r value is selected. This is repeated for the 
4-input model to the 7-input model for both Group 1 and Group 2. The flowchart for 
this method is shown in Figure 6.3.  
 
 
 
 
 
 
 
 
 
 
Figure 6.3: Correlation coefficient feature selection flowchart 
 
6.3.3 Relief-F Algorithm 
Relief-F belongs to the filter approach. In this method, each feature input is ranked and 
weighted using the k-nearest neighbours classification, in which k = 1. The top features 
with large positive weights are selected for both groups of dataset. Figure 6.4 shows the 
flowchart for the Relief-F method. The features selected by using this method are listed 
in the next chapter. 
 
 
Oral Cancer Prognosis Data 
Calculate correlation  
coefficient, r 
Select n variables with highest r 
Rank the variables using r 
start 
End 
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Figure 6.4: Relief-F feature selection flowchart 
 
6.3.4 Correlation Coefficient and Genetic Algorithm (CC-GA) 
This is the hybrid feature selection approach which consists of two stages: first, it is a 
filter approach which calculates the correlation coefficient, r, and second, it is a wrapper 
approach of GA. In the first stage, ten features with the highest r are selected and fed 
into the second stage of the GA approach. The procedures of GA are the same as 
described in Section 6.3.1. In the second stage, n-input is selected for both groups. 
Figure 6.5 shows the flowchart for the CC-GA method. 
 
6.3.5  Relief-F and Genetic Algorithm (ReliefF-GA) 
This hybrid feature selection approach consists of two stages: first, it is a filter approach 
of Relief-F, and second, it is a wrapper approach of GA. In the first stage, ten features 
with the highest weights are selected and fed into the second stage of the GA approach. 
The procedures of GA are the same as described in Section 6.3.1. In the second stage, n-
input is selected for both groups and the features selected are listed in chapter 7. Figure 
6.6 shows the flowchart for the ReliefF-GA method. 
Oral Cancer Prognosis Data 
Calculate the weights using 1-
nearest neighbours classification 
Select n variables with highest 
weights 
Rank the variables using weights 
start 
End 
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Figure 6.5: CC-GA feature selection flowchart 
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Fitness function for each solution 
(Error rate using 10-fold cross validation) 
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Figure 6.6: ReliefF-GA feature selection flowchart 
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6.4 ANFIS Classification Model 
The proposed ANFIS model is implemented for both Group 1 and Group 2 for the n-
input models generated from the five proposed feature selection methods. The details 
for the proposed ANFIS model are described in section 2.3.1. The proposed ANFIS has 
n-inputs, with two to four membership functions for each input, and (m2
n1 
x m3
n2 
x m4
n3
) 
rules (refer to section 4.3.3). The type of membership function used is the Gaussian and 
the number of membership functions for each input variable is shown in Table 6.4. The 
membership functions for each input variables are shown in Appendix (c). Figure 6.7 
shows an example of the membership functions for input variable 'age'. Each ANFIS 
was run for 5 epochs. A 5-fold cross-validation is implemented on the dataset. 
 
Table 6.4: Membership functions for each input variable 
Name 
No. of 
membership 
function 
Name of Membership function 
Age 4 40-50, >50-60, >60-70<,>70 
Eth 3 Malay, Chinese, Indian 
Gen 2 Male, Female 
Smoke 2 Yes, No 
Drink 2 Yes, No 
Chew 2 Yes, No 
Site 4 Buccal mucosa, tongue, floor, others 
Subtype 3 Well differentiated, moderate differentiated, poorly 
differentiated 
Inv 2 Non-cohesive, cohesive 
Node 2 Negative, positive 
PT 4 T1, T2, T3, T4 
PN 4 N0, N1, N2A, N2B 
Stage 4 I, II, III, IV 
Size 4 0-2cm, >2-4cm, >4-6cm, >6cm 
Treat 3 Surgery only, Surgery+Radiotherapy, 
Surgery+Chemotherapy 
p53 2 Negative, positive 
p63 2 Negative, positive 
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Figure 6.7: Membership functions for input variable "Age" 
 
6.5 Summary 
This chapter describes the data pre-processing methods namely data cleansing, data 
discretization, data transformation and feature extraction/feature selection used for the 
oral cancer prognosis dataset. Five types of feature selection methods were chosen and 
compared; these are genetic algorithm (GA), Pearson’s correlation coefficient (CC), 
Relief-F algorithm, CC+GA and ReliefF+GA. The proposed ANFIS classification 
model is discussed. The membership functions for each input variable are listed in 
Table 6.4. The results for the feature selection methods and the ANFIS classification 
model are discussed in Chapter 7. 
 
The sample size for oral cancer prognosis data is very small, thus, the feature selection 
method is a must to reduce the number of input variables to avoid the over-fitting 
problem. Feature selection methods are suitable for medical research which has the key 
features of limited time, cost and tissue samples.  
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CHAPTER 7 
 
RESULTS AND DISCUSSIONS 
 
7.1 Introduction 
In this chapter, we discuss the proposed oral cancer prognostic model to classify 
whether the patients are alive or dead after 1-3-year of diagnosis.  
 
The oral cancer dataset was divided into 2 groups, which were Group 1 with 
clinicopathologic variables (15 variables) only and Group 2 with both of the 
clinicopathologic and genomic variables (17 variables). The feature selection methods 
as described in Chapter 6 was implemented on both groups in order to select the n-input 
models, with the optimum feature selected.  
 
Next, the proposed ANFIS classification model with 5-fold cross-validation was 
implemented on the n-input models generated from the feature selection methods. For 
validation purpose, the ANFIS classification results were compared with two AI 
methods which are artificial neural network (ANN) and support vector machine (SVM), 
the statistical method of logistic regression (LR), different permutations of n-input 
model and also the full model. Lastly, the ANFIS prognostic model was used to classify 
1-year oral cancer prognosis and 2-year oral cancer prognosis.  
 
The three main objectives of this chapter are first, to show the classification results are 
better in Group 2 (clinicopathologic and genomic variables) if compared to Group 1 
(clinicopathologic variables only). Second, to obtain an optimum subset of features for 
the oral cancer prognosis, and third, to show that the ANFIS classification model is the 
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optimum tool for oral cancer prognosis if compared to other methods such as ANN, 
SVM and LR. 
 
7.2 Feature Selection Methods 
Before the implementation of the feature selection methods, first, the oral cancer 
prognosis dataset was divided into two groups; Group 1 consists of clinicopathologic 
variables only (15 variables) and Group 2 consists of clinicopathologic and genomic 
variables (17 variables). The feature selection methods were implemented to both 
groups and the selected features are listed in Table 7.1 and Table 7.2 respectively. In 
Table 7.2, almost all the feature selection methods included the genomic variable as one 
of the key features, except for the ReliefF-3-input and ReliefF-4-input. 
 
Table 7.3 listed the number of times a particular feature was selected for each of the 
feature selection method for Group 1 and Group 2 and Table 7.4 summarised the most 
selected features for each of the feature selection method for both groups. From Table 
7.4, it is noted that for both Group 1 and Group 2, the most selected features for CC, 
ReliefF and ReliefF-GA are the same as the 3-input model selected for each method 
respectively.  
 
However, in order to obtain the optimum subset of features, the features selected needed 
to be tested and validated using classification methods. In the next section, each n-input 
model for both groups were tested with the proposed ANFIS classification system and 
compared with the artificial neural network (ANN), support vector machine (SVM) and 
logistic regression (LR) classification methods. Classification accuracy and the area 
under the Receiver-Operating-Characteristic (ROC) curve for each model were being 
calculated. In addition, the accuracy of the n-input models was compared with the most 
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selected features from Table 7.4, other combination of n-input models and the full 
model (the model with all 17 variables) 
 
Table 7.1: Feature Subset Selected for Group 1* 
Method Feature Subset Selected 
GA  
3-input Gen,Smo,PN 
4-input Dri,Inv,PN,Size 
5-input Dri,Node,PT,PN,Size 
6-input Age,Gen,Smo,Inv,PT,Size 
7-input Age,Eth,Chew,Inv,Node,PN,Size 
CC  
3-input Age,Inv,PN 
4-input Age,Gen,Inv,PN 
5-input Age,Gen,Inv,PN,Size 
6-input Age,Gen,Inv,PN,Sta,Size 
7-input Age,Gen,Dri,Inv,PN,Sta,Size 
ReliefF  
3-input Eth,Dri,Sta 
4-input Age,Eth,Dri,Sta 
5-input Age,Eth,Dri,Sta,Tre 
6-input Age,Eth,Gen,Dri,Sta,Tre 
7-input Age,Eth,Gen,Dri,PT,Sta,Tre 
CC-GA  
3-input PT,PN,Sta 
4-input Dri,Inv,PN,Size 
5-input Age,Gen,Inv,PN,Size 
6-input Gen,Dri,Node,PT,PN,Sta 
7-input Gen,Dri,Chew,Inv,Node,PN,Size 
ReliefF-GA  
3-input Gen,Inv,Node 
4-input Gen,Dri,Inv,Node 
5-input Gen,Dri,Inv,Node,PT 
6-input Eth,Gen,Dri,Inv,Node,PT 
7-input Age,Eth,Gen,Smo,Dri,Node,Tre 
*Group 1 - clinicopathologic variables only 
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Table 7.2: Feature Subset Selected for Group 2* 
Method  Feature Subset Selected 
GA  
3-input Inv,Node,p63 
4-input Gen,Inv,Size,p53 
5-input Age,PT,PN,Size,p53 
6-input Age,PT,PN,Size,Tre,p53 
7-input Age,Eth,Smo,PT,PN,Size,p53 
CC  
3-input Inv,PN,p63 
4-input Age,Inv,PN,p63 
5-input Age,Gen,Inv,PN,p63 
6-input Age,Gen,Inv,PN,Size,p63 
7-input Age,Gen,Inv,PN,Size,p53,p63 
ReliefF  
3-input Age,Eth,Dri 
4-input Age,Eth,Dri,Tre 
5-input Age,Eth,Dri,Tre,p53 
6-input Age,Eth,Dri,Tre,p53,p63 
7-input Age,Eth,Gen,Dri,Tre,p53,p63 
CC-GA  
3-input Inv,Node,p63 
4-input Gen,Inv,Size,p53 
5-input Age,Dri,PN,Size,p53 
6-input Gen,Inv,Node,PN,Size,p53 
7-input Gen,Dri,Inv,Node,PN,Size,p53 
ReliefF-GA  
3-input Dri,Inv,p63 
4-input Dri,Inv,Tre,p63 
5-input Age,Gen,Smo,Dri,p63 
6-input Age,Gen,Smo,Dri,Inv,p63 
7-input Age,Eth,Inv,Sta,Tre,p53,p63 
*Group 2 - clinicopathologic and genomic variables  
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Table 7.3: The Number of Times Feature is Selected  
(a) Group 1 
Features GA CC ReliefF 
CC-
GA 
ReliefF-
GA 
Age 2 5 4 1 1 
Eth 1 0 5 0 2 
Gen 2 4 2 3 5 
Smo 2 0 0 0 1 
Dri 2 1 5 3 4 
Chew 1 0 0 1 0 
Site 0 0 0 0 0 
Subtype 0 0 0 0 0 
Inv 3 5 0 3 4 
Node 2 0 0 2 5 
PT 2 0 1 2 2 
PN 4 5 0 5 0 
Sta 0 2 5 2 0 
Size 4 3 0 3 0 
Tre 0 0 3 0 1 
 
(b) Group 2 
Features GA CC ReliefF 
CC-
GA 
ReliefF-
GA 
Age 3 4 5 1 3 
Eth 1 0 5 0 1 
Gen 1 3 1 3 2 
Smo 1 0 0 0 2 
Dri 0 0 5 2 4 
Chew 0 0 0 0 0 
Site 0 0 0 0 0 
Subtype 0 0 0 0 0 
Inv 2 5 0 4 4 
Node 1 0 0 3 0 
PT 3 0 0 0 0 
PN 3 5 0 3 0 
Sta 0 0 0 0 1 
Size 4 2 0 4 0 
Tre 1 0 4 0 2 
p53 4 1 3 4 1 
p63 1 5 2 1 5 
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Table 7.4: Most selected features for feature selection methods 
Feature selection 
methods Group 1 Group 2 
GA Inv, PN, Size Age, PT, PN, Size, p53 
CC Age, Inv, PN Inv, PN, p63 
ReliefF Eth, Dri, Sta Age, Eth, Dri 
CC-GA Gen, Dri, Inv, PN, Size Inv, Size, p53 
ReliefF-GA Gen, Dri, Inv, Node Dri, Inv, p63 
 
7.3 ANFIS Classification Model 
The ANFIS model was implemented for both Group 1 and Group 2 for the n-input 
models generated from the five proposed feature selection methods.  The details for the 
proposed ANFIS model were provided in section 2.3.1 and section 6.4. The results 
obtained from the implementation of these models are given in Table 7.5 to Table 7.8. 
The results using data for Group 1 are shown in Table 7.5 and 7.6 while results of 
Group 2 are shown in Table 7.7 and 7.8.  
 
Table 7.5: Classification accuracy for ANFIS in Group 1 
Feature selection ANFIS 
Method 3-input 4-input 5-input 6-input 7-input 
GA 70.95 67.42 64.76 58.57 57.62 
CC 58.10 74.76 51.43 57.62 64.29 
ReliefF 61.43 50.59 58.10 64.29 64.29 
CC-GA 44.76 67.62 63.81 64.29 57.62 
ReliefF-GA 67.14 60.48 67.62 51.90 64.76 
 
Table 7.6: AUC for ANFIS in Group 1 
Feature selection ANFIS 
method 3-input 4-input 5-input 6-input 7-input 
GA 0.66 0.61 0.63 0.55 0.54 
CC 0.53 0.70 0.43 0.50 0.58 
ReliefF 0.53 0.50 0.50 0.54 0.54 
CC-GA 0.44 0.57 0.55 0.54 0.52 
ReliefF-GA 0.55 0.59 0.59 0.47 0.57 
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Table 7.7: Classification accuracy for ANFIS in Group 2  
Feature selection ANFIS 
method 3-input 4-input 5-input 6-input 7-input 
GA 74.76 67.62 41.90 58.57 35.71 
CC 58.10 58.10 51.90 48.57 61.90 
ReliefF 54.29 44.29 48.10 67.14 67.14 
CC-GA 74.76 70.48 54.76 61.43 64.29 
ReliefF-GA 93.81 93.81 65.71 64.76 68.10 
 
Table 7.8: AUC for ANFIS in Group 2 
Feature selection ANFIS 
method 3-input 4-input 5-input 6-input 7-input 
GA 0.74 0.70 0.40 0.58 0.36 
CC 0.48 0.52 0.48 0.46 0.59 
ReliefF 0.47 0.38 0.53 0.62 0.62 
CC-GA 0.70 0.71 0.57 0.61 0.65 
ReliefF-GA 0.90 0.90 0.63 0.62 0.67 
 
For Group 1, there are two models with the accuracy of more than 70%, these are 
namely, GA-3-input and CC-4-input model (as shown in Table 7.5). The model with the 
best accuracy is the CC-4-input with an accuracy of 74.76% and an AUC of 0.70 
(shown in Table 7.5 and 7.6). The features selected by this model are age, gender, 
invasion, and PN (refer Table 7.1).  
 
For Group 2 (Table 7.7 and 7.8), there are five models with a accuracy above 70%, 
these are namely, GA-3-input, CC-GA-3-input, CC-GA-4-input ReliefF-GA-3-input 
and ReliefF-GA-4-input. The best models are ReliefF-GA-3-input and ReliefF-GA-4-
input with the accuracy of 93.81% and AUC of 0.90 and the features selected for 
ReliefF-GA-3-input are drink, invasion, and p63 and features selected for ReliefF-GA-
4-input are drink, invasion, treatment and p63 (refer Table 7.2).  
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7.4 Other classification models 
In this section, the oral cancer dataset are tested using other classification models. Two 
AI methods which are artificial neural network (ANN) and support vector machine 
(SVM), and a statistical method which is logistic regression (LR) are selected and tested 
and the results are discussed and verified in section 7.5.  
 
7.4.1 Artificial Neural Network 
The artificial neural network (ANN) that was employed in this research is the feed 
forward (FF) neural network, which is the most common type of ANN. The FF neural 
network was trained using the Levenberg-Marquardt algorithm. In this research, one 
hidden layer with five neurons (achieved the best results) was used in the FF neural 
network and a 5-fold cross-validation was implemented on the dataset. The average 
classification accuracy and the area under ROC curve (AUC) for ten runs were taken. 
The results generated from the neural network experiments are shown in Table 7.9, and 
7.10 for Group 1 and Table 7.11 and 7.12 for Group 2 respectively.  
 
Table 7.9: Classification accuracy for feed forward neural network in Group 1 
Feature selection Feed Forward Neural Network** 
method 3-input 4-input 5-input 6-input 7-input 
GA 45.52 52.43 45.05 48.38 45.33 
CC 54.48 53.57 51.29 51.29 52.33 
ReliefF 51.52 41.62 46.05 46.05 44.10 
CC-GA 49.24 49.48 46.67 48.29 50.48 
ReliefF-GA 50.24 52.86 56.76 47.00 50.05 
** Average for 10 runs     
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Table 7.10: AUC for feed forward neural network in Group 1 
Feature selection Feed Forward Neural Network** 
method 3-input 4-input 5-input 6-input 7-input 
GA 0.53 0.53 0.47 0.52 0.50 
CC 0.61 0.59 0.58 0.51 0.53 
ReliefF 0.48 0.47 0.49 0.48 0.48 
CC-GA 0.51 0.52 0.49 0.49 0.51 
ReliefF-GA 0.55 0.59 0.58 0.51 0.54 
** Average for 10 runs     
 
Table 7.11: Classification accuracy for feed forward neural network in Group 2 
Feature selection Feed Forward Neural Network** 
method 3-input 4-input 5-input 6-input 7-input 
GA 45.14 51.48 45.81 46.14 47.71 
CC 46.24 49.38 46.14 57.38 55.48 
ReliefF 40.62 43.24 47.71 49.48 48.76 
CC-GA 49.38 53.90 47.05 44.76 55.19 
ReliefF-GA 84.62 73.38 48.00 51.57 45.86 
** Average for 10 runs     
 
Table 7.12: AUC for feed forward neural network in Group 2 
Feature selection Feed Forward Neural Network** 
method 3-input 4-input 5-input 6-input 7-input 
GA 0.50 0.55 0.49 0.50 0.51 
CC 0.46 0.49 0.50 0.58 0.57 
ReliefF 0.48 0.49 0.50 0.51 0.50 
CC-GA 0.52 0.60 0.52 0.48 0.57 
ReliefF-GA 0.83 0.75 0.52 0.53 0.47 
** Average for 10 runs     
 
None of the models from Group 1 achieved an accuracy above 70%. For Group 2, the 
FF neural network together with ReliefF-GA-3-input model achieved the best result at 
accuracy of 84.62% and an AUC of 0.83. Figure 7.1 shows the mean square error for 
the neural network training, testing and validation results. It shows that the best 
validation mean squared error (1.1822 x 10
-15
) was obtained after 4 epochs of training. 
Figure 7.2 shows the training regression for training, test and validation data for 
ReliefF-GA-3-input model. For a perfect fit, the data should fall along a 45 degree line, 
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where the network outputs are equal to the targets, with R = 1. For this experiment, the 
fit is reasonably good for all data sets, with R for training set = 0.86723, R for 
validation set = 1 and R for testing set = 0.99558. The R for all data sets is 0.91952.  
 
Figure 7.1: Mean Squared Error for ReliefF-GA-3-input model 
 
Figure 7.2: Training regression for ReliefF-GA-3-input model 
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7.4.2 Support Vector Machine  
The support vector machine (SVM) tool that was used is the LIBSVM. LIBSVM is a 
library for support vector machines and it is one of the most widely used SVM software 
(Chih-Chung, 2011). A 5-fold cross-validation was implemented on the dataset as well. 
The results are tabulated in Table 7.13 to Table 7.16 respectively.  
 
Table 7.13: Classification accuracy for SVM in Group 1 
Feature selection Support Vector Machines (SVM) 
method 3-input 4-input 5-input 6-input 7-input 
GA 60.95 61.43 58.10 58.10 61.43 
CC 60.95 60.95 58.10 51.43 51.43 
ReliefF 54.29 50.95 51.43 48.10 50.95 
CC-GA 63.81 61.43 58.10 58.10 58.10 
ReliefF-GA 64.29 64.29 64.29 64.29 54.76 
 
Table 7.14: AUC for SVM in Group 1 
Feature selection Support Vector Machines (SVM) 
method 3-input 4-input 5-input 6-input 7-input 
GA 0.53 0.51 0.48 0.46 0.49 
CC 0.53 0.53 0.46 0.41 0.41 
ReliefF 0.44 0.42 0.42 0.40 0.45 
CC-GA 0.55 0.51 0.46 0.48 0.49 
ReliefF-GA 0.50 0.50 0.50 0.50 0.46 
 
Table 7.15: Classification accuracy for SVM in Group 2 
Feature selection Support Vector Machines (SVM) 
method 3-input 4-input 5-input 6-input 7-input 
GA 74.76 54.76 70.95 60.95 50.95 
CC 64.76 64.76 64.76 67.62 67.62 
ReliefF 54.29 54.29 44.29 48.10 34.76 
CC-GA 74.76 54.76 61.43 58.10 61.43 
ReliefF-GA 74.76 71.43 74.76 74.43 54.76 
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Table 7.16: AUC for SVM in Group 2 
Feature selection Support Vector Machines (SVM) 
method 3-input 4-input 5-input 6-input 7-input 
GA 0.70 0.51 0.65 0.55 0.42 
CC 0.55 0.55 0.55 0.56 0.62 
ReliefF 0.44 0.44 0.36 0.46 0.28 
CC-GA 0.70 0.51 0.50 0.54 0.57 
ReliefF-GA 0.70 0.68 0.70 0.66 0.53 
 
Table 7.13 to Table 7.16 show that the classification results generated from SVM are 
generally better in Group 2 when compared to Group 1 with some exceptions. None of 
the model from Group 1 could achieve an accuracy above 70%. Whereas, there are 
seven models from Group 2 with an accuracy of above 70%, which are the GA-3-input, 
GA-5-input, CC-GA-3-input, ReliefF-GA-3-input, ReliefF-GA-4-input, ReliefF-GA-5-
input and ReliefF-GA-6-input. The best accuracy in Group 2 is obtained by the GA-3-
input, CC-GA-3-input, ReliefF-GA-3-input, and ReliefF-GA-5-input with an accuracy 
of 74.76% and an AUC of 0.70.  
 
7.4.3 Logistic Regression 
Logistic regression (LR) is selected as the benchmark test for the statistical method and 
the results are compared with the AI methods as discussed earlier. A 5-fold cross-
validation was implemented in the dataset and the results are tabulated in Table 7.17 to 
Table 7.20 respectively. 
 
Table 7.17: Classification accuracy for logistic regression in Group 1 
Feature selection Logistic Regression 
method 3-input 4-input 5-input 6-input 7-input 
GA 64.29 67.62 64.76 68.10 64.29 
CC 64.29 60.48 67.62 67.62 64.29 
ReliefF 50.59 50.59 48.10 41.43 44.29 
CC-GA 67.62 67.62 61.43 70.95 64.76 
ReliefF-GA 54.29 51.43 61.43 47.62 48.10 
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Table 7.18: AUC for logistic regression in Group 1 
Feature selection Logistic Regression 
method 3-input 4-input 5-input 6-input 7-input 
GA 0.56 0.60 0.55 0.64 0.60 
CC 0.56 0.57 0.61 0.61 0.58 
ReliefF 0.44 0.44 0.39 0.34 0.39 
CC-GA 0.57 0.60 0.51 0.73 0.67 
ReliefF-GA 0.54 0.52 0.62 0.55 0.51 
 
Table 7.19: Classification accuracy for logistic regression in Group 2 
Feature selection Logistic Regression 
method 3-input 4-input 5-input 6-input 7-input 
GA 74.76 63.81 67.14 54.76 54.29 
CC 71.43 71.43 61.43 68.10 61.43 
ReliefF 50.59 48.10 48.10 44.76 41.43 
CC-GA 74.76 63.81 60.48 64.29 60.48 
ReliefF-GA 74.76 74.76 71.43 58.10 61.43 
 
Table 7.20: AUC for logistic regression in Group 2 
Feature selection Logistic Regression 
method 3-input 4-input 5-input 6-input 7-input 
GA 0.70 0.64 0.57 0.43 0.47 
CC 0.67 0.67 0.59 0.65 0.59 
ReliefF 0.45 0.39 0.41 0.43 0.41 
CC-GA 0.70 0.64 0.61 0.63 0.54 
ReliefF-GA 0.70 0.70 0.68 0.55 0.60 
 
As in the other classification methods, the results from Group 2 are generally better than 
the results obtained in Group 1. Table 7.17 to Table 7.20 also show that the best 
accuracy is obtained by Group 1 at 70.95% and by CC-GA-6-input model. Whereas, for 
Group 2, GA-3-input, CC-GA-3-input, ReliefF-GA-3-input and ReliefF-GA-4-input 
achieved the best classification accuracy of 74.76% and the AUC of 0.70.  
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7.5  Discussion 
This section summarises and compares the results generated from different 
classification methods as discussed in section 7.4. Table 7.21 and Table 7.22 summarize 
the best accuracy for the n-input model based on the feature selection method for Group 
1 and Group 2. The summary is also depicted in the graph as shown in Figure 7.3 and 
Figure 7.4 respectively.  
 
Table 7.21: Best accuracy for n-input model based on  
feature selection method for Group 1 
 
Feature selection n-input model 
method 3-input 4-input 5-input 6-input 7-input 
GA 70.95 67.62 64.76 68.10 64.29 
CC 64.29 74.76 67.62 67.62 64.29 
ReliefF 61.43 50.59 58.10 64.29 64.29 
CC-GA 67.62 67.62 63.81 70.95 64.76 
ReliefF-GA 67.14 64.29 67.62 64.29 64.76 
 
Table 7.22: Best accuracy for n-input model based on  
feature selection method for Group 2 
 
Feature selection n-input model 
method 3-input 4-input 5-input 6-input 7-input 
GA 74.76 67.62 70.95 60.95 54.29 
CC 71.43 71.43 64.76 68.10 67.62 
ReliefF 54.29 54.29 48.10 67.14 67.14 
CC-GA 74.76 70.48 61.43 64.29 64.29 
ReliefF-GA 93.81 93.81 74.76 74.43 68.10 
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Figure 7.3: Graphs for best accuracy for n-input model based on feature selection 
method for Group 1 
 
 
Figure 7.4: Graphs for best accuracy for n-input model based on feature selection 
method for Group 2 
 
For Group 1 (Figure 7.3), the correlation coefficient (CC) feature selection method 
performed better than the other methods with the highest accuracy of 74.76% in 4-input 
model. There are three models that achieved accuracy of above 70%; the other two are 
GA-3-input and CC-GA-6-input (Table 7.21). ReliefF feature selection method obtained 
the worst results when compared to the other methods.  
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As regards to Group 2, the ReliefF-GA feature selection method outperformed the 
others in all n-input models, with the highest accuracy of 93.81%. There are ten models 
with an accuracy above 70% as shown in Table 7.22; this confirms that Group 2 which 
includes genomic variables achieved higher accuracy with feature selection methods. In 
addition, most of the models with higher accuracy are the lower input models with 3 or 
4-input only.  
 
Next, Table 7.23 and 7.24 lists the best accuracy by classification method and the 
graphs are depicted in Figure 7.5 and 7.6 for both Group 1 and Group 2.  
 
Table 7.23: Best accuracy by classification method for Group 1 
Feature selection Classification method 
method ANFIS ANN SVM LR 
GA 70.95 52.43 61.43 68.10 
CC 74.76 54.48 60.95 67.62 
ReliefF 64.29 51.52 54.29 50.59 
CC-GA 67.62 50.48 63.81 70.95 
ReliefF-GA 67.62 56.76 64.29 61.43 
 
Table 7.24: Best accuracy by classification method for Group 2 
Feature selection Classification method 
method ANFIS ANN SVM LR 
GA 74.76 51.48 74.76 74.76 
CC 61.90 57.38 67.62 71.43 
ReliefF 67.14 49.48 54.29 50.59 
CC-GA 74.76 55.19 74.76 74.76 
ReliefF-GA 93.81 84.62 74.76 74.76 
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Figure 7.5: Graphs for best accuracy by classification method for Group 1 
 
 
Figure 7.6: Graphs for best accuracy by classification method for Group 2 
 
From Figure 7.5, ANFIS performed the best in Group 1 for all types of feature selection 
methods except CC-GA method. All the classification methods except for the ANN 
performed worst in ReliefF feature selection method. ANN had the lowest accuracy rate 
if compared to other methods.  
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Whereas, in Group 2, ANFIS outperformed the others except in CC feature selection 
method. The best accuracy is achieved by ANFIS in ReliefF-GA method with the 
accuracy of 93.81%. All classification methods performed better in CC-GA and 
ReliefF-GA feature selection methods. As with Group 1, ANN had the lowest 
classification rate except in ReliefF-GA method. In overall, the performance of the 
classification method is better in Group 2 as compared to Group 1. Table 7.25 
summarises the best model with their selected features. 
 
Table 7.25: Best models with accuracy, AUC, classification method  
and selected features 
 
  Accuracy AUC 
Classification 
method Selected features 
Group 1         
CC-4-input 74.76 0.70 ANFIS Age,Gen,Inv,PN 
GA-3-input 70.95 0.66 ANFIS Gen,Smo,PN 
CC-GA-6-input 70.95 0.72 LR Gen,Dri,Node,PT,PN,Sta 
Group 2         
ReliefF-GA-3-input 93.81 0.90 ANFIS Dri,Inv,p63 
ReliefF-GA-4-input 93.81 0.90 ANFIS Dri,Inv,Tre,p63 
ReliefF-GA-3-input 84.62 0.83 ANN Dri,Inv,p63 
GA-3-input 74.76 0.74 ANFIS Inv,Node,p63 
CC-GA-3-input 74.76 0.70 ANFIS Inv,Node,p63 
CC-GA-3-input 74.76 0.70 SVM Inv,Node,p63 
CC-GA-3-input 74.76 0.70 LR Inv,Node,p63 
ReliefF-GA-3-input 74.76 0.70 SVM Dri,Inv,p63 
ReliefF-GA-3-input 74.76 0.70 LR Dri,Inv,p63 
Relief-GA-4-input 74.76 0.70 LR Dri,Inv,Tre,p63 
Relief-GA-5-input 74.76 0.70 SVM Age,Gen,Smo,Dri,p63 
Relief-GA-6-input 74.43 0.66 SVM Age,Gen,Smo,Dri,Inv,p63 
Relief-GA-4-input 73.38 0.75 ANN Dri,Inv,Tre,p63 
Relief-GA-4-input 71.43 0.68 SVM Dri,Inv,Tre,p63 
Relief-GA-5-input 71.43 0.68 LR Age,Gen,Smo,Dri,p63 
CC-3-input 71.43 0.67 LR Inv,PN,p63 
CC-4-input 71.43 0.67 LR Age,Inv,PN,p63 
CC-GA-4-input 70.48 0.71 ANFIS Gen,Inv,Size,p53 
 
From Table 7.25, the models with the highest accuracy are ReliefF-GA-3-input and 
ReliefF-GA-4-input from Group 2 with ANFIS classification, the accuracy is 93.81% 
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and AUC of 0.90. The features selected are Drink, Invasion and p63 and Drink, 
Invasion, Treatment, and p63 respectively. This is followed by the ReliefF-GA-3-input 
model from Group 2 with ANN classification, with the accuracy of 84.62% and AUC of 
0.83. Most of the best models are generated from the ReliefF-GA feature selection 
method; this proves that the features selected by this method are the optimum features 
for the oral cancer prognosis dataset.  
 
The results shown are in accordance with the objective of this research in which the 
classification performance is much better with the existence of genomic variables in 
Group 2. From the results in Table 7.25, the best feature selection method for oral 
cancer prognosis is ReliefF-GA with ANFIS classification. This proves that the ANFIS 
is the most optimum classification tool for oral cancer prognosis.  
 
Since there are two top models with the same accuracy, hence, the simpler one will be 
chosen, which is the ReliefF-GA-3-input model with ANFIS classification, and the 
optimum subset of features are Drink, Invasion and p63. These findings are in 
accordance with some previous studies which have proved that these features are 
important prognosis factor for oral cancer survival. Alcohol consumption has always 
been considered as a risk factor and one of the reasons for poor prognosis of oral cancer 
(Cordon et al., 2001; Jefferies & Foulkes, 2001; Leite, 1997; Reichart, 2001; Zain, 
2001).Walker et al., (2003) have shown that the depth of invasion is one of the most 
important predictors of lymph node metastasis in tongue cancer and in the different 
researches done by Asakage et al., (1998), Giacomarra et al., (1999), Morton et al., 
(1994), Williams et al., (1994), discovered a significant link between the depth of 
invasion and oral cancer survival. As regards to p63, Muzio, et al. (2005b) showed that 
p63 over expression associates with poor prognosis in oral cancer. In the next section, 
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the top best model, ReliefF-GA-3-input will be compared and validated with other 
permutation of 3-input features and also the full model. 
 
7.6  Significance Testing 
The significance test used in this research is the Kruskal-Wallis test. Kruskal-Wallis is a 
non-parametric test to compare samples from two or more groups and returns the p-
value. Non-parametric tests means the tests are not severely affected by changes in a 
small portion of the data. For this research, we want to test is there any statistical 
significant difference between the accuracy results generated for the 3-input model of 
Group 2 for five feature selection methods. Thus, the null hypothesis is set as: H0 = 
There is no difference between the results of the different feature selection models. If the 
p-value computed from the test is 0.05 or less, the H0 is rejected, which means there is a 
difference between the results of the different feature selection methods; if the p-value > 
0.05, the null hypothesis is accepted, which means there is no difference between the 
results of the different feature selection methods. The results and box-plots for the 
Kruskal-Wallis test are shown in Figure 7.7 and 7.8 respectively. Figure 7.7 is a 
standard ANOVA table, calculated using the ranks of the data rather than their numeric 
values. Ranks are found by ordering the data from smallest to largest across all groups, 
and taking the numeric index of this ordering. The entries in the ANOVA table are the 
sums of squares (SS), degrees of freedom (df), and mean square (MS) on the ranks. The 
chi-square statistic is used and the p-value measures the significance of the chi-square 
statistic. Figure 7.8 shows the box plots for each column of x (the value of x), in this 
case, the accuracy results by each type of feature selection methods.  
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The p-value (Prob>Chi-sq in Figure 7.7) that generated was 0.0312, which is less than 
0.05, this means the H0 is rejected and there is a significant difference between the 
feature selection methods. 
 
 
Figure 7.7: Kruskal-Wallis ANOVA table 
 
Figure 7.8:  Box plots for Kruskal-Wallis test 
 
 
 
GA CC ReliefF CC-GA ReliefF-GA
40
50
60
70
80
90
Chapter 7- Results and Discussions 
 
131 
 
7.7 Validation Testing  
In this section, the best model of ReliefF-GA-3-input model is compared with other 
models with a random permutation of three inputs and also compared with the model 
with most selected features as listed in Table 7.4. The purpose is to validate that the 
features selected by the ReliefF-GA method are the optimum subset for oral cancer 
prognosis. In addition, the full-input model (the model with all the 17 variables) will be 
tested as well in order to verify that the reduced model can achieve the same or better 
results than the full model. In this testing, the classification method used is ANFIS due 
to its best performance in the section 7.4 and the results are tabulated in Table 7.26. 
 
In Table 7.26, different permutation of the 3-input models are tested and classified using 
ANFIS. The three inputs are generated randomly and the best accuracy obtained is 
80.48% with an AUC of 0.70. The features selected are Drink, p53 and p63. With 
regards to the most selected features (refer to Table 7.4), the best result is achieved by 
the ReliefF-GA method with the accuracy of 93.81% and the AUC of 0.90 as shown in 
Table 7.26. The features selected are Drink, Invasion and p63, which are the same as the 
features selected by the ReliefF-GA-3-input model as shown in Table 7.2. This proved 
that the features selected using ReliefF-GA are the optimum features to oral cancer 
prognosis in this research.  
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Table 7.26: Validation test with random permutation of 3-input model, most selected 
features model and full input model for Group 2 
 
Models ANFIS 
  Accuracy (%) AUC 
Random permutation model   
Age, Inv, p63  64.76 0.63 
Eth, Dri, p53 57.14 0.49 
PT, PN, Sta 58.10 0.51 
Gen, Node, Tre 70.95 0.59 
Eth, Gen, Sub 39.05 0.32 
Dri, p53, p63 80.48 0.70 
Age, p53, p63 67.14 0.67 
Gen, Dri, Inv 54.76 0.55 
Site, Inv, Size 32.86 0.28 
Age, Chew, Size 48.10 0.41 
Smo, Site, PN 41.90 0.35 
PM, Size, Tre 61.43 0.52 
Sta, Size, p63 39.05 0.30 
Dri, PN, p53 67.62 0.60 
Model with most selected features   
Age, PT, PN, Size, p53 (GA) 44.76 0.42 
Inv, PN, p63 (CC) 58.10 0.48 
Age, Eth, Dri (ReliefF) 54.29 0.47 
Inv, Size, p53 (CC-GA) 74.29 0.75 
Dri, Inv, p63 (ReliefF-GA) 93.81 0.90 
Full model    
Full model with ANFIS N.A.* N.A.* 
Full model with NN 42.90 0.47 
Full model with SVM 54.76 0.46 
Full model with LR 54.76 0.59 
   
*N.A. - Results not available due to over-fitting problem as the  
rule-base generated was too large 
 
On the other hand, the full model with all the 17 variables is tested using different 
classification methods and the results are compared with the reduced model. The results 
of the full model are not promising and the results of full model using ANFIS cannot be 
generated due to the over-fitting problems as the rule base generated is too large.  
 
Finally, the selected features are tested on the oral cancer dataset for 1-year and 2-year 
with ANFIS classification and the results are very promising with an accuracy for 1-
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year prognosis of 93.33% and 2-year prognosis observed at 84.29%, the results are 
shown in Table 7.27.  
 
Table 7.27: Classification results for 1-year, 2-year and 3-year oral cancer prognosis 
Oral cancer prognosis Accuracy (%) AUC 
1-year  93.33 0.90 
2-year 84.29 0.77 
3-year 93.81 0.90 
 
7.8 Model Validation Study for Oral Cancer Clinicians 
Human experts' prediction ability in medical prognosis can never be replaced by any 
computerised tools/models. The purpose of developing such computerised tools/models 
is to provide aids in the prediction by combining the prognosis generated by the model 
with the clinician's own estimate of prognosis in order to improve the accuracy of 
prognosis. Thus, the validation study for the clinicians is necessary to further validate 
and assess the performance of such developed computerised models (Goddard et al. 
2011; Scott et al., 2011; Wyatt & Altman, 1995).  
 
A model validation study was carried out involving five (5) oral cancer clinicians from 
the Faculty of Dentistry, University of Malaya, Malaysia. The group of clinicians ranges 
from senior lecturers to professors.  
 
The objectives of this model validation study were: 
(i) To measure the prediction accuracy of human expert predictions. 
(ii) To measure the prediction consistency of human expert predictions. 
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The clinicians were asked to choose the most significant variables for oral cancer, to 
state whether the inclusion of the genomic markers would improve the accuracy of oral 
cancer prognosis and to make a 3-year prognosis for oral cancer based on the selected 
clinicopathologic variables. The form for the model validation study is attached in 
Appendix D.  
 
This validation study is divided into two sections, which are section A and section B. 
There are two questions in section A. In Question 1, the clinicians were required to 
choose four (4) most significant variables for oral cancer prognosis from the list of 
clinicopathologic variables given and rank the variables accordingly. As in question 2, 
the clinicians were asked to give their opinion whether the inclusion of the genomic 
markers would improve the accuracy of oral cancer prognosis or not. For section B, the 
clinicians were asked to indicate their prognosis based on the combination of 
clinicopathologic variables listed in the three models, which are Model 1, Model 2 and 
Model 3.  
 
7.8.1 Results and Analysis on the Model Validation Study for Oral Cancer 
 Clinicians 
(a)  Section A - Question 1 
 Four most significant clinicopathologic variables listed by the clinicians were 
summarised and weighted. More weightage was given to the variable with higher rank. 
For example, the variable ranked number one was given a weightage of "4", the variable 
ranked number two was given a weightage of "3" and so on. The results are shown as in 
Table 7.28 and Figure 7.9 respectively. Table 7.28 shows the number of oral cancer 
clinicians for each variable and weightage while Figure 7.9 shows the bar chart of total 
weightage for each variable.  
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Table 7.28: Number of oral cancer clinicians for each variable and weightage 
 Variables 
  
Weightage Total 
  4 3 2 1 
PN  2 2 0 0 14 
Stage  2 1 1 0 13 
Site 0 1 1 1 6 
Inv 0 0 2 2 6 
PT 1 0 0 1 5 
Size 0 1 0 0 3 
Treat 0 0 1 0 2 
Subtype 0 0 0 1 1 
 
 
Figure 7.9: Bar chart for Section A - Question 1 
 
From Figure 7.9, the top four most significant clinicopathologic variables chosen by the 
clinicians are PN, Stage, Inv and Site. Three out of these four variables, which are PN, 
Stage and Inv were selected as the most selected features for the feature selection 
methods as listed in Table 7.4. This finding shows that the developed feature selection 
methods were almost similar to the clinicians' selections on the clinicopathologic 
variables. 
 
(b) Section A - Question 2 
 All the clinicians agreed that the inclusion of genomic markers will help to 
improve the accuracy of oral cancer prognosis. However, all of the clinicians agreed 
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that currently there is no specific genomic marker yet for oral cancer prognosis and the 
results from different studies on genomic markers are varied, thus it makes genomic 
markers difficult to put in real cancer practice.  
 
(c) Section B 
 In this section, three models were selected and given to the clinicians for the 
prognosis. The models selected are the top three best models for Group 1 as listed in the 
Table 7.25, which are CC-4 input-ANFIS, GA-3 input-ANFIS and CC-GA-6 input-LR. 
Table 7.29 shows the information for these three models. 
Table 7.29: Information for the selected models 
 AI model in Group 1 Clinicopathologic Variables 
Model 1 GA-3-input-ANFIS Gen, Smo, PN 
Model 2 CC-4-input-ANFIS Age, Gen, Inv, PN 
Model 3 CC-GA-6-input-LR Gen, Dri, Nodes, PT, PN, Sta 
 
In this validation study, only models from Group 1 were selected, as clinicians never 
make prognosis based on the genomic markers. Currently, there is no genomic marker 
accepted as prognostic value in oral cancer as mentioned in the discussions in Section 
A- Question 2.  
 
Oral cancer clinicians' prognoses for the three models were measured. The accuracy, 
sensitivity, specificity and areas under receiver operating characteristic curve (AUC) of 
the oral cancer clinician prognosis are shown in Table 7.30 and the receiver operating 
characteristic (ROC) curve for the models are shown in Figure 7.10. Table 7.31 
compares the accuracy and AUC for the oral cancer clinician prognosis and the AI 
prognosis.  
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Table 7.30: Accuracy, sensitivity, specificity and AUC of oral cancer clinician 
prognosis 
 
Model Accuracy (%) Sensitivity (%) Specificity (%)  AUC 
Model 1 67.70 80.00 45.45 0.64 
Model 2 71.00 100.00 18.20 0.76 
Model 3 67.70 80.00 45.45 0.66 
 
 
Figure 7.10: Receiver operating characteristic (ROC) curves for the oral cancer clinician 
prognosis 
 
Table 7.31: Accuracy and AUC for oral cancer clinician prognosis and AI prognosis 
 
 
 
Model 
Oral cancer clinician 
prognosis 
AI prognosis 
Accuracy (%) AUC Accuracy (%) AUC 
Model 1 67.70 0.64 70.95 0.66 
Model 2 71.00 0.76 74.76 0.70 
Model 3 67.70 0.66 70.95 0.72 
 
From Table 7.30, the accuracy and AUC for both oral cancer clinician prognosis and AI 
prognosis are about the same. Model 2 has the best performance among the three, with 
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an accuracy of 71.00% and an AUC of 0.76 for oral cancer clinician prognosis, and an 
accuracy of 74.76%, AUC of 0.70 for AI prognosis. These findings proved that our AI 
prognoses are correct and that similar to the oral cancer clinicians' prognoses. It is hope 
that with the inclusion of genomic markers, the accuracy of oral cancer prognosis could 
be improved as shown in our best AI model (ReliefF-GA-3-input-ANFIS model) in 
Group 2, with the accuracy of 93.81% and AUC of 0.90 (as shown in Table 7.25).  
 
7.9 Summary  
This chapter discusses and compares the results generated using the proposed 5 feature 
selection methods and the ANFIS classification model. First, the feature selection 
methods are applied on the two groups of oral cancer dataset, which are Group 1 with 
clinicopathologic variables only and Group 2 with clinicopathological and genomic 
variables. For both groups, n-input models are selected, with n = 3, 4, 5, 6, 7 and the 
selected features are listed in Table 7.1 and 7.2 respectively. The most selected features 
for each feature selection methods are summarised in Table 7.4.  
 
Next, ANFIS classification model using the oral cancer prognosis dataset with features 
selected from the proposed feature selection methods is implemented. Two other AI 
classification methods, which are artificial neural network (ANN) and support vector 
machine (SVM) and one statistical method which is logistic regression (LR), are used to 
test and compare with the ANFIS model. All the classification experiments are 
performed on both Group 1 and Group 2.  
 
In summary, first, ANFIS outperformed the rest of the classification methods for both 
Group 1 and Group 2. Second, the performances of Group 2 are generally much better 
than those from Group 1. Third, the best model is the ReliefF-GA-3-input with ANFIS, 
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and the optimum feature subset selected is Drink, Invasion and p63. The optimum 
feature subset is validated with other random permutation of the 3-input model, the 
model with most selected features for each feature selection method, and the full model 
and it was shown that the model with the optimum feature subset achieved the highest 
accuracy. A validation study for oral cancer clinicians was conducted in order to 
validate the results obtained with the developed AI models and the oral cancer clinicians. 
The results showed that the prognoses by the oral cancer clinicians were similar to the 
prognoses from the developed AI models. 
 
In accordance with the aims of this chapter, we have shown that Group 2 with 
clinicopathologic and genomic variables performs better when compared to Group 1. 
Next, the optimum subset of features have been identified and verified, the key features 
for oral cancer prognosis are Drink, Invasion and p63. Lastly, the ANFIS classification 
model has been proved to be the optimum classification tool for oral cancer prognosis.  
 
The sample size of this research is very small, which is 31 samples only, this may not be 
sufficient for some researchers in the classification research. However, this is inevitable 
in the medical research, especially for oral cancer research in Malaysia where we do not 
have many samples and there are many medical confidentiality problems as discussed in 
Chapter 1. In order to overcome this problem, a re-sampling technique, which is the 
cross-validation, is implemented in the classification experiments.  
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CHAPTER 8 
 
Conclusion and Future Work 
 
8.1 Research Summary 
The overall aim of this research is to apply artificial intelligent (AI) techniques in oral 
cancer prognosis based on the clinicopathologic and genomic markers. To this end, a 
hybrid of AI oral cancer prognostic model with optimum feature subset has been 
developed and the end results are very promising. This section summarises the findings 
in the development of the oral cancer prognostic model in line with the research 
objectives.  
 
Chapter 4 explains the overview path of this research and all the methodologies used. 
There are five objectives for this research. First, is to identify the most common 
clinicopathologic markers and second, to analyse the genomic markers from the results 
of immunohistochemistry (IHC) staining. These are described in Chapter 5 where the 
methods, preparations and procedures for acquiring oral cancer prognosis data were 
discussed. Third, is to determine the optimum clinicopathologic and genomic markers 
for oral cancer prognosis using feature selection methods. The details of feature 
selection methods were discussed in Chapter 6 and the results and discussions were 
further discussed in Chapter 7. Fourth, is to develop a prognostic model for oral cancer 
prognosis using ANFIS techniques and to prove that the proposed model is the optimum 
tool for oral cancer prognosis. For this objective, ANFIS is proposed to cater for the 
needs of the small sample size and the results and comparisons with other techniques 
(artificial neural network, support vector machine and logistic regression) were 
discussed in Chapter 7. Lastly, is to prove that the prognostic results are more accurate 
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with the presence of both clinicopathologic and genomic markers, as discussed in 
Chapter 7.  
 
The clinicopathologic data used in this research are available from MOCDTBS at Oral 
Cancer Research and Coordinating Centre (OCRCC), Faculty of Dentistry, University 
of Malaya. With the help from the oral cancer experts from OCRCC, 15 
clinicopathologic variables were identified. As regards to the genomic data,  due to time, 
cost and medical tissues limitation, only two genomic variables were identified and used 
in this research, which are p53 and p63. 31 oral cancer cases were selected with the help 
from the staff of OCRCC and the tissues of the selected cases were prepared in the form 
of formalin-fixed paraffin embedded macroarray block (TMaA block). 
Immunohistochemistry (IHC) staining was performed on the selected tissues and the 
results of staining were analysed using the image analyser system. The results were 
categorised into two which are positive and negative staining, the tissue is considered 
positive if more than 10% of the nuclear is stained.  
 
Next, pre-processing methods were implemented on the oral cancer prognosis dataset 
with clinicopathologic and genomic variables.  Data cleansing, discretization and 
transformation were implemented on the selected dataset. The dataset was divided into 
two groups, with Group 1 (clinicopathologic variables) and Group 2 (clinicopathologic 
and genomic variables). 3-year prognostic data was used. Subsequently, feature 
selection methods were implemented with the objectives to reduce the number of input 
variables to avoid over-fitting and to find out an optimum feature subset for oral cancer 
prognosis. Five feature selection methods were implemented, which were genetic 
algorithm (GA), Pearson's correlation coefficient, Relief-F, hybrid CC-GA, and hybrid 
ReliefF-GA. The number of features selected was ranged from three to seven inputs (n-
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input model) and the selected features from each method were tested using the proposed 
ANFIS classification model.  
 
The proposed ANFIS classification model was proposed in order to classify whether the 
patients were alive or dead after subsequent years of diagnosis, in this case, 1-year to 3-
year. ANFIS is implemented on the n-input models generated from the five feature 
selection methods. Due to the small sample size, a re-sampling technique which was the 
k-fold cross-validation was used. The results generated from ANFIS were compared 
with other AI methods (Artificial neural network and support vector machine) and the 
statistical method of logistic regression. Furthermore, the ANFIS classification model 
was validated using different permutations of the n-input model, most selected features 
model, full input model and also used to classify for 1-year and 2-year oral cancer 
prognosis. The analyses and findings from the proposed oral cancer prognostic model 
are: 
 
(i) The performance of Group 2 (clinicopathologic and genomic variables) is better 
than Group 1 (clinicopathologic variables). This is in accordance with the 
objective of this research, which shows that the prognostic result is more 
accurate with the combination of clinicopathologic and genomic markers. 
(ii) The model with the best accuracy is the ReliefF-GA-3-input model with the 
ANFIS classification model and the Kruskal-Wallis test carried shows that the 
results from this model shows a significant difference as compared to the 3-input 
model of GA, CC, ReliefF and CC-GA. 
(iii) The optimum subset of features for oral cancer prognosis is drink, invasion and 
p63 and this finding is in accordance with similar studies in the literature. 
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(iv) The ANFIS classification model achieved the best accuracy in oral cancer 
prognosis when compared to artificial neural network, support vector machine 
and statistical method of logistic regression.  
(v) The prognostic result is more accurate with fewer inputs (reduced model) in 
comparison with the full model. 
(vi) The hybrid ReliefF-GA-ANFIS prognostic model performed well in 1-year and 
2-year oral cancer prognosis data.  
 
As a conclusion, the hybrid AI model of ReliefF-GA-ANFIS with 3-input features of 
drink, invasion and p63 achieved the best accuracy and is feasible to be used as an aid to 
clinicians for the prognosis of oral cancer.  
 
8.2 Research Constraints 
Medical informatics is a comparatively new research area in Malaysia, hence the 
medical databases that are available are very limited. This has limited the research 
activities in this area, as there are not enough medical samples or tissues available for 
the research experiments. Furthermore, most of the medical records available are kept in 
the hardcopy format (paper format), thus, it takes time to transform these data into the 
softcopy or computerised format.  
 
Limited medical samples/tissues is a constraint for the genomic data, this is the main 
reason for the small sample size of the medical data. Moreover, it is time consuming to 
prepare the medical samples/tissues for the purpose of genomic data, from cutting of the 
tissues during the surgery, preparation of the tissues in the lab, staining using specific 
reagents/antibody, and analysis of the staining results by the oral cancer experts. The 
whole process takes several weeks to several months depending on the number of 
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samples. Besides that, a high cost is needed in obtaining the genomic data, costs 
incurred in the purchasing of the testing equipments (microscope, software, camera, 
computer, etc.) and materials (reagents, antibody, etc.), payment and honorarium for the 
laboratory technicians and other costs.   
 
In this research, data for a maximum of 3-year prognosis was available. This is due to 
the incomplete records for cases of more than three years. For records of more than 3-
year, another one or two years are needed to obtain sufficient cases for the proposed 
prognostic model. Due to the time and cost limitation, only 1-year to 3-year survival are 
included in this research, and only two genomic data are selected, which are p53 and 
p63.  
 
8.3 Research Contributions 
The contribution of this research can be divided into four parts. First, it has been proven 
that the prognostic results are better with both clinicopathologic and genomic markers. 
This is supported by the research done by Catto et al., (2006), Exarchos et al. (2011), 
Futschik et al., (2003), Gevaert et al., (2006), Oliveira et al., (2008), Passaro et al., 
(2005), Seker et al., (2003), and Sun et al. (2007). 
 
Second, a hybrid feature selection model of ReliefF-GA was proposed as the feature 
selection method for oral cancer prognosis. This hybird model had shown to predict 
prognosis better than the full input model. Thus, the proposed ReliefF-GA is feasible to 
use as a feature selection method for other medical dataset as well, especially for those 
researches which utilize both clinicopathologic and genomic markers.  
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Third, a 3-input model with the features of drink, invasion and p63 had been identified 
as the optimum subset for oral cancer prognosis.  
 
Fourth, the proposed ANFIS classification model was found to have high classification 
ability when compared to artificial neural network, support vector machine and logistic 
regression. The results showed that the ANFIS prognostic model is suitable for small 
sample size data with the proposed optimum feature subset. This finding will help the 
clinicians and oral cancer experts in determining the prognosis/survival of oral cancer 
patients with very few markers. However, more tests and experiments needed to be 
done in order to further verify the results obtained in this research as discussed in the 
future work section of 8.4. Nevertheless, this finding provides a good foundation for 
future computer-based intelligent prognostic modelling especially at the local scenario.  
 
Fifth, through the identification of fewer markers for oral cancer prognosis, it is hoped 
that this will aid clinicians in carrying out prognostic procedures, and thus help them in 
making a more accurate prognosis in a shorter time at lower costs. Furthermore, the 
results of this research help patients and their family plan their future and lifestyle 
through a more reliable prognosis.  
 
8.4 Future Work 
This is the first research in Malaysia which implements AI techniques in oral cancer 
prognosis using both clinicopathologic and genomic data, the contributions of this 
research is discussed in section 8.3. However, there is still room for improvement for 
this research. Some suggestions for future work are listed below: 
(i) Increase the sample size of the dataset by providing more medical samples thus 
making it closer to the real population and improving the prediction accuracy.  
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(ii) Include more genomic markers such as EGFR, p16, CYP1A1, cyclin D1 and 
others as discussed in section 3.4.2.  
(iii)The validation exercise of the proposed model could be extended to other 
classifiers such as Bayesian approach, k-nearest neighbour algorithm, genetic 
algorithm, decision tree and hybrid AI models.  
(iv) Use other feature selection methods such as simulated annealing, information 
gain, gain ratio, decision tree, and others.  
(v) Use DNA microarray as the alternate source for the genomic data. A microarray 
is a tool containing samples of many genes that are arranged in a regular pattern 
in a small membrane or glass slide for the purpose of gene expression analysis. 
By using microarrays, researchers can get the expression levels of hundreds or 
thousands of genes in a single experiment, thus, reducing time and cost. 
 
8.5 Concluding Remarks 
As a summary, the proposed prognostic model with ReliefF-GA and ANFIS provides a 
computer-based intelligent approach to oral cancer prognosis using only three 
combinations of clinicopathologic and genomic markers. This prognostic model is 
feasible to aid the clinicians in the decision support stage and to identify the high risk 
markers to better predict the survival rate for each oral cancer patient. However, it is not 
recommended for clinical use yet as more tests and validations are needed to be done in 
order to further verify the results obtained in this research. Although the sample size is 
small, it is hoped that this research will set a stepping stone to embark more Malaysians 
in a similar research.  
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APPENDIX  
(a) Oral Cancer Prognosis Dataset 
No. Location Age Date of 1st diagnosis Ethnicity Gender Smoke 
1 TMaA 1-1,4-3 67 190706 INDIAN F No 
2 TMaA 1-1,2-7 73 181105 INDIAN F No 
3 TMaA 1-2,2-9 59 210704 CHINESE F Yes 
4 TMaA 1-2,2-8 60 70206 MALAY F  No 
5 TMaA 1-3,2-9 59 160106 INDIAN  F  No 
6 TMaA 1-8,4-2 59 70405 INDIAN F No 
7 TMaA 1-4,4-3 51 230106 INDIAN  F  No 
8 TMaA 1-5,2-7,2-10,3-2 48 310506 INDIAN F No 
9 TMaA 1-6,2-7,4-3 70 240804 INDIAN F No 
10 TMaA 1-7,4-1 55 61003 INDIAN M Yes 
11 TMaA 1-7,3-1,4-1 63 151003 INDIAN F No 
12 TMaA 1-8,3-1,4-2 64 291204 INDIAN F No 
13 TMaA 1-8,2-8,4-4 64 140105 INDIAN F No 
14 TMaA 3-1 70 10306 INDIAN  F No 
15 TMaA 3-2 71 310306 INDIAN  F No 
16 TMaA 1-2,3-2,4-1 66 30505 INDIAN F No 
17 TMaA 3-2 54 221204 MALAY M Yes 
18 TMaA 3-3 57 111006 INDIAN  F No 
19 TMaA 3-3 41 90804 MALAY M Yes 
20 TMaA 3-4 79 90404 INDIAN  F No 
21 TMaA 3-4,4-1 50 20904 INDIAN  F No 
22 TMaA 8-3A 48 280307 MALAY F  No 
23 TMaA 8-3A 66 Apr-04 CHINESE M No 
24 TMaA 1-6,4-2,8-5A 66 280104 INDIAN F No 
25 TMaA 8-5A 69 141107 INDIAN  F  No 
26 TMaA 1-4 48 140703 INDIAN M No 
27 TMaA 1-3 62 NA MALAY F No 
28 TMaA 2-9 48 201204 INDIAN F No 
29 TMaA 3-1 73 NA CHINESE M No 
30 TMaA 8-3a 58 250406 INDIAN  F  No 
31 TMaA 8-3a 64 51005 INDIAN M Yes 
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No. Drink Chew Site Diagnosis & Grading Invasion 
1 Yes Yes Buccal OSCC-Well Differentiated non cohesive 
2 No Yes Buccal 
OSCC- Moderately 
Differentiated non cohesive 
3 No No Buccal 
OSCC- Moderately 
Differentiated non cohesive 
4 No Yes Buccal 
OSCC- Moderately 
Differentiated non cohesive  
5 No Yes Buccal OSCC-Moderately Differentiated cohesive  
6 No Yes Others OSCC- Well  Differentiated non cohesive 
7 No Yes Buccal OSCC-Well Differentiated cohesive  
8 No Yes Buccal 
OSCC- Moderately 
Differentiated cohesive  
9 No Yes Buccal OSCC-moderately-differentiated non cohesive 
10 No Yes Buccal OSCC-moderately differentiated non cohesive  
11 No Yes Others OSCC-moderately differentiated non cohesive  
12 No Yes Others OSCC-well-differentiated non cohesive 
13 No Yes Others 
OSCC- Moderately 
Differentiated non cohesive  
14 No Yes Buccal OSCC-Well Differentiated non cohesive 
15 No Yes Buccal OSCC-Well Differentiated non cohesive 
16 No Yes Others OSCC-well-differentiated cohesive  
17 No No Others OSCC-well-differentiated non cohesive  
18 No Yes Floor OSCC-Well Differentiated Non cohesive 
19 No No Buccal OSCC-Moderate Differentiated Non cohesive  
20 Yes Yes Others OSCC-Well Differentiated Non cohesive  
21 No Yes Buccal 
OSCC- Moderately 
Differentiated Non cohesive  
22 No No Tongue OSCC-Moderately Differentiated Non cohesive  
23 Yes No Tongue OSCC-moderately-differentiated non cohesive 
24 No Yes Others OSCC-basaloid (mod-diff.) non cohesive  
25 Yes Yes Buccal OSCC-Moderately Differentiated non cohesive  
26 No Yes Buccal OSCC-Well Differentiated cohesive  
27 No Yes Buccal OSCC-Moderately Differentiated noncohesive 
28 Yes Yes Others OSCC-moderately-differentiated cohesive  
29 No Yes Floor OSCC-Moderately Differentiated Non-cohesive 
30 No Yes Tongue OSCC-Moderately Differentiated Non cohesive 
31 Yes No Floor OSCC-basaloid (mod-diff.) cohesive  
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No. Nodes PT PN Stage Size Treatment 
1 POSITIVE  T1 N2b IV >6 Surgery, post-op radiotherapy 
2 NEGATIVE T2 N0 II >4 – 6 Surgery, post-op radiotherapy 
3 NEGATIVE T2 N0 II >4 – 6 Surgery, post-op radiotherapy 
4 NEGATIVE T2 N0 II >2 – 4 
Surgery, post-op 
chemotherapy 
5 POSITIVE T2 N2b IV >2 – 4 Surgery, post-op radiotherapy 
6 NEGATIVE T1 N0 I 0 – 2 Surgery alone 
7 NEGATIVE T1 N0 I >6 Surgery alone 
8 NEGATIVE T4  N0 IV >4 – 6 Surgery, post-op radiotherapy 
9 NEGATIVE T3 N0 III >4 – 6 Surgery, post-op radiotherapy 
10 NEGATIVE T1 N0 I >2 – 4 Surgery alone 
11 POSITIVE T2 N2b IV >4 – 6 Surgery, post-op radiotherapy 
12 NEGATIVE T4 N0 IV >4 – 6 Surgery, post-op radiotherapy 
13 POSITIVE T4 N0 IV >2 – 4 Surgery, post-op radiotherapy 
14 POSITIVE T4 N2b IV >6 Pre-op radiotherapy, surgery 
15 POSITIVE T3 N2b IV >4 – 6 Surgery alone 
16 NEGATIVE T4 N0 IV >4 – 6 Surgery, post-op radiotherapy 
17 NEGATIVE T4 N0 IV >4 – 6 Surgery, post-op radiotherapy 
18 POSITIVE T3 N2a IV 0 – 2 Surgery alone 
19 POSITIVE T2 N2b IV 0 – 2 
Surgery, post-op 
chemotherapy 
20 POSITIVE T4 N0 IV >6 Surgery, post-op radiotherapy 
21 POSITIVE T4 N1 IV >6 Surgery, post-op radiotherapy 
22 NEGATIVE T3 N0 III >2 – 4 Surgery alone 
23 NEGATIVE T3 N0 III >2 – 4 Surgery, post-op radiotherapy 
24 POSITIVE T4 N2b IV >6 Surgery, post-op radiotherapy 
25 NEGATIVE T4 N0 IV 0 – 2 Surgery alone 
26 NEGATIVE 2 0 II 0 – 2 Surgery, post-op radiotherapy 
27 NEGATIVE 4 0 IV >4-6 Surgery + radiotheraphy 
28 POSITIVE 4 1 IV >4 – 6 
Surgery, post-op 
chemotherapy 
29 NEGATIVE 4 0 IV >4-6 Surgery + radiotherapy 
30 POSITIVE T3 2b IV 0 – 2 Surgery alone 
31 POSITIVE 4 1 IV >4 – 6 
Surgery, post-op 
chemotherapy 
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No. p53 p63 
1-year 
survival 
2-year 
survival 
3-year 
survival 
1 neg neg Survive Lost Lost 
2 neg pos Survive Survive Lost 
3 pos neg Survive Dead Dead 
4 neg pos Survive Dead Dead 
5 pos neg Survive Survive survive 
6 neg pos Survive Survive survive 
7 pos pos Survive Survive survive 
8 pos neg Survive Survive survive 
9 neg pos Survive Survive survive 
10 neg pos Survive Survive survive 
11 pos pos Survive Dead Dead 
12 pos neg Dead Dead Dead 
13 neg pos Survive Survive survive 
14 neg neg Dead Dead Dead 
15 neg neg Dead Dead Dead 
16 neg pos Survive Lost Lost 
17 neg pos Survive Survive survive 
18 neg neg Dead Dead Dead 
19 pos pos Survive Survive survive 
20 neg neg Survive Survive survive 
21 neg pos Survive Survive survive 
22 pos pos Survive Survive survive 
23 pos pos Survive Dead Dead 
24 neg pos Survive Survive survive 
25 neg pos Survive Dead Dead 
26 neg pos Survive Survive survive 
27 neg pos Survive Survive survive 
28 neg neg Survive Survive survive 
29 pos pos Survive Survive survive 
30 neg neg Survive Dead Dead 
31 pos pos Survive Survive Dead 
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(b) Categorization for Oral Cancer Prognosis Dataset  
 
Categorization for Oral Cancer Prognosis Dataset 
Feature Codes/Value Feature Codes/Value 
Gender 1 - Male Nodes 1 - Negative 
  2 - Female   2 - Positive 
Ethnicity 1 - Malay Subtype 1 - Well differentiated 
  2 - Chinese   2 - Moderate differentiated 
  3 - Indian   3 - Poorly differentiated 
Age 1 - 40-50 PT 1 - T1 
  2 - >50-60   2 - T2 
  3 - >60-70   3 - T3 
  4 - >70   4 - T4 
Smoke 1 - No PN 1 - N0 
  2 - Yes   2 - N1 
Drink 1 - No   3 - N2A 
  2 - Yes   4 - N2B 
Chew 1 - No Stage 1 - Stage I 
  2 - Yes   2 - Stage II 
Site 1 - Buccal mucosa   3 - Stage III 
  2 - Tongue   4 - Stage IV 
  3 - Floor Treatment 1 - Surgery only 
  4 - Others   2 - Surgery + Radiotherapy 
Size 1 - 0-2cm   
3 - Surgery + 
Chemotherapy 
  2 - >2-4cm p53 1-Nagative 
  3 - >4-6cm   2-Positive 
  4 - >6cm p63 1-Nagative 
Invasion 1 - Non-cohesive   2-Positive 
  2 - Cohesive Survive -1 - Survive 
  
  1 - Dead 
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(c) Membership functions for input variables 
 
 
Figure B1: Membership functions for input variable "Age" 
 
 
 
 
Figure B2: Membership functions for input variable "Eth" 
 
 
 
 
Figure B3: Membership functions for input variable "Gen" 
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Figure B4: Membership functions for input variable "Smoke" 
 
 
 
 
Figure B5: Membership functions for input variable "Drink" 
 
 
 
 
Figure B6: Membership functions for input variable "Chew" 
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Figure B7: Membership functions for input variable "Site" 
 
 
 
 
Figure B8: Membership functions for input variable "Size" 
 
 
 
 
Figure B9: Membership functions for input variable "Inv" 
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Figure B10: Membership functions for input variable "Node" 
 
 
 
 
Figure B11: Membership functions for input variable "Subtype" 
 
 
 
 
Figure B12: Membership functions for input variable "PT" 
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Figure B13: Membership functions for input variable "PN" 
 
 
 
 
Figure B14: Membership functions for input variable "Stage" 
 
 
 
Figure B15: Membership functions for input variable "Treat" 
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Figure B16: Membership functions for input variable "p53" 
 
 
 
 
Figure B17: Membership functions for input variable "p63" 
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(d) Model Validation Study for Oral Cancer Clinicians 
 
Introduction: 
 
Artificial intelligent (AI) techniques are becoming useful as an alternative approach to 
conventional medical diagnosis or prognosis. AI techniques are good for handling noisy 
and incomplete data, and significant results can be attained despite the small sample size.  
Various AI techniques have been applied in medical research such as artificial neural 
networks, fuzzy logic, genetic algorithm and other hybrid methods. The main aim of 
this research is to apply AI techniques in the prognosis of oral cancer based on the 
parameters of the correlation of clinicopathologic and genomic markers. To this end, a 
hybrid AI model for oral cancer prognosis is developed. In order to validate the 
developed AI prognostic model, a validation study which involved oral cancer 
clinicians is required.  
 
The objectives of this validation exercise were: 
(i) To measure the prediction accuracy of human expert predictions 
 
(ii) To measure the prediction consistency of human expert predictions 
 
 
Researcher: 
Chang Siow Wee 
Faculty of Computer Science and Information Technology 
University of Malaya 
Email: changsiowwee@yahoo.com , siowwee@um.edu.my 
H/P: 016-3852738 
 
Co-researcher: 
1. Assoc. Prof. Datin Dr. Sameem Abdul Kareem 
Faculty of Computer Science and Information Technology, UM. 
2. Assoc. Prof. Amir Feisal Merican Aljunid Merican 
Institute of Biological Science, Faculty of Science, UM. 
3. Prof. Rosnah Binti Mohd Zain 
Department of Oral Pathology and Oral Medicine and Periodontology,  
Oral Cancer Research and Coordinating Centre (OCRCC), Faculty of Dentistry, UM. 
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Instruction: Respondents are required to make a 3-year prognosis for oral cancer based 
on the selected variables. That is, clinicians are supposed to predict whether an 
individual is having poor prognosis or better prognosis. 
 
This exercise contains Sections A, and B. Please indicate your responses in the 
indicated space provided. 
 
Variable descriptions: 
 
Clinicopathologic variables:  
 
 Name Description 
1. Age Age at diagnosis 
2. Eth Ethnicity 
3. Gen Gender 
4. Smoke Smoking habit 
5. Drink Alcohol drinking habit 
6. Chew Quid chewing habit 
7. Site Primary site of tumor 
8. Subtype Subtype and differentiation for SCC 
9. Inv Pattern of Invasion front 
10. Node Neck nodes 
11. PT Pathological tumor staging 
12. PN Pathological lymph nodes 
13. Stage Overall stage 
14. Size Size of tumor 
15. Treat Type of treatment 
 
Section A 
 
1. From the list of clinicopathologic variables listed above, please choose: 
Four (4) most significant variables for oral cancer prognosis (Please rank 
accordingly) 
 
i. _________________ 
 
ii. _________________ 
 
iii. _________________ 
 
iv. _________________ 
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2. In your opinion, would the inclusion of the genomic markers improve the accuracy 
of oral cancer prognosis? 
 
Yes    No 
 
Comments/Reasons: 
___________________________________________________________________
___________________________________________________________________
___________________________________________________________________ 
 
 
Section B 
Model 1: Based on the combination of three (3) clinicopathologic variables below, 
please indicate your prognosis. 
 
Gender 
(Male/ 
Female) 
Smoking 
(Yes/No) 
PN 
(N0/N1/ 
N2A/N2B) 
3-year Prognosis  
(P=Poor prognosis/ 
B=Better prognosis) 
Female No N0  
Female No N1  
Female No N2A  
Female No N2B  
Female Yes N0  
Male No N0  
Male Yes N0  
Male Yes N1  
Male Yes N2B  
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Model 2: Based on the combination of four (4) clinicopathologic variables below, 
please indicate your prognosis. 
 
Age 
(40-50/ 
>50-60/ 
>60-70/ 
>70) 
Gender 
(Male/ 
Female) 
Pattern of 
Invasion 
(Non-
cohesive/cohesive) 
PN 
(N0/N1/ 
N2A/N2B) 
3-year Prognosis 
(P=Poor prognosis/ 
B=Better prognosis) 
40-50 Female Cohesive N0  
40-50 Female Non-cohesive N1  
40-50 Male Cohesive N0  
40-50 Male Non-cohesive N2B  
>50-60 Female Cohesive N0  
>50-60 Female Cohesive N2B  
>50-60 Female Non-cohesive N0  
>50-60 Female Non-cohesive N2A  
>50-60 Female Non-cohesive N2B  
>50-60 Male Non-cohesive N0  
>60-70 Female Cohesive N0  
>60-70 Female Non-cohesive N0  
>60-70 Female Non-cohesive N2B  
>60-70 Male Non-cohesive N0  
>60-70 Male Non-cohesive N1  
>70 Female Non-cohesive N0  
>70 Female Non-cohesive N2B  
>70 Male Non-cohesive N0  
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Model 3: Based on the combination of six (6) clinicopathologic variables below, please 
indicate your prognosis. 
 
Gender 
(Male/ 
Female) 
Drink 
(Yes/No) 
Nodes 
(Negative/
Positive) 
PT 
(T1/T2/ 
T3/T4) 
PN 
(N0/N1/ 
N2A/N2B) 
Stage 
(I/II/ 
III/IV) 
3-year 
Prognosis 
(P=Poor 
prognosis/ 
B=Better 
prognosis) 
Female No Negative T1 N0 I  
Female No Negative T2 N0 II  
Female No Negative T3 N0 III  
Female No Negative T4 N0 IV  
Female No Positive T2 N2b IV  
Female No Positive T3 N2a IV  
Female No Positive T3 N2b IV  
Female No Positive T4 N0 IV  
Female No Positive T4 N1 IV  
Female No Positive T4 N2b IV  
Female Yes Negative T4 N0 IV  
Female Yes Positive T1 N2b IV  
Female Yes Positive T4 N0 IV  
Female Yes Positive T4 N1 IV  
Male No Negative T1 N0 I  
Male No Negative T2 N0 II  
Male No Negative T4 N0 IV  
Male No Positive T2 N2b IV  
Male Yes Negative T3 N0 III  
Male Yes Positive T4 N1 IV  
 
 
~ The End ~ 
 
 
THANK YOU. 
 
